CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: benzoates
Accession: CHEBI:22718
browse the term
Definition: A monocarboxylic acid anion obtained by deprotonation of the carboxy group of any benzoic acid.
Synonyms: related_synonym: benzoate anion
alt_id: MESH:D001565
xref_mesh: MESH:D001565
G
Ahcy
adenosylhomocysteinase
decreases expression
ISO
Benzoates analog results in decreased expression of AHCY mRNA
CTD
PMID:29472718
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Ahr
aryl hydrocarbon receptor
decreases expression
ISO
Benzoates analog results in decreased expression of AHR mRNA
CTD
PMID:29472718
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Alcam
activated leukocyte cell adhesion molecule
decreases expression
ISO
Benzoates analog results in decreased expression of ALCAM mRNA
CTD
PMID:29472718
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Anxa4
annexin A4
decreases expression
ISO
Benzoates analog results in decreased expression of ANXA4 mRNA
CTD
PMID:29472718
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Batf3
basic leucine zipper ATF-like transcription factor 3
increases expression
ISO
Benzoates analog results in increased expression of BATF3 mRNA
CTD
PMID:29472718
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Benzoates analog results in decreased expression of BCL2 mRNA
CTD
PMID:29472718
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmp2
bone morphogenetic protein 2
decreases expression
ISO
Benzoates analog results in decreased expression of BMP2 mRNA
CTD
PMID:29472718
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Capg
capping actin protein, gelsolin like
decreases expression
ISO
Benzoates analog results in decreased expression of CAPG mRNA
CTD
PMID:29472718
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
G
Casp3
caspase 3
increases expression decreases expression
ISO
Benzoates analog results in increased expression of CASP3 protein modified form Benzoates analog results in decreased expression of CASP3 mRNA
CTD
PMID:29472718
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccnd2
cyclin D2
decreases expression
ISO
Benzoates analog results in decreased expression of CCND2 mRNA
CTD
PMID:29472718
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccnd3
cyclin D3
decreases expression
ISO
Benzoates analog results in decreased expression of CCND3 mRNA
CTD
PMID:29472718
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccne1
cyclin E1
decreases expression
ISO
Benzoates analog results in decreased expression of CCNE1 mRNA
CTD
PMID:29472718
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cd44
CD44 molecule
affects expression
ISO
Benzoates analog affects the expression of CD44 mRNA
CTD
PMID:29472718
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd48
Cd48 molecule
increases expression
ISO
Benzoates analog results in increased expression of CD48 mRNA
CTD
PMID:29472718
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd81
Cd81 molecule
decreases expression
ISO
Benzoates analog results in decreased expression of CD81 mRNA
CTD
PMID:29472718
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
G
Cdc42se2
CDC42 small effector 2
decreases expression
ISO
Benzoates analog results in decreased expression of CDC42SE2 mRNA
CTD
PMID:29472718
NCBI chr10:38,836,549...38,905,056
Ensembl chr10:38,836,555...38,905,059 Ensembl chr 1:38,836,555...38,905,059
G
Cdc6
cell division cycle 6
decreases expression
ISO
Benzoates analog results in decreased expression of CDC6 mRNA
CTD
PMID:29472718
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cish
cytokine inducible SH2-containing protein
increases expression
ISO
Benzoates analog results in increased expression of CISH mRNA
CTD
PMID:29472718
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Ckap4
cytoskeleton-associated protein 4
increases expression
ISO
Benzoates analog results in increased expression of CKAP4 mRNA
CTD
PMID:29472718
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
G
Csf1
colony stimulating factor 1
increases expression
ISO
Benzoates analog results in increased expression of CSF1 mRNA
CTD
PMID:29472718
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Cst7
cystatin F
increases expression
ISO
Benzoates analog results in increased expression of CST7 mRNA
CTD
PMID:29472718
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
G
Ctsz
cathepsin Z
increases expression
ISO
Benzoates analog results in increased expression of CTSZ mRNA
CTD
PMID:29472718
NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
Benzoates analog results in increased expression of CXCL10 mRNA
CTD
PMID:29472718
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression decreases expression
ISO
Benzoates results in increased expression of CXCL2 protein Benzoates results in decreased expression of CXCL2 protein
CTD
PMID:23178550
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cyfip1
cytoplasmic FMR1 interacting protein 1
decreases expression
ISO
Benzoates analog results in decreased expression of CYFIP1 mRNA
CTD
PMID:29472718
NCBI chr 1:106,710,924...106,799,393
Ensembl chr 1:106,711,016...106,799,386
G
Dcps
decapping enzyme, scavenger
decreases expression
ISO
Benzoates analog results in decreased expression of DCPS mRNA
CTD
PMID:29472718
NCBI chr 8:33,468,669...33,524,407
Ensembl chr 8:33,415,671...33,524,389
G
Dennd5a
DENN domain containing 5A
increases expression
ISO
Benzoates analog results in increased expression of DENND5A mRNA
CTD
PMID:29472718
NCBI chr 1:163,928,183...163,994,207
Ensembl chr 1:163,928,183...163,994,316
G
Dhrs3
dehydrogenase/reductase 3
decreases expression
ISO
Benzoates analog results in decreased expression of DHRS3 mRNA
CTD
PMID:29472718
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Ecm1
extracellular matrix protein 1
decreases expression
ISO
Benzoates analog results in decreased expression of ECM1 mRNA
CTD
PMID:29472718
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
G
Eef1akmt1
EEF1A lysine methyltransferase 1
decreases expression
ISO
Benzoates analog results in decreased expression of EEF1AKMT1 mRNA
CTD
PMID:29472718
NCBI chr15:31,694,284...31,711,367
Ensembl chr15:31,694,292...31,711,336
G
Emp1
epithelial membrane protein 1
increases expression
ISO
Benzoates analog results in increased expression of EMP1 mRNA
CTD
PMID:29472718
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
G
Esr1
estrogen receptor 1
increases activity
ISO
Benzoates results in increased activity of ESR1 protein
CTD
PMID:16756374
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Etv4
ETS variant transcription factor 4
decreases expression
ISO
Benzoates analog results in decreased expression of ETV4 mRNA
CTD
PMID:29472718
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
G
Fah
fumarylacetoacetate hydrolase
increases expression
ISO
Benzoates analog results in increased expression of FAH mRNA
CTD
PMID:29472718
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fgl2
fibrinogen-like 2
decreases expression
ISO
Benzoates analog results in decreased expression of FGL2 mRNA
CTD
PMID:29472718
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Flt3
Fms related receptor tyrosine kinase 3
increases response to substance
ISO
FLT3 protein mutant form results in increased susceptibility to Benzoates analog
CTD
PMID:29472718
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
ISO
Benzoates analog results in increased expression of GABARAPL1 mRNA
CTD
PMID:29472718
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
Benzoates analog results in increased expression of GADD45B mRNA
CTD
PMID:29472718
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Galm
galactose mutarotase
decreases expression
ISO
Benzoates analog results in decreased expression of GALM mRNA
CTD
PMID:29472718
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
G
Gbp4
guanylate binding protein 4
decreases expression
ISO
Benzoates analog results in decreased expression of GBP4 mRNA
CTD
PMID:29472718
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gh1
growth hormone 1
multiple interactions
ISO
Benzoates analog inhibits the reaction [GH protein promotes the reaction [STAT5A protein binds to STAT5A protein]]; Benzoates analog inhibits the reaction [GH protein results in increased phosphorylation of STAT5A protein]
CTD
PMID:29472718
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
multiple interactions
ISO
[INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein
CTD
PMID:2523799
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
Benzoates analog results in decreased expression of GPX4 mRNA
CTD
PMID:29472718
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
EXP
Benzoates analog binds to and results in decreased activity of GRIA1 protein
CTD
PMID:14667236
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
multiple interactions
EXP
Benzoates analog binds to and results in decreased activity of GRIA2 protein
CTD
PMID:14667236
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
multiple interactions
EXP
Benzoates analog binds to and results in decreased activity of GRIA3 protein
CTD
PMID:14667236
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Gria4
glutamate ionotropic receptor AMPA type subunit 4
multiple interactions
EXP
Benzoates analog binds to and results in decreased activity of GRIA4 protein
CTD
PMID:14667236
NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979
G
Grik1
glutamate ionotropic receptor kainate type subunit 1
multiple interactions
ISO
Benzoates analog binds to and results in decreased activity of GRIK1 protein
CTD
PMID:14667236
NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
multiple interactions
ISO
Benzoates analog binds to and results in decreased activity of GRIK2 protein
CTD
PMID:14667236
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
G
Gsto1
glutathione S-transferase omega 1
decreases expression
ISO
Benzoates analog results in decreased expression of GSTO1 mRNA
CTD
PMID:29472718
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Hk2
hexokinase 2
decreases expression
ISO
Benzoates analog results in decreased expression of HK2 mRNA
CTD
PMID:29472718
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Ifitm3
interferon induced transmembrane protein 3
decreases expression
ISO
Benzoates analog results in decreased expression of IFITM3 mRNA
CTD
PMID:29472718
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifngr1
interferon gamma receptor 1
increases expression
ISO
Benzoates analog results in increased expression of IFNGR1 mRNA
CTD
PMID:29472718
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il10ra
interleukin 10 receptor subunit alpha
decreases expression
ISO
Benzoates analog results in decreased expression of IL10RA mRNA
CTD
PMID:29472718
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
G
Il1a
interleukin 1 alpha
increases expression
ISO
Benzoates results in increased expression of IL1A protein
CTD
PMID:23178550
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il2rb
interleukin 2 receptor subunit beta
increases expression
ISO
Benzoates analog results in increased expression of IL2RB mRNA
CTD
PMID:29472718
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il3
interleukin 3
multiple interactions
ISO
Benzoates analog inhibits the reaction [IL3 protein results in increased activity of STAT5A protein]
CTD
PMID:29472718
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4r
interleukin 4 receptor
decreases expression
ISO
Benzoates analog results in decreased expression of IL4R mRNA
CTD
PMID:29472718
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
multiple interactions
ISO
Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein]
CTD
PMID:29472718
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
ISO
[INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein
CTD
PMID:2523799
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Irf4
interferon regulatory factor 4
decreases expression
ISO
Benzoates analog results in decreased expression of IRF4 mRNA
CTD
PMID:29472718
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irf8
interferon regulatory factor 8
decreases expression
ISO
Benzoates analog results in decreased expression of IRF8 mRNA
CTD
PMID:29472718
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Itga6
integrin subunit alpha 6
decreases expression
ISO
Benzoates analog results in decreased expression of ITGA6 mRNA
CTD
PMID:29472718
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Klf6
KLF transcription factor 6
increases expression
ISO
Benzoates analog results in increased expression of KLF6 mRNA
CTD
PMID:29472718
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Lif
LIF, interleukin 6 family cytokine
decreases expression
ISO
Benzoates analog results in decreased expression of LIF mRNA
CTD
PMID:29472718
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
Benzoates analog results in increased expression of MAP3K8 mRNA
CTD
PMID:29472718
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapkapk2
MAPK activated protein kinase 2
decreases expression
ISO
Benzoates analog results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:29472718
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
Benzoates analog results in decreased expression of MKI67 protein
CTD
PMID:29472718
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mxd1
max dimerization protein 1
increases expression
ISO
Benzoates analog results in increased expression of MXD1 mRNA
CTD
PMID:29472718
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
Benzoates analog results in decreased expression of MYC mRNA
CTD
PMID:29472718
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myo1c
myosin 1C
affects expression
ISO
Benzoates analog affects the expression of MYO1C mRNA
CTD
PMID:29472718
NCBI chr10:60,498,372...60,520,752
Ensembl chr10:60,498,280...60,520,752
G
Ncoa3
nuclear receptor coactivator 3
increases expression
ISO
Benzoates analog results in increased expression of NCOA3 mRNA
CTD
PMID:29472718
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
G
Ncs1
neuronal calcium sensor 1
decreases expression
ISO
Benzoates analog results in decreased expression of NCS1 mRNA
CTD
PMID:29472718
NCBI chr 3:14,523,220...14,568,829
Ensembl chr 3:14,523,220...14,568,829
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
Benzoates analog results in increased expression of NDRG1 mRNA
CTD
PMID:29472718
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
ISO
Benzoates analog results in increased expression of NFIL3 mRNA
CTD
PMID:29472718
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkbiz
NFKB inhibitor zeta
increases expression
ISO
Benzoates analog results in increased expression of NFKBIZ mRNA
CTD
PMID:29472718
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nop2
NOP2 nucleolar protein
decreases expression
ISO
Benzoates analog results in decreased expression of NOP2 mRNA
CTD
PMID:29472718
NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459
G
Odc1
ornithine decarboxylase 1
decreases expression
ISO
Benzoates analog results in decreased expression of ODC1 mRNA
CTD
PMID:29472718
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
P2rx4
purinergic receptor P2X 4
increases expression
ISO
Benzoates analog results in increased expression of P2RX4 mRNA
CTD
PMID:29472718
NCBI chr12:33,844,609...33,862,265
Ensembl chr12:33,844,396...33,862,253
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
increases expression
ISO
Benzoates analog results in increased expression of P4HA1 mRNA
CTD
PMID:29472718
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Benzoates analog results in increased cleavage of PARP1 protein
CTD
PMID:29472718
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdgfrb
platelet derived growth factor receptor beta
decreases expression
ISO
Benzoates analog results in decreased expression of PDGFRB protein
CTD
PMID:29472718
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Phlda1
pleckstrin homology-like domain, family A, member 1
decreases expression
ISO
Benzoates analog results in decreased expression of PHLDA1 mRNA
CTD
PMID:29472718
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phtf2
putative homeodomain transcription factor 2
decreases expression
ISO
Benzoates analog results in decreased expression of PHTF2 mRNA
CTD
PMID:29472718
NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
decreases expression
ISO
Benzoates analog results in decreased expression of PIM1 mRNA
CTD
PMID:29472718
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Plin2
perilipin 2
increases expression
ISO
Benzoates analog results in increased expression of PLIN2 mRNA
CTD
PMID:29472718
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plscr1
phospholipid scramblase 1
increases expression
ISO
Benzoates analog results in increased expression of PLSCR1 mRNA
CTD
PMID:29472718
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
G
Pnp
purine nucleoside phosphorylase
decreases expression
ISO
Benzoates analog results in decreased expression of PNP mRNA
CTD
PMID:29472718
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Prnp
prion protein
increases expression
ISO
Benzoates analog results in increased expression of PRNP mRNA
CTD
PMID:29472718
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Ptch1
patched 1
increases expression
ISO
Benzoates analog results in increased expression of PTCH1 mRNA
CTD
PMID:29472718
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
G
Ptrh2
peptidyl-tRNA hydrolase 2
decreases expression
ISO
Benzoates analog results in decreased expression of PTRH2 mRNA
CTD
PMID:29472718
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
G
Pus1
pseudouridine synthase 1
decreases expression
ISO
Benzoates analog results in decreased expression of PUS1 mRNA
CTD
PMID:29472718
NCBI chr12:45,880,364...45,889,196
Ensembl chr12:45,880,440...45,889,196
G
Rabgap1l
RAB GTPase activating protein 1-like
increases expression
ISO
Benzoates analog results in increased expression of RABGAP1L mRNA
CTD
PMID:29472718
NCBI chr13:72,464,114...73,059,845
Ensembl chr13:72,468,110...73,059,984
G
Rgs16
regulator of G-protein signaling 16
affects expression
ISO
Benzoates analog affects the expression of RGS16 mRNA
CTD
PMID:29472718
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rhoh
ras homolog family member H
increases expression
ISO
Benzoates analog results in increased expression of RHOH mRNA
CTD
PMID:29472718
NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,337,751...42,386,369
G
Rragd
Ras-related GTP binding D
increases expression
ISO
Benzoates analog results in increased expression of RRAGD mRNA
CTD
PMID:29472718
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
G
Sh3bgrl2
SH3 domain binding glutamate-rich protein like 2
increases expression
ISO
Benzoates analog results in increased expression of SH3BGRL2 mRNA
CTD
PMID:29472718
NCBI chr 8:84,461,019...84,553,124
Ensembl chr 8:84,461,121...84,551,564
G
Slc1a5
solute carrier family 1 member 5
increases expression
ISO
Benzoates analog results in increased expression of SLC1A5 mRNA
CTD
PMID:29472718
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
Benzoates analog results in increased expression of SLC2A3 mRNA
CTD
PMID:29472718
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc39a8
solute carrier family 39 member 8
decreases expression
ISO
Benzoates analog results in decreased expression of SLC39A8 mRNA
CTD
PMID:29472718
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
increases expression
ISO
Benzoates analog results in increased expression of SMPDL3A mRNA
CTD
PMID:29472718
NCBI chr20:37,132,592...37,155,567
Ensembl chr20:37,132,592...37,155,567
G
Snx9
sorting nexin 9
increases expression
ISO
Benzoates analog results in increased expression of SNX9 mRNA
CTD
PMID:29472718
NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036
G
Socs2
suppressor of cytokine signaling 2
increases expression
ISO
Benzoates analog results in increased expression of SOCS2 mRNA
CTD
PMID:29472718
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Spred2
sprouty-related, EVH1 domain containing 2
decreases expression
ISO
Benzoates analog results in decreased expression of SPRED2 mRNA
CTD
PMID:29472718
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
G
St3gal4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
affects expression
ISO
Benzoates analog affects the expression of ST3GAL4 mRNA
CTD
PMID:29472718
NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:33,415,671...33,524,389
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein]
CTD
PMID:29472718
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
decreases phosphorylation multiple interactions
ISO
Benzoates analog results in decreased phosphorylation of STAT5A protein Benzoates analog inhibits the reaction [GH protein promotes the reaction [STAT5A protein binds to STAT5A protein]]; Benzoates analog inhibits the reaction [GH protein results in increased phosphorylation of STAT5A protein]; Benzoates analog inhibits the reaction [IL3 protein results in increased activity of STAT5A protein]
CTD
PMID:29472718
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat5b
signal transducer and activator of transcription 5B
multiple interactions
ISO
Benzoates analog binds to and results in decreased phosphorylation of STAT5B protein
CTD
PMID:29472718
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
G
Swap70
switching B-cell complex subunit SWAP70
increases expression
ISO
Benzoates analog results in increased expression of SWAP70 mRNA
CTD
PMID:29472718
NCBI chr 1:164,267,588...164,328,796
Ensembl chr 1:164,267,609...164,328,794
G
Syt11
synaptotagmin 11
increases expression
ISO
Benzoates analog results in increased expression of SYT11 mRNA
CTD
PMID:29472718
NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964
G
Tgm2
transglutaminase 2
decreases expression
ISO
Benzoates analog results in decreased expression of TGM2 mRNA
CTD
PMID:29472718
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Tiam1
TIAM Rac1 associated GEF 1
decreases expression
ISO
Benzoates analog results in decreased expression of TIAM1 mRNA
CTD
PMID:29472718
NCBI chr11:29,031,347...29,380,153
Ensembl chr11:29,031,348...29,159,901
G
Tnfrsf1b
TNF receptor superfamily member 1B
decreases expression
ISO
Benzoates analog results in decreased expression of TNFRSF1B mRNA
CTD
PMID:29472718
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfrsf21
TNF receptor superfamily member 21
decreases expression
ISO
Benzoates analog results in decreased expression of TNFRSF21 mRNA
CTD
PMID:29472718
NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
Benzoates analog results in increased expression of TRAF1 mRNA
CTD
PMID:29472718
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Ttc39b
tetratricopeptide repeat domain 39B
increases expression
ISO
Benzoates analog results in increased expression of TTC39B mRNA
CTD
PMID:29472718
NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270
G
Uck2
uridine-cytidine kinase 2
decreases expression
ISO
Benzoates analog results in decreased expression of UCK2 mRNA
CTD
PMID:29472718
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
G
Umps
uridine monophosphate synthetase
decreases expression
ISO
Benzoates analog results in decreased expression of UMPS mRNA
CTD
PMID:29472718
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Xbp1
X-box binding protein 1
increases expression
ISO
Benzoates analog results in increased expression of XBP1 mRNA
CTD
PMID:29472718
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Epas1
endothelial PAS domain protein 1
increases expression multiple interactions
ISO
3,4-dihydroxybenzoate results in increased expression of EPAS1 mRNA [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of EPAS1 mRNA
CTD
PMID:19679656
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression affects localization multiple interactions
ISO EXP
3,4-dihydroxybenzoate results in increased expression of HIF1A mRNA 3,4-dihydroxybenzoate affects the localization of HIF1A protein [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite] affects the localization of HIF1A protein [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HIF1A mRNA
CTD
PMID:19679656
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 mRNA; [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 protein 3,4-dihydroxybenzoate results in increased expression of HMOX1 mRNA; 3,4-dihydroxybenzoate results in increased expression of HMOX1 protein
CTD
PMID:19679656
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Slc40a1
solute carrier family 40 member 1
multiple interactions
ISO
3,4-dihydroxybenzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC40A1 protein]
CTD
PMID:19679656
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SOD2 protein 3,4-dihydroxybenzoate results in increased expression of SOD2 protein
CTD
PMID:19679656
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Eosine Yellowish-(YS) inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases activity
ISO
Erythrosine results in decreased activity of ABCB1 protein
CTD
PMID:20041016
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Casp9
caspase 9
multiple interactions
EXP
[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA
CTD
PMID:32981412
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccnd1
cyclin D1
increases expression
ISO
Erythrosine results in increased expression of CCND1 protein
CTD
PMID:8927716
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdk2
cyclin dependent kinase 2
increases activity
ISO
Erythrosine results in increased activity of CDK2 protein
CTD
PMID:8927716 PMID:9168006
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
EXP
Erythrosine results in decreased activity of CYP19A1 protein
CTD
PMID:18310892
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
Erythrosine results in decreased activity of CYP3A4 protein
CTD
PMID:20041016
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
Erythrosine results in increased expression of FOSL1 protein
CTD
PMID:20025956
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Erythrosine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA
CTD
PMID:32981412
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hpgds
hematopoietic prostaglandin D synthase
decreases activity
ISO
Erythrosine results in decreased activity of HPGDS protein
CTD
PMID:25603235
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
G
Iyd
iodotyrosine deiodinase
decreases activity
ISO
Erythrosine results in decreased activity of IYD protein
CTD
PMID:24012475
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Erythrosine results in increased expression of JUN protein
CTD
PMID:20025956
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Orm1
orosomucoid 1
increases expression
ISO
Erythrosine results in increased expression of ORM1 protein
CTD
PMID:20025956
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Phex
phosphate regulating endopeptidase X-linked
increases expression
ISO
Erythrosine results in increased expression of PHEX protein
CTD
PMID:20025956
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA
CTD
PMID:32981412
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases activity
ISO
Erythrosine results in increased activity of TP53 protein
CTD
PMID:9168006
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trh
thyrotropin releasing hormone
multiple interactions
EXP
Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein]
CTD
PMID:2160137
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions
EXP
Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein]
CTD
PMID:2160137
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases activity
ISO
Erythrosine results in decreased activity of UGT1A6 protein
CTD
PMID:20041016
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
decreases activity
ISO
Erythrosine results in decreased activity of UGT2B7 protein
CTD
PMID:20041016
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
Erythrosine results in increased expression of VEGFA protein
CTD
PMID:20025956
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Car2
carbonic anhydrase 2
decreases activity
ISO
Merbromin results in decreased activity of CA2 protein
CTD
PMID:16858005
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Merbromin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Ache
acetylcholinesterase
decreases activity
ISO
physostigmine salicylate results in decreased activity of ACHE protein
CTD
PMID:623676
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ache
acetylcholinesterase
multiple interactions increases activity
EXP
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased activity of ACHE protein]
CTD
PMID:35187746
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
CTD
PMID:19860415
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
EXP
Sodium Benzoate promotes the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein]
CTD
PMID:17609678
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
multiple interactions increases expression increases activity
ISO EXP
Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein] Sodium Benzoate results in increased expression of CASP3 protein Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of CASP3 protein] Sodium Benzoate results in increased activity of CASP3 protein
CTD
PMID:11329530 PMID:32911041 PMID:35187746
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]
CTD
PMID:12540492
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases activity multiple interactions
EXP
Sodium Benzoate results in decreased activity of CAT protein Ascorbic Acid inhibits the reaction [Sodium Benzoate results in decreased activity of CAT protein]
CTD
PMID:32911041 PMID:35187746
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
CTD
PMID:19860415
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dao
D-amino-acid oxidase
multiple interactions decreases activity
ISO EXP
Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] Sodium Benzoate results in decreased activity of DAO protein
CTD
PMID:19860415 PMID:20952482
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
G
Esr1
estrogen receptor 1
decreases activity
ISO
Sodium Benzoate results in decreased activity of ESR1 protein
CTD
PMID:22562034
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fshb
follicle stimulating hormone subunit beta
increases expression
EXP
Sodium Benzoate results in increased expression of FSHB protein
CTD
PMID:32911041
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Ifng
interferon gamma
multiple interactions
ISO EXP
Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein] [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IFNG mRNA
CTD
PMID:26706697 PMID:32179172
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
multiple interactions
EXP
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL10 mRNA
CTD
PMID:32179172
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
EXP
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL1B mRNA
CTD
PMID:32179172
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions increases expression
ISO EXP
Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL6 mRNA Sodium Benzoate results in increased expression of IL6 protein
CTD
PMID:26706697 PMID:32179172 PMID:32911041
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lhb
luteinizing hormone subunit beta
increases expression
EXP
Sodium Benzoate results in increased expression of LHB protein
CTD
PMID:32911041
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Msr1
macrophage scavenger receptor 1
multiple interactions
ISO
Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form]; Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]
CTD
PMID:9614211
NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676
G
Otc
ornithine transcarbamylase
multiple interactions
ISO
Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Glycine]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Serotonin]; Sodium Benzoate affects the reaction [OTC gene mutant form results in increased abundance of Ammonium Compounds]
CTD
PMID:3091026 PMID:3374991
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
Tfam
transcription factor A, mitochondrial
increases expression
EXP
Sodium Benzoate results in increased expression of TFAM protein
CTD
PMID:32911041
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of TNF mRNA; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of TNF protein]
CTD
PMID:26706697 PMID:32179172 PMID:32911041 PMID:35187746
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO EXP
Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA] Sodium Benzoate results in increased expression of TP53 protein
CTD
PMID:16357363 PMID:32911041
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ucp2
uncoupling protein 2
increases expression
EXP
Sodium Benzoate results in increased expression of UCP2 protein
CTD
PMID:32911041
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Xdh
xanthine dehydrogenase
increases activity
EXP
Sodium Benzoate results in increased activity of XDH protein
CTD
PMID:32911041
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Abhd17b
abhydrolase domain containing 17B, depalmitoylase
increases expression
ISO
Thimerosal results in increased expression of ABHD17B mRNA
CTD
PMID:27188386
NCBI chr 1:219,198,294...219,232,733
Ensembl chr 1:219,198,471...219,231,933
G
Abtb3
ankyrin repeat and BTB domain containing 3
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA
CTD
PMID:27188386
NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834
G
Acacb
acetyl-CoA carboxylase beta
decreases expression
ISO
Thimerosal results in decreased expression of ACACB mRNA
CTD
PMID:27188386
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression
ISO
Thimerosal results in increased expression of ACSL4 mRNA
CTD
PMID:27188386
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Actmap
actin maturation protease
decreases expression
ISO
Thimerosal results in decreased expression of ACTMAP mRNA
CTD
PMID:27188386
NCBI chr 1:82,490,313...82,499,841
Ensembl chr 1:82,490,363...82,499,841
G
Actr2
actin related protein 2
decreases expression
ISO
Thimerosal results in decreased expression of ACTR2 mRNA
CTD
PMID:27188386
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
G
Adcy7
adenylate cyclase 7
decreases expression
ISO
Thimerosal results in decreased expression of ADCY7 mRNA
CTD
PMID:27188386
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Adgrb2
adhesion G protein-coupled receptor B2
decreases expression
ISO
Thimerosal results in decreased expression of ADGRB2 mRNA
CTD
PMID:24675092
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
G
Adgrl3
adhesion G protein-coupled receptor L3
increases expression
ISO
Thimerosal results in increased expression of ADGRL3 mRNA
CTD
PMID:27188386
NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860
G
Adgrv1
adhesion G protein-coupled receptor V1
increases expression
ISO
Thimerosal results in increased expression of ADGRV1 mRNA
CTD
PMID:27188386
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adm
adrenomedullin
decreases expression
ISO
Thimerosal results in decreased expression of ADM mRNA
CTD
PMID:27188386
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adss1
adenylosuccinate synthase 1
decreases expression
ISO
Thimerosal results in decreased expression of ADSS1 mRNA
CTD
PMID:27188386
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
G
Afap1l1
actin filament associated protein 1-like 1
decreases expression
ISO
Thimerosal results in decreased expression of AFAP1L1 mRNA
CTD
PMID:27188386
NCBI chr18:55,183,786...55,244,174
Ensembl chr18:55,183,786...55,244,146
G
Aff4
ALF transcription elongation factor 4
decreases expression
ISO
Thimerosal results in decreased expression of AFF4 mRNA
CTD
PMID:27188386
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
G
Agbl5
AGBL carboxypeptidase 5
decreases expression
ISO
Thimerosal results in decreased expression of AGBL5 mRNA
CTD
PMID:27188386
NCBI chr 6:25,472,333...25,492,173
Ensembl chr 6:25,472,333...25,490,738
G
Agfg1
ArfGAP with FG repeats 1
decreases expression
ISO
Thimerosal results in decreased expression of AGFG1 mRNA
CTD
PMID:27188386
NCBI chr 9:84,124,845...84,182,615
Ensembl chr 9:84,125,120...84,178,128
G
Ago1
argonaute RISC component 1
decreases expression
ISO
Thimerosal results in decreased expression of AGO1 mRNA
CTD
PMID:27188386
NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546
G
Agpat1
1-acylglycerol-3-phosphate O-acyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of AGPAT1 mRNA
CTD
PMID:27188386
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
G
Ahcy
adenosylhomocysteinase
decreases expression
ISO
Thimerosal results in decreased expression of AHCY mRNA
CTD
PMID:27188386
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Ahnak2
AHNAK nucleoprotein 2
decreases expression
ISO
Thimerosal results in decreased expression of AHNAK2 mRNA
CTD
PMID:27188386
NCBI chr 6:131,830,668...131,876,311
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
increases secretion
ISO
Thimerosal results in increased secretion of AIFM1 protein
CTD
PMID:12140745
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Ak4
adenylate kinase 4
decreases expression
ISO
Thimerosal results in decreased expression of AK4 mRNA
CTD
PMID:27188386
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akap11
A-kinase anchoring protein 11
increases expression
ISO
Thimerosal results in increased expression of AKAP11 mRNA
CTD
PMID:27188386
NCBI chr15:53,911,635...53,956,138
Ensembl chr15:53,911,657...53,941,605
G
Akap8l
A-kinase anchoring protein 8 like
increases expression
ISO
Thimerosal results in increased expression of AKAP8L mRNA
CTD
PMID:27188386
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
G
Akap9
A-kinase anchoring protein 9
increases expression
ISO
Thimerosal results in increased expression of AKAP9 mRNA
CTD
PMID:27188386
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO
Thimerosal promotes the reaction [wortmannin results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Thimerosal results in decreased phosphorylation of AKT1 protein]
CTD
PMID:23145070
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt3
AKT serine/threonine kinase 3
decreases expression
ISO
Thimerosal results in decreased expression of AKT3 mRNA
CTD
PMID:27188386
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
G
Alas1
5'-aminolevulinate synthase 1
decreases expression
ISO
Thimerosal results in decreased expression of ALAS1 mRNA
CTD
PMID:27188386
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Alb
albumin
affects binding
ISO
Thimerosal binds to ALB protein
CTD
PMID:18197631
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
ISO
Thimerosal results in decreased expression of ALDH3A2 mRNA
CTD
PMID:27188386
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
decreases expression
ISO
Thimerosal results in decreased expression of ALDH5A1 mRNA
CTD
PMID:27188386
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
Thimerosal results in decreased expression of ALDH6A1 mRNA
CTD
PMID:27188386
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldoa
aldolase, fructose-bisphosphate A
decreases expression
ISO
Thimerosal results in decreased expression of ALDOA mRNA
CTD
PMID:27188386
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldoc
aldolase, fructose-bisphosphate C
decreases expression
ISO
Thimerosal results in decreased expression of ALDOC mRNA
CTD
PMID:27188386
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alg13
ALG13, UDP-N-acetylglucosaminyltransferase subunit
increases expression
ISO
Thimerosal results in increased expression of ALG13 mRNA
CTD
PMID:27188386
NCBI chr X:107,906,320...107,968,232
Ensembl chr X:107,885,093...107,942,695
G
Alox5
arachidonate 5-lipoxygenase
decreases expression
ISO
Thimerosal results in decreased expression of ALOX5 mRNA
CTD
PMID:27188386
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Angpt1
angiopoietin 1
decreases expression
ISO
Thimerosal results in decreased expression of ANGPT1 mRNA
CTD
PMID:27188386
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Ank2
ankyrin 2
increases expression
ISO
Thimerosal results in increased expression of ANK2 mRNA
CTD
PMID:27188386
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
G
Ankdd1a
ankyrin repeat and death domain containing 1A
decreases expression
ISO
Thimerosal results in decreased expression of ANKDD1A mRNA
CTD
PMID:27188386
NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
G
Ankef1
ankyrin repeat and EF-hand domain containing 1
decreases expression
ISO
Thimerosal results in decreased expression of ANKEF1 mRNA
CTD
PMID:27188386
NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059
G
Ankrd10
ankyrin repeat domain 10
increases expression
ISO
Thimerosal results in increased expression of ANKRD10 mRNA
CTD
PMID:27188386
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
G
Ankrd35
ankyrin repeat domain 35
decreases expression
ISO
Thimerosal results in decreased expression of ANKRD35 mRNA
CTD
PMID:27188386
NCBI chr 2:184,207,076...184,227,063
Ensembl chr 2:184,207,071...184,227,063
G
Ankrd37
ankyrin repeat domain 37
decreases expression
ISO
Thimerosal results in decreased expression of ANKRD37 mRNA
CTD
PMID:27188386
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Ankrd44
ankyrin repeat domain 44
increases expression
ISO
Thimerosal results in increased expression of ANKRD44 mRNA
CTD
PMID:24675092 PMID:27188386
NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508
G
Ankrd9
ankyrin repeat domain 9
decreases expression
ISO
Thimerosal results in decreased expression of ANKRD9 mRNA
CTD
PMID:27188386
NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923
G
Ano4
anoctamin 4
decreases expression
ISO
Thimerosal results in decreased expression of ANO4 mRNA
CTD
PMID:24675092
NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
decreases expression
ISO
Thimerosal results in decreased expression of ANP32B mRNA
CTD
PMID:27188386
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
G
Anpep
alanyl aminopeptidase, membrane
decreases expression
ISO
Thimerosal results in decreased expression of ANPEP mRNA
CTD
PMID:27188386
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Apc
APC regulator of WNT signaling pathway
increases expression
ISO
Thimerosal results in increased expression of APC mRNA
CTD
PMID:27188386
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Apoh
apolipoprotein H
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA
CTD
PMID:27188386
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
decreases expression
ISO
Thimerosal results in decreased expression of APPL2 mRNA
CTD
PMID:27188386
NCBI chr 7:20,135,248...20,184,757
Ensembl chr 7:20,135,375...20,184,754
G
Arap3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
decreases expression
ISO
Thimerosal results in decreased expression of ARAP3 mRNA
CTD
PMID:27188386
NCBI chr18:29,806,214...29,834,217
Ensembl chr18:29,807,536...29,833,555
G
Arb2a
ARB2 cotranscriptional regulator A
decreases expression
ISO
Thimerosal results in decreased expression of ARB2A mRNA
CTD
PMID:27188386
NCBI chr 2:7,553,873...8,018,183
Ensembl chr 2:7,553,891...8,018,162
G
Arc
activity-regulated cytoskeleton-associated protein
increases expression
ISO
Thimerosal results in increased expression of ARC mRNA
CTD
PMID:16870260
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Arfgef3
ARFGEF family member 3
decreases expression
ISO
Thimerosal results in decreased expression of ARFGEF3 mRNA
CTD
PMID:27188386
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
G
Arglu1
arginine and glutamate rich 1
decreases expression
ISO
Thimerosal results in decreased expression of ARGLU1 mRNA
CTD
PMID:27188386
NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349
G
Arhgap18
Rho GTPase activating protein 18
decreases expression
ISO
Thimerosal results in decreased expression of ARHGAP18 mRNA
CTD
PMID:27188386
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgap5
Rho GTPase activating protein 5
increases expression
ISO
Thimerosal results in increased expression of ARHGAP5 mRNA
CTD
PMID:27188386
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Arhgef10
Rho guanine nucleotide exchange factor 10
decreases expression
ISO
Thimerosal results in decreased expression of ARHGEF10 mRNA
CTD
PMID:27188386
NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173
G
Arhgef12
Rho guanine nucleotide exchange factor 12
increases expression
ISO
Thimerosal results in increased expression of ARHGEF12 mRNA
CTD
PMID:27188386
NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366
G
Arhgef4
Rho guanine nucleotide exchange factor 4
decreases expression
ISO
Thimerosal results in decreased expression of ARHGEF4 mRNA
CTD
PMID:27188386
NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075
G
Armc7
armadillo repeat containing 7
decreases expression
ISO
Thimerosal results in decreased expression of ARMC7 mRNA
CTD
PMID:27188386
NCBI chr10:100,723,080...100,739,636
Ensembl chr10:100,723,105...100,739,636
G
Armcx5
armadillo repeat containing, X-linked 5
increases expression
ISO
Thimerosal results in increased expression of ARMCX5 mRNA
CTD
PMID:27188386
NCBI chr X:98,709,921...98,714,347
Ensembl chr X:98,709,841...98,714,674
G
Arnt
aryl hydrocarbon receptor nuclear translocator
decreases expression
ISO
Thimerosal results in decreased expression of ARNT mRNA
CTD
PMID:27188386
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
decreases expression
ISO
Thimerosal results in decreased expression of ARPC1B mRNA
CTD
PMID:27188386
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
G
Arrdc3
arrestin domain containing 3
increases expression
ISO
Thimerosal results in increased expression of ARRDC3 mRNA
CTD
PMID:27188386
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Arsk
arylsulfatase family, member K
decreases expression
ISO
Thimerosal results in decreased expression of ARSK mRNA
CTD
PMID:27188386
NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467
G
Asf1a
anti-silencing function 1A histone chaperone
increases expression
ISO
Thimerosal results in increased expression of ASF1A mRNA
CTD
PMID:27188386
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
G
Asmtl
acetylserotonin O-methyltransferase-like
decreases expression
ISO
Thimerosal results in decreased expression of ASMTL mRNA
CTD
PMID:27188386
NCBI chr12:16,315,335...16,318,083
Ensembl chr12:16,315,414...16,318,080
G
Aspm
assembly factor for spindle microtubules
decreases expression
ISO
Thimerosal results in decreased expression of ASPM mRNA
CTD
PMID:27188386
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Atad2b
ATPase family, AAA domain containing 2B
increases expression
ISO
Thimerosal results in increased expression of ATAD2B mRNA
CTD
PMID:27188386
NCBI chr 6:27,914,546...28,070,103
Ensembl chr 6:27,912,862...28,067,047
G
Atf3
activating transcription factor 3
increases expression
ISO
Thimerosal results in increased expression of ATF3 mRNA
CTD
PMID:16870260
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf7ip
activating transcription factor 7 interacting protein
increases expression
ISO
Thimerosal results in increased expression of ATF7IP mRNA
CTD
PMID:27188386
NCBI chr 4:169,385,872...169,471,652
Ensembl chr 4:169,385,872...169,471,650
G
Atg10
autophagy related 10
increases expression
ISO
Thimerosal results in increased expression of ATG10 mRNA
CTD
PMID:27188386
NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
G
Atg13
autophagy related 13
decreases expression
ISO
Thimerosal results in decreased expression of ATG13 mRNA
CTD
PMID:27188386
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
G
Atg2b
autophagy related 2B
decreases expression
ISO
Thimerosal results in decreased expression of ATG2B mRNA
CTD
PMID:27188386
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
G
Atm
ATM serine/threonine kinase
increases expression
ISO
Thimerosal results in increased expression of ATM mRNA
CTD
PMID:27188386
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atp11b
ATPase phospholipid transporting 11B (putative)
decreases expression
ISO
Thimerosal results in decreased expression of ATP11B mRNA
CTD
PMID:27188386
NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232
G
Atp13a3
ATPase 13A3
decreases expression
ISO
Thimerosal results in decreased expression of ATP13A3 mRNA
CTD
PMID:27188386
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
G
Atp1b2
ATPase Na+/K+ transporting subunit beta 2
decreases expression
ISO
Thimerosal results in decreased expression of ATP1B2 mRNA
CTD
PMID:27188386
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
G
Atp5f1d
ATP synthase F1 subunit delta
decreases expression
ISO
Thimerosal results in decreased expression of ATP5F1D mRNA
CTD
PMID:27188386
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
G
Atp5f1e
ATP synthase F1 subunit epsilon
increases expression
ISO
Thimerosal results in increased expression of ATP5F1E mRNA
CTD
PMID:27188386
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
G
Atp5if1
ATP synthase inhibitory factor subunit 1
decreases expression
ISO
Thimerosal results in decreased expression of ATP5IF1 mRNA
CTD
PMID:27188386
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
G
Atp6v1d
ATPase H+ transporting V1 subunit D
increases expression
ISO
Thimerosal results in increased expression of ATP6V1D mRNA
CTD
PMID:27188386
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
G
Atp8b3
ATPase phospholipid transporting 8B3
decreases expression
ISO
Thimerosal results in decreased expression of ATP8B3 mRNA
CTD
PMID:27188386
NCBI chr 7:9,175,544...9,195,449
Ensembl chr 7:9,175,391...9,195,442
G
Atrx
ATRX, chromatin remodeler
decreases expression
ISO
Thimerosal results in decreased expression of ATRX mRNA
CTD
PMID:27188386
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
G
Atxn1
ataxin 1
decreases expression
ISO
Thimerosal results in decreased expression of ATXN1 mRNA
CTD
PMID:27188386
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
G
Atxn7l3b
ataxin 7-like 3B
decreases expression
ISO
Thimerosal results in decreased expression of ATXN7L3B mRNA
CTD
PMID:27188386
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
G
Azi2
5-azacytidine induced 2
increases expression
ISO
Thimerosal results in increased expression of AZI2 mRNA
CTD
PMID:27188386
NCBI chr 8:117,773,248...117,797,844
Ensembl chr 8:117,773,279...117,797,847
G
B3galnt2
beta-1,3-N-acetylgalactosaminyltransferase 2
increases expression
ISO
Thimerosal results in increased expression of B3GALNT2 mRNA
CTD
PMID:27188386
NCBI chr17:51,334,921...51,377,469
Ensembl chr17:51,334,921...51,377,469
G
Bace1
beta-secretase 1
decreases expression
ISO
Thimerosal results in decreased expression of BACE1 mRNA
CTD
PMID:27188386
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bace2
beta-secretase 2
decreases expression
ISO
Thimerosal results in decreased expression of BACE2 mRNA
CTD
PMID:27188386
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
G
Bag3
BAG cochaperone 3
increases expression
ISO
Thimerosal results in increased expression of BAG3 mRNA
CTD
PMID:16870260
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Bag4
BAG cochaperone 4
decreases expression
ISO
Thimerosal results in decreased expression of BAG4 mRNA
CTD
PMID:27188386
NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Thimerosal results in increased expression of BAX
CTD
PMID:24942245
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbip1
BBSome interacting protein 1
increases expression
ISO
Thimerosal results in increased expression of BBIP1 mRNA
CTD
PMID:27188386
NCBI chr 1:252,943,589...252,959,512
Ensembl chr 1:252,945,557...252,959,352
G
Bbln
bublin coiled coil protein
decreases expression
ISO
Thimerosal results in decreased expression of BBLN mRNA
CTD
PMID:27188386
NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374
G
Bcas3
BCAS3, microtubule associated cell migration factor
decreases expression
ISO
Thimerosal results in decreased expression of BCAS3 mRNA
CTD
PMID:27188386
NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080
G
Bcat2
branched chain amino acid transaminase 2
decreases expression
ISO
Thimerosal results in decreased expression of BCAT2 mRNA
CTD
PMID:27188386
NCBI chr 1:96,040,407...96,060,008
Ensembl chr 1:96,042,625...96,060,007
G
Bcl6b
BCL6B, transcription repressor
decreases expression
ISO
Thimerosal results in decreased expression of BCL6B mRNA
CTD
PMID:27188386
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
G
Bclaf1
BCL2-associated transcription factor 1
increases expression
ISO
Thimerosal results in increased expression of BCLAF1 mRNA
CTD
PMID:27188386
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
G
Bcor
BCL6 co-repressor
decreases expression
ISO
Thimerosal results in decreased expression of BCOR mRNA
CTD
PMID:27188386
NCBI chr X:10,609,756...10,729,613
Ensembl chr X:10,687,732...10,729,613
G
Bdp1
BDP1 general transcription factor IIIB subunit
decreases expression
ISO
Thimerosal results in decreased expression of BDP1 mRNA
CTD
PMID:27188386
NCBI chr 2:31,378,407...31,470,140
Ensembl chr 2:31,378,924...31,470,119
G
Bhlhe40
basic helix-loop-helix family, member e40
decreases expression
ISO
Thimerosal results in decreased expression of BHLHE40 mRNA
CTD
PMID:27188386
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions decreases expression
ISO
Glutathione inhibits the reaction [Thimerosal results in decreased expression of BIRC3 protein]
CTD
PMID:12140745
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein]
CTD
PMID:23145070
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bloc1s3
biogenesis of lysosomal organelles complex-1, subunit 3
decreases expression
ISO
Thimerosal results in decreased expression of BLOC1S3 mRNA
CTD
PMID:27188386
NCBI chr 1:79,155,873...79,158,247
Ensembl chr 1:79,155,693...79,158,505
G
Bltp3a
bridge-like lipid transfer protein family member 3A
decreases expression
ISO
Thimerosal results in decreased expression of BLTP3A mRNA
CTD
PMID:24675092
NCBI chr20:5,910,261...5,954,641
Ensembl chr20:5,910,260...5,952,404
G
Bmp2k
BMP-2 inducible kinase
increases expression
ISO
Thimerosal results in increased expression of BMP2K mRNA
CTD
PMID:27188386
NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134
G
Bnip3
BCL2 interacting protein 3
decreases expression
ISO
Thimerosal results in decreased expression of BNIP3 mRNA
CTD
PMID:27188386
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bod1l1
biorientation of chromosomes in cell division 1-like 1
decreases expression
ISO
Thimerosal results in decreased expression of BOD1L1 mRNA
CTD
PMID:27188386
NCBI chr14:69,108,483...69,163,255
Ensembl chr14:69,108,491...69,162,490
G
Bok
BCL2 family apoptosis regulator BOK
decreases expression
ISO
Thimerosal results in decreased expression of BOK mRNA
CTD
PMID:27188386
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
G
Bola2
bolA family member 2
increases expression
ISO
Thimerosal results in increased expression of BOLA2 mRNA
CTD
PMID:27188386
NCBI chr 1:181,291,967...181,292,833
Ensembl chr 1:181,291,398...181,292,676
G
Brca2
BRCA2, DNA repair associated
increases expression
ISO
Thimerosal results in increased expression of BRCA2 mRNA
CTD
PMID:27188386
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Brwd1
bromodomain and WD repeat domain containing 1
increases expression
ISO
Thimerosal results in increased expression of BRWD1 mRNA
CTD
PMID:27188386
NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768
G
Brwd3
bromodomain and WD repeat domain containing 3
decreases expression
ISO
Thimerosal results in decreased expression of BRWD3 mRNA
CTD
PMID:27188386
NCBI chr X:73,768,343...73,861,643
Ensembl chr X:73,774,340...73,861,622
G
Btg3
BTG anti-proliferation factor 3
increases expression
ISO
Thimerosal results in increased expression of BTG3 mRNA
CTD
PMID:27188386
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
C11h3orf38
similar to human chromosome 3 open reading frame 38
increases expression
ISO
Thimerosal results in increased expression of C3ORF38 mRNA
CTD
PMID:27188386
NCBI chr11:2,483,983...2,488,631
Ensembl chr11:2,481,189...2,488,660
G
C13h1orf115
similar to human chromosome 1 open reading frame 115
decreases expression
ISO
Thimerosal results in decreased expression of C1ORF115 mRNA
CTD
PMID:27188386
NCBI chr13:96,422,308...96,432,044
Ensembl chr13:96,422,302...96,432,068
G
C13h1orf53
similar to human chromosome 1 open reading frame 53
increases expression
ISO
Thimerosal results in increased expression of C1ORF53 mRNA
CTD
PMID:27188386
NCBI chr13:50,413,785...50,418,974
Ensembl chr13:50,413,785...50,419,120
G
C13h2orf76
similar to chromosome 2 open reading frame 76
increases expression
ISO
Thimerosal results in increased expression of C2ORF76 mRNA
CTD
PMID:27188386
NCBI chr13:31,249,733...31,335,367
Ensembl chr13:31,249,959...31,314,943
G
C15h8orf58
similar to human chromosome 8 open reading frame 58
decreases expression
ISO
Thimerosal results in decreased expression of C8ORF58 mRNA
CTD
PMID:27188386
NCBI chr15:45,228,615...45,235,274
Ensembl chr15:45,228,615...45,233,254
G
C16h8orf48
similar to human chromosome 8 open reading frame 48
increases expression
ISO
Thimerosal results in increased expression of C8ORF48 mRNA
CTD
PMID:27188386
NCBI chr16:55,244,744...55,246,642
Ensembl chr16:55,236,322...55,246,650
G
C17h5orf24
similar to human chromosome 5 open reading frame 24
decreases expression
ISO
Thimerosal results in decreased expression of C5ORF24 mRNA
CTD
PMID:27188386
NCBI chr17:8,923,041...8,932,958
Ensembl chr17:8,922,675...8,933,356
G
C1qtnf3
C1q and TNF related 3
decreases expression
ISO
Thimerosal results in decreased expression of C1QTNF3 mRNA
CTD
PMID:27188386
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
G
C1qtnf4
C1q and TNF related 4
decreases expression
ISO
Thimerosal results in decreased expression of C1QTNF4 mRNA
CTD
PMID:27188386
NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139
G
C1rl
complement C1r subcomponent like
decreases expression
ISO
Thimerosal results in decreased expression of C1RL mRNA
CTD
PMID:27188386
NCBI chr 4:157,394,183...157,410,771
Ensembl chr 4:157,394,200...157,410,134
G
C20h6orf136
similar to human chromosome 6 open reading frame 136
decreases expression
ISO
Thimerosal results in decreased expression of C6ORF136 mRNA
CTD
PMID:27188386
NCBI chr20:2,857,840...2,861,952
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of C2CD2 mRNA
CTD
PMID:27188386
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
G
C5h1orf174
similar to human chromosome 1 open reading frame 174
increases expression
ISO
Thimerosal results in increased expression of C1ORF174 mRNA
CTD
PMID:27188386
NCBI chr 5:164,515,578...164,520,022
Ensembl chr 5:164,515,559...164,520,021
G
C7h8orf82
similar to human chromosome 8 open reading frame 82
decreases expression
ISO
Thimerosal results in decreased expression of C8ORF82 mRNA
CTD
PMID:27188386
NCBI chr 7:108,443,772...108,446,116
Ensembl chr 7:108,443,782...108,446,121
G
Cadm2
cell adhesion molecule 2
increases expression
ISO
Thimerosal results in increased expression of CADM2 mRNA
CTD
PMID:27188386
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
G
Cadm3
cell adhesion molecule 3
decreases expression
ISO
Thimerosal results in decreased expression of CADM3 mRNA
CTD
PMID:27188386
NCBI chr13:85,784,785...85,817,412
Ensembl chr13:85,786,483...85,817,749
G
Calm3
calmodulin 3
decreases expression
ISO
Thimerosal results in decreased expression of CALM3 mRNA
CTD
PMID:27188386
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
G
Calml4
calmodulin-like 4
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA
CTD
PMID:27188386
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Capn5
calpain 5
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA
CTD
PMID:27188386
NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923
G
Capn9
calpain 9
increases expression
ISO
Thimerosal results in increased expression of CAPN9 mRNA
CTD
PMID:27188386
NCBI chr19:52,549,448...52,586,413
Ensembl chr19:52,549,448...52,586,413
G
Car10
carbonic anhydrase 10
increases expression
ISO
Thimerosal results in increased expression of CA10 mRNA
CTD
PMID:27188386
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
G
Car14
carbonic anhydrase 14
decreases expression
ISO
Thimerosal results in decreased expression of CA14 mRNA
CTD
PMID:27188386
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
G
Card10
caspase recruitment domain family, member 10
decreases expression
ISO
Thimerosal results in decreased expression of CARD10 mRNA
CTD
PMID:27188386
NCBI chr 7:110,330,460...110,371,551
Ensembl chr 7:110,330,408...110,359,224
G
Carm1
coactivator-associated arginine methyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of CARM1 mRNA
CTD
PMID:27188386
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
G
Casp3
caspase 3
increases cleavage multiple interactions increases activity
ISO EXP
Thimerosal results in increased cleavage of CASP3 protein MC1568 inhibits the reaction [Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein]; Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [Wortmannin results in increased cleavage of CASP3 protein]; Wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein] Thimerosal results in increased activity of CASP3 protein [[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; [Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]
CTD
PMID:12140745 PMID:15869795 PMID:16649253 PMID:17698513 PMID:17888894 PMID:23145070 PMID:27660204 PMID:30503815 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases cleavage multiple interactions increases activity
ISO
Thimerosal results in increased cleavage of CASP9 protein benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP9 protein]; wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] Thimerosal results in increased activity of CASP9 protein Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein]
CTD
PMID:12140745 PMID:15869795 PMID:23145070
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO
[Thimerosal co-treated with Aluminum Hydroxide] results in increased activity of CAT protein
CTD
PMID:36411272
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbl
Cbl proto-oncogene
decreases expression
ISO
Thimerosal results in decreased expression of CBL mRNA
CTD
PMID:27188386
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Cbx3
chromobox 3
increases expression
ISO
Thimerosal results in increased expression of CBX3 mRNA
CTD
PMID:27188386
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
G
Cbx5
chromobox 5
decreases expression
ISO
Thimerosal results in decreased expression of CBX5 mRNA
CTD
PMID:27188386
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
G
Cbx7
chromobox 7
decreases expression
ISO
Thimerosal results in decreased expression of CBX7 mRNA
CTD
PMID:27188386
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Cc2d2b
coiled-coil and C2 domain containing 2B
decreases expression
ISO
Thimerosal results in decreased expression of CC2D2B mRNA
CTD
PMID:27188386
NCBI chr 1:239,561,506...239,655,771
Ensembl chr 1:239,561,987...239,682,416
G
Ccdc113
coiled-coil domain containing 113
decreases expression
ISO
Thimerosal results in decreased expression of CFAP263 mRNA
CTD
PMID:27188386
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
G
Ccdc126
coiled-coil domain containing 126
increases expression
ISO
Thimerosal results in increased expression of CCDC126 mRNA
CTD
PMID:27188386
NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655
G
Ccdc183
coiled-coil domain containing 183
decreases expression
ISO
Thimerosal results in decreased expression of CCDC183 mRNA
CTD
PMID:27188386
NCBI chr 3:8,428,784...8,438,948
Ensembl chr 3:8,428,787...8,437,194
G
Ccdc186
coiled-coil domain containing 186
decreases expression
ISO
Thimerosal results in decreased expression of CCDC186 mRNA
CTD
PMID:27188386
NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935
G
Ccdc66
coiled-coil domain containing 66
increases expression
ISO
Thimerosal results in increased expression of CCDC66 mRNA
CTD
PMID:27188386
NCBI chr16:2,662,125...2,694,031
Ensembl chr16:2,662,131...2,694,023
G
Ccdc71l
coiled-coil domain containing 71-like
decreases expression
ISO
Thimerosal results in decreased expression of CCDC71L mRNA
CTD
PMID:27188386
NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841 Ensembl chr 6:48,960,191...48,960,841
G
Ccdc82
coiled-coil domain containing 82
increases expression
ISO
Thimerosal results in increased expression of CCDC82 mRNA
CTD
PMID:27188386
NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963
G
Ccdc85b
coiled-coil domain containing 85B
decreases expression
ISO
Thimerosal results in decreased expression of CCDC85B mRNA
CTD
PMID:27188386
NCBI chr 1:202,763,645...202,764,660
Ensembl chr 1:202,763,631...202,764,703
G
Ccm2l
CCM2 like scaffold protein
decreases expression
ISO
Thimerosal results in decreased expression of CCM2L mRNA
CTD
PMID:27188386
NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140
G
Ccn1
cellular communication network factor 1
increases expression
ISO
Thimerosal results in increased expression of CCN1 mRNA
CTD
PMID:16870260
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccnb1
cyclin B1
multiple interactions
ISO
Thimerosal results in increased expression of and results in increased activity of CCNB1 protein
CTD
PMID:16649253
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
decreases expression
ISO
Thimerosal results in decreased expression of CCND1 mRNA
CTD
PMID:27188386
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
decreases expression
ISO
Thimerosal results in decreased expression of CCND2 mRNA
CTD
PMID:27188386
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccnt1
cyclin T1
decreases expression
ISO
Thimerosal results in decreased expression of CCNT1 mRNA
CTD
PMID:27188386
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
G
Ccnt2
cyclin T2
increases expression
ISO
Thimerosal results in increased expression of CCNT2 mRNA
CTD
PMID:27188386
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
G
Ccser1
coiled-coil serine-rich protein 1
increases expression
ISO
Thimerosal results in increased expression of CCSER1 mRNA
CTD
PMID:27188386
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
G
Cct6b
chaperonin containing TCP1 subunit 6B
increases expression
ISO
Thimerosal results in increased expression of CCT6B mRNA
CTD
PMID:27188386
NCBI chr10:67,652,461...67,701,385
Ensembl chr10:67,652,546...67,701,284
G
Cd28
Cd28 molecule
affects response to substance
ISO
CD28 affects the susceptibility to Thimerosal
CTD
PMID:15808517
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd40
CD40 molecule
decreases expression
ISO
Thimerosal results in decreased expression of CD40 mRNA
CTD
PMID:27188386
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd6
Cd6 molecule
decreases expression
ISO
Thimerosal results in decreased expression of CD6 mRNA
CTD
PMID:24675092
NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634
G
Cd79b
CD79b molecule
increases expression
ISO
Thimerosal results in increased expression of CD79B mRNA
CTD
PMID:24675092
NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625
G
Cd81
Cd81 molecule
decreases expression
ISO
Thimerosal results in decreased expression of CD81 mRNA
CTD
PMID:27188386
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
G
Cd86
CD86 molecule
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Cysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Glutathione inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein]
CTD
PMID:15737199 PMID:20417223 PMID:20457211
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cd99
CD99 molecule (Xg blood group)
decreases expression
ISO
Thimerosal results in decreased expression of CD99 mRNA
CTD
PMID:27188386
NCBI chr20:54,418,239...54,422,882
G
Cdc20b
cell division cycle 20B
increases expression
ISO
Thimerosal results in increased expression of CDC20B mRNA
CTD
PMID:27188386
NCBI chr 2:44,688,349...44,738,056
G
Cdc27
cell division cycle 27
decreases expression
ISO
Thimerosal results in decreased expression of CDC27 mRNA
CTD
PMID:27188386
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
G
Cdc37l1
cell division cycle 37-like 1
increases expression
ISO
Thimerosal results in increased expression of CDC37L1 mRNA
CTD
PMID:27188386
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
G
Cdc42se2
CDC42 small effector 2
increases expression
ISO
Thimerosal results in increased expression of CDC42SE2 mRNA
CTD
PMID:27188386
NCBI chr10:38,836,549...38,905,056
Ensembl chr10:38,836,555...38,905,059 Ensembl chr 1:38,836,555...38,905,059
G
Cdca2
cell division cycle associated 2
decreases expression
ISO
Thimerosal results in decreased expression of CDCA2 mRNA
CTD
PMID:27188386
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdh8
cadherin 8
increases expression
ISO
Thimerosal results in increased expression of CDH8 mRNA
CTD
PMID:27188386
NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669
G
Cdhr1
cadherin-related family member 1
increases expression
ISO
Thimerosal results in increased expression of CDHR1 mRNA
CTD
PMID:24675092
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
Thimerosal results in increased expression of CDK1 mRNA
CTD
PMID:27188386
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk14
cyclin-dependent kinase 14
affects expression
ISO
Thimerosal affects the expression of CDK14 mRNA
CTD
PMID:27188386
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
G
Cdk16
cyclin-dependent kinase 16
decreases expression
ISO
Thimerosal results in decreased expression of CDK16 mRNA
CTD
PMID:27188386
NCBI chr X:1,492,814...1,504,309
Ensembl chr X:1,492,814...1,504,148
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Thimerosal results in decreased expression of CDK4 protein
CTD
PMID:16649253
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Thimerosal results in decreased expression of CDK6 mRNA
CTD
PMID:27188386
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
Thimerosal results in decreased expression of CDKN1C mRNA
CTD
PMID:27188386
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdt1
chromatin licensing and DNA replication factor 1
decreases expression
ISO
Thimerosal results in decreased expression of CDT1 mRNA
CTD
PMID:27188386
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Cenpn
centromere protein N
increases expression
ISO
Thimerosal results in increased expression of CENPN mRNA
CTD
PMID:27188386
NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012
G
Cenpq
centromere protein Q
increases expression
ISO
Thimerosal results in increased expression of CENPQ mRNA
CTD
PMID:27188386
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
G
Cenpu
centromere protein U
increases expression
ISO
Thimerosal results in increased expression of CENPU mRNA
CTD
PMID:27188386
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cep126
centrosomal protein 126
decreases expression
ISO
Thimerosal results in decreased expression of CEP126 mRNA
CTD
PMID:27188386
NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467
G
Cep350
centrosomal protein 350
decreases expression
ISO
Thimerosal results in decreased expression of CEP350 mRNA
CTD
PMID:27188386
NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214
G
Cep89
centrosomal protein 89
decreases expression
ISO
Thimerosal results in decreased expression of CEP89 mRNA
CTD
PMID:27188386
NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112
G
Cfap300
cilia and flagella associated protein 300
increases expression
ISO
Thimerosal results in increased expression of CFAP300 mRNA
CTD
PMID:27188386
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
G
Cfap44
cilia and flagella associated protein 44
increases expression
ISO
Thimerosal results in increased expression of CFAP44 mRNA
CTD
PMID:27188386
NCBI chr11:56,199,772...56,283,964
Ensembl chr11:56,201,049...56,283,986
G
Cfap96
cilia and flagella associated protein 96
decreases expression
ISO
Thimerosal results in decreased expression of CFAP96 mRNA
CTD
PMID:27188386
NCBI chr16:46,291,075...46,315,616
Ensembl chr16:46,291,311...46,315,625
G
Cfp
complement factor properdin
decreases expression
ISO
Thimerosal results in decreased expression of CFP mRNA
CTD
PMID:24675092
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
G
Cga
glycoprotein hormones, alpha polypeptide
increases expression
ISO
Thimerosal results in increased expression of CGA mRNA
CTD
PMID:24675092
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
G
Chchd10
coiled-coil-helix-coiled-coil-helix domain containing 10
decreases expression
ISO
Thimerosal results in decreased expression of CHCHD10 mRNA
CTD
PMID:27188386
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
G
Chd4
chromodomain helicase DNA binding protein 4
decreases expression
ISO
Thimerosal results in decreased expression of CHD4 mRNA
CTD
PMID:27188386
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Chd9
chromodomain helicase DNA binding protein 9
increases expression
ISO
Thimerosal results in increased expression of CHD9 mRNA
CTD
PMID:27188386
NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556
G
Chmp5
charged multivesicular body protein 5
increases expression
ISO
Thimerosal results in increased expression of CHMP5 mRNA
CTD
PMID:27188386
NCBI chr 5:56,081,385...56,098,529
Ensembl chr 5:56,081,343...56,098,529
G
Chn2
chimerin 2
increases expression
ISO
Thimerosal results in increased expression of CHN2 mRNA
CTD
PMID:27188386
NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709
G
Chpt1
choline phosphotransferase 1
increases expression
ISO
Thimerosal results in increased expression of CHPT1 mRNA
CTD
PMID:27188386
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
G
Cib2
calcium and integrin binding family member 2
decreases expression
ISO
Thimerosal results in decreased expression of CIB2 mRNA
CTD
PMID:27188386
NCBI chr 8:54,930,265...54,947,157
G
Cibar1
CBY1 interacting BAR domain containing 1
decreases expression
ISO
Thimerosal results in decreased expression of CIBAR1 mRNA
CTD
PMID:27188386
NCBI chr 5:25,613,993...25,632,440
Ensembl chr 5:25,614,033...25,632,489
G
Cilp2
cartilage intermediate layer protein 2
decreases expression
ISO
Thimerosal results in decreased expression of CILP2 mRNA
CTD
PMID:27188386
NCBI chr16:19,539,755...19,547,191
Ensembl chr16:19,539,706...19,547,191
G
Cisd2
CDGSH iron sulfur domain 2
increases expression
ISO
Thimerosal results in increased expression of CISD2 mRNA
CTD
PMID:27188386
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
ISO
Thimerosal results in increased expression of CITED2 mRNA
CTD
PMID:16870260
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Clasp2
cytoplasmic linker associated protein 2
increases expression
ISO
Thimerosal results in increased expression of CLASP2 mRNA
CTD
PMID:27188386
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
G
Clk4
CDC-like kinase 4
increases expression
ISO
Thimerosal results in increased expression of CLK4 mRNA
CTD
PMID:27188386
NCBI chr10:35,523,382...35,541,387
Ensembl chr10:35,524,755...35,541,352
G
Clp1
cleavage factor polyribonucleotide kinase subunit 1
increases expression
ISO
Thimerosal results in increased expression of CLP1 mRNA
CTD
PMID:27188386
NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421
G
Clu
clusterin
increases expression decreases expression
ISO
Thimerosal results in increased expression of CLU mRNA Thimerosal results in decreased expression of CLU mRNA
CTD
PMID:16870260 PMID:27188386
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmip
c-Maf-inducing protein
decreases expression
ISO
Thimerosal results in decreased expression of CMIP mRNA
CTD
PMID:27188386
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
G
Cnfn
cornifelin
decreases expression
ISO
Thimerosal results in decreased expression of CNFN mRNA
CTD
PMID:27188386
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
G
Cnot7
CCR4-NOT transcription complex, subunit 7
increases expression
ISO
Thimerosal results in increased expression of CNOT7 mRNA
CTD
PMID:27188386
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
G
Cnot9
CCR4-NOT transcription complex subunit 9
increases expression
ISO
Thimerosal results in increased expression of CNOT9 mRNA
CTD
PMID:27188386
NCBI chr 9:76,084,269...76,109,111
Ensembl chr 9:76,084,334...76,109,100
G
Cnpy2
canopy FGF signaling regulator 2
decreases expression
ISO
Thimerosal results in decreased expression of CNPY2 mRNA
CTD
PMID:27188386
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
G
Cntnap2
contactin associated protein 2
decreases expression
ISO
Thimerosal results in decreased expression of CNTNAP2 mRNA
CTD
PMID:27188386
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
G
Cobll1
cordon-bleu WH2 repeat protein-like 1
increases expression
ISO
Thimerosal results in increased expression of COBLL1 mRNA
CTD
PMID:24675092
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
G
Cog3
component of oligomeric golgi complex 3
increases expression
ISO
Thimerosal results in increased expression of COG3 mRNA
CTD
PMID:24675092
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
G
Col22a1
collagen type XXII alpha 1 chain
decreases expression
ISO
Thimerosal results in decreased expression of COL22A1 mRNA
CTD
PMID:27188386
NCBI chr 7:103,730,939...103,968,452
Ensembl chr 7:103,731,037...103,968,462
G
Col4a6
collagen type IV alpha 6 chain
increases expression
ISO
Thimerosal results in increased expression of COL4A6 mRNA
CTD
PMID:27188386
NCBI chr X:104,766,463...105,117,499
Ensembl chr X:104,766,957...105,117,500
G
Col9a2
collagen type IX alpha 2 chain
decreases expression
ISO
Thimerosal results in decreased expression of COL9A2 mRNA
CTD
PMID:27188386
NCBI chr 5:134,607,616...134,624,678
Ensembl chr 5:134,607,616...134,624,677
G
Cops7b
COP9 signalosome subunit 7B
increases expression
ISO
Thimerosal results in increased expression of COPS7B mRNA
CTD
PMID:27188386
NCBI chr 9:87,238,132...87,263,967
Ensembl chr 9:87,238,375...87,263,967
G
Cox15
cytochrome c oxidase assembly homolog COX15
decreases expression
ISO
Thimerosal results in decreased expression of COX15 mRNA
CTD
PMID:27188386
NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261
G
Cox4i1
cytochrome c oxidase subunit 4i1
increases expression
ISO
Thimerosal results in increased expression of COX4I1 mRNA
CTD
PMID:27188386
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
G
Cpeb2
cytoplasmic polyadenylation element binding protein 2
multiple interactions increases expression
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA Thimerosal results in increased expression of CPEB2 mRNA
CTD
PMID:27188386
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
G
Cpeb3
cytoplasmic polyadenylation element binding protein 3
increases expression
ISO
Thimerosal results in increased expression of CPEB3 mRNA
CTD
PMID:16870260
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
G
Cpne3
copine 3
decreases expression
ISO
Thimerosal results in decreased expression of CPNE3 mRNA
CTD
PMID:27188386
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
ISO
Thimerosal results in decreased expression of CPS1 mRNA
CTD
PMID:27188386
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Crcp
CGRP receptor component
decreases expression
ISO
Thimerosal results in decreased expression of CRCP mRNA
CTD
PMID:27188386
NCBI chr12:26,623,968...26,659,756
Ensembl chr12:26,623,976...26,768,225
G
Creb1
cAMP responsive element binding protein 1
decreases expression
ISO
Thimerosal results in decreased expression of CREB1 mRNA
CTD
PMID:24675092
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crip3
cysteine-rich protein 3
decreases expression
ISO
Thimerosal results in decreased expression of CRIP3 mRNA
CTD
PMID:24675092
NCBI chr 9:14,554,450...14,557,344
Ensembl chr 9:14,554,450...14,557,302
G
Cryab
crystallin, alpha B
increases expression
ISO
Thimerosal results in increased expression of CRYAB mRNA
CTD
PMID:16870260
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Cs
citrate synthase
decreases expression
ISO
Thimerosal results in decreased expression of CS mRNA
CTD
PMID:27188386
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Cspp1
centrosome and spindle pole associated protein 1
increases expression
ISO
Thimerosal results in increased expression of CSPP1 mRNA
CTD
PMID:27188386
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
G
Ctdspl2
CTD small phosphatase like 2
increases expression
ISO
Thimerosal results in increased expression of CTDSPL2 mRNA
CTD
PMID:27188386
NCBI chr 3:108,915,263...108,970,620
Ensembl chr 3:108,915,280...108,967,227
G
Ctnna1
catenin alpha 1
decreases expression
ISO
Thimerosal results in decreased expression of CTNNA1 mRNA
CTD
PMID:27188386
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctxn3
cortexin 3
increases expression
ISO
Thimerosal results in increased expression of CTXN3 mRNA
CTD
PMID:27188386
NCBI chr18:50,930,244...50,940,642
Ensembl chr18:50,930,235...50,940,641
G
Cxhxorf38
similar to human chromosome X open reading frame 38
decreases expression
ISO
Thimerosal results in decreased expression of CXORF38 mRNA
CTD
PMID:27188386
NCBI chr X:10,128,070...10,150,904
Ensembl chr X:10,129,657...10,150,900
G
Cyb5r3
cytochrome b5 reductase 3
decreases expression
ISO
Thimerosal results in decreased expression of CYB5R3 mRNA
CTD
PMID:27188386
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Cyb5r4
cytochrome b5 reductase 4
increases expression
ISO
Thimerosal results in increased expression of CYB5R4 mRNA
CTD
PMID:27188386
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
G
Cyp39a1
cytochrome P450, family 39, subfamily a, polypeptide 1
increases expression
ISO
Thimerosal results in increased expression of CYP39A1 mRNA
CTD
PMID:27188386
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
G
Dact3
dishevelled-binding antagonist of beta-catenin 3
decreases expression
ISO
Thimerosal results in decreased expression of DACT3 mRNA
CTD
PMID:27188386
NCBI chr 1:77,546,900...77,558,631
Ensembl chr 1:77,546,900...77,558,630
G
Dbh
dopamine beta-hydroxylase
multiple interactions
ISO
[Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of DBH protein
CTD
PMID:36411272
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Dbn1
drebrin 1
decreases expression
ISO
Thimerosal results in decreased expression of DBN1 mRNA
CTD
PMID:27188386
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Dcaf13
DDB1 and CUL4 associated factor 13
increases expression
ISO
Thimerosal results in increased expression of DCAF13 mRNA
CTD
PMID:27188386
NCBI chr 7:70,160,983...70,196,142
Ensembl chr 7:70,160,941...70,196,142
G
Dcaf16
DDB1 and CUL4 associated factor 16
decreases expression
ISO
Thimerosal results in decreased expression of DCAF16 mRNA
CTD
PMID:27188386
NCBI chr14:65,449,631...65,450,015
G
Dcaf4
DDB1 and CUL4 associated factor 4
decreases expression
ISO
Thimerosal results in decreased expression of DCAF4 mRNA
CTD
PMID:27188386
NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982
G
Dcaf7
DDB1 and CUL4 associated factor 7
decreases expression
ISO
Thimerosal results in decreased expression of DCAF7 mRNA
CTD
PMID:27188386
NCBI chr10:90,974,095...90,996,275
Ensembl chr10:90,974,095...90,996,275
G
Dcc
DCC netrin 1 receptor
increases expression
ISO
Thimerosal results in increased expression of DCC mRNA
CTD
PMID:27188386
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
G
Dcun1d1
defective in cullin neddylation 1 domain containing 1
increases expression
ISO
Thimerosal results in increased expression of DCUN1D1 mRNA
CTD
PMID:27188386
NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602
G
Dcx
doublecortin
increases expression
ISO
Thimerosal results in increased expression of DCX mRNA
CTD
PMID:24675092
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
G
Ddx39b
DExD-box helicase 39B
decreases expression
ISO
Thimerosal results in decreased expression of DDX39B mRNA
CTD
PMID:27188386
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
G
Ddx6
DEAD-box helicase 6
decreases expression
ISO
Thimerosal results in decreased expression of DDX6 mRNA
CTD
PMID:27188386
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dennd1b
DENN domain containing 1B
increases expression
ISO
Thimerosal results in increased expression of DENND1B mRNA
CTD
PMID:27188386
NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601
G
Dexi
Dexi homolog
decreases expression
ISO
Thimerosal results in decreased expression of DEXI mRNA
CTD
PMID:27188386
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
G
Dgat1
diacylglycerol O-acyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of DGAT1 mRNA
CTD
PMID:27188386
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
Thimerosal results in decreased expression of DHCR24 mRNA
CTD
PMID:27188386
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
decreases expression
ISO
Thimerosal results in decreased expression of DHCR7 mRNA
CTD
PMID:27188386
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dhrs1
dehydrogenase/reductase 1
decreases expression
ISO
Thimerosal results in decreased expression of DHRS1 mRNA
CTD
PMID:27188386
NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838
G
Dhx36
DEAH-box helicase 36
increases expression
ISO
Thimerosal results in increased expression of DHX36 mRNA
CTD
PMID:27188386
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
Thimerosal results in decreased expression of DHX9 mRNA
CTD
PMID:27188386
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dkkl1
dickkopf like acrosomal protein 1
decreases expression
ISO
Thimerosal results in decreased expression of DKKL1 mRNA
CTD
PMID:24675092
NCBI chr 1:95,694,010...95,699,259
Ensembl chr 1:95,694,010...95,699,259
G
Dlg1
discs large MAGUK scaffold protein 1
decreases expression
ISO
Thimerosal results in decreased expression of DLG1 mRNA
CTD
PMID:27188386
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression
ISO
Thimerosal results in increased expression of DNAJB1 mRNA
CTD
PMID:16870260
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
Thimerosal results in increased expression of DNAJB4 mRNA
CTD
PMID:16870260
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajc13
DnaJ heat shock protein family (Hsp40) member C13
decreases expression
ISO
Thimerosal results in decreased expression of DNAJC13 mRNA
CTD
PMID:27188386
NCBI chr 8:104,767,785...104,877,317
Ensembl chr 8:104,767,788...104,877,317
G
Dnajc4
DnaJ heat shock protein family (Hsp40) member C4
decreases expression
ISO
Thimerosal results in decreased expression of DNAJC4 mRNA
CTD
PMID:27188386
NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387
G
Dnase1
deoxyribonuclease 1
decreases expression
ISO
Thimerosal results in decreased expression of DNASE1 mRNA
CTD
PMID:27188386
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
G
Dnmt3a
DNA methyltransferase 3 alpha
decreases expression
ISO
Thimerosal results in decreased expression of DNMT3A mRNA
CTD
PMID:27188386
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dock11
dedicator of cytokinesis 11
decreases expression
ISO
Thimerosal results in decreased expression of DOCK11 mRNA
CTD
PMID:27188386
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
Thimerosal results in increased expression of DOCK4 mRNA
CTD
PMID:27188386
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
G
Dock6
dedicator of cytokinesis 6
decreases expression
ISO
Thimerosal results in decreased expression of DOCK6 mRNA
CTD
PMID:27188386
NCBI chr 8:20,342,430...20,394,660
Ensembl chr 8:20,342,089...20,394,552
G
Dst
dystonin
affects expression
ISO
Thimerosal affects the expression of DST mRNA
CTD
PMID:27188386
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Thimerosal results in increased expression of DUSP1 mRNA
CTD
PMID:16870260
NCBI chr10:16,680,478...16,683,275
G
Dusp7
dual specificity phosphatase 7
decreases expression
ISO
Thimerosal results in decreased expression of DUSP7 mRNA
CTD
PMID:27188386
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
G
Dynlt2b
dynein light chain Tctex-type 2B
increases expression
ISO
Thimerosal results in increased expression of DYNLT2B mRNA
CTD
PMID:27188386
NCBI chr11:68,359,138...68,367,573
Ensembl chr11:68,358,263...68,367,499
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of ECHDC2 mRNA
CTD
PMID:27188386
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
G
Ecrg4
ECRG4 augurin precursor
decreases expression
ISO
Thimerosal results in decreased expression of ECRG4 mRNA
CTD
PMID:27188386
NCBI chr 9:45,992,954...46,012,605
Ensembl chr 9:45,992,954...46,012,595
G
Ednrb
endothelin receptor type B
decreases expression
ISO
Thimerosal results in decreased expression of EDNRB mRNA
CTD
PMID:27188386
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Eea1
early endosome antigen 1
decreases expression
ISO
Thimerosal results in decreased expression of EEA1 mRNA
CTD
PMID:27188386
NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
decreases expression
ISO
Thimerosal results in decreased expression of EEF1A2 mRNA
CTD
PMID:27188386
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
G
Eef1akmt3
EEF1A lysine methyltransferase 3
decreases expression
ISO
Thimerosal results in decreased expression of EEF1AKMT3 mRNA
CTD
PMID:27188386
NCBI chr 7:62,853,304...62,864,558
Ensembl chr 7:62,854,899...62,864,617
G
Efcab14
EF-hand calcium binding domain 14
decreases expression
ISO
Thimerosal results in decreased expression of EFCAB14 mRNA
CTD
PMID:27188386
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
G
Egfl7
EGF-like-domain, multiple 7
decreases expression
ISO
Thimerosal results in decreased expression of EGFL7 mRNA
CTD
PMID:24675092 PMID:27188386
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
G
Egln1
egl-9 family hypoxia-inducible factor 1
decreases expression
ISO
Thimerosal results in decreased expression of EGLN1 mRNA
CTD
PMID:27188386
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
G
Egln3
egl-9 family hypoxia-inducible factor 3
decreases expression
ISO
Thimerosal results in decreased expression of EGLN3 mRNA
CTD
PMID:27188386
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
G
Ehbp1
EH domain binding protein 1
decreases expression
ISO
Thimerosal results in decreased expression of EHBP1 mRNA
CTD
PMID:27188386
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
G
Ehd4
EH-domain containing 4
decreases expression
ISO
Thimerosal results in decreased expression of EHD4 mRNA
CTD
PMID:27188386
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
G
Ehmt1
euchromatic histone lysine methyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of EHMT1 mRNA
CTD
PMID:27188386
NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007
G
Eif3f
eukaryotic translation initiation factor 3, subunit F
decreases expression
ISO
Thimerosal results in decreased expression of EIF3F mRNA
CTD
PMID:27188386
NCBI chr 1:162,934,220...162,943,204
Ensembl chr 1:162,934,212...162,943,204
G
Eif4b
eukaryotic translation initiation factor 4B
decreases expression
ISO
Thimerosal results in decreased expression of EIF4B mRNA
CTD
PMID:27188386
NCBI chr 7:133,206,637...133,228,436
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
decreases expression
ISO
Thimerosal results in decreased expression of EIF4G1 mRNA
CTD
PMID:27188386
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
G
Eif5a2
eukaryotic translation initiation factor 5A2
decreases expression
ISO
Thimerosal results in decreased expression of EIF5A2 mRNA
CTD
PMID:27188386
NCBI chr 2:111,728,587...111,746,087
Ensembl chr 2:111,729,323...111,746,087
G
Elac1
elaC ribonuclease Z 1
increases expression
ISO
Thimerosal results in increased expression of ELAC1 mRNA
CTD
PMID:27188386
NCBI chr18:67,321,231...67,341,358
Ensembl chr18:67,323,583...67,340,936
G
Elmo1
engulfment and cell motility 1
decreases expression
ISO
Thimerosal results in decreased expression of ELMO1 mRNA
CTD
PMID:27188386
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
G
Eloa
elongin A
decreases expression
ISO
Thimerosal results in decreased expression of ELOA mRNA
CTD
PMID:27188386
NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765
G
Eml5
EMAP like 5
increases expression
ISO
Thimerosal results in increased expression of EML5 mRNA
CTD
PMID:27188386
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
G
Eno1
enolase 1
decreases expression
ISO
Thimerosal results in decreased expression of ENO1 mRNA
CTD
PMID:27188386
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Eno2
enolase 2
decreases expression
ISO
Thimerosal results in decreased expression of ENO2 mRNA
CTD
PMID:27188386
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Eno3
enolase 3
decreases expression
ISO
Thimerosal results in decreased expression of ENO3 mRNA
CTD
PMID:27188386
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Enpp5
ectonucleotide pyrophosphatase/phosphodiesterase family member 5
decreases expression
ISO
Thimerosal results in decreased expression of ENPP5 mRNA
CTD
PMID:27188386
NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480
G
Ep400
E1A binding protein p400
decreases expression
ISO
Thimerosal results in decreased expression of EP400 mRNA
CTD
PMID:27188386
NCBI chr12:45,891,886...46,002,523
Ensembl chr12:45,891,916...45,998,861
G
Epb41l1
erythrocyte membrane protein band 4.1-like 1
decreases expression
ISO
Thimerosal results in decreased expression of EPB41L1 mRNA
CTD
PMID:27188386
NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721
G
Epb41l4a
erythrocyte membrane protein band 4.1 like 4A
decreases expression
ISO
Thimerosal results in decreased expression of EPB41L4A mRNA
CTD
PMID:27188386
NCBI chr18:25,405,461...25,615,392
Ensembl chr18:25,406,057...25,615,149
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
decreases expression
ISO
Thimerosal results in decreased expression of EPB41L5 mRNA
CTD
PMID:27188386
NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360
G
Epc1
enhancer of polycomb homolog 1
increases expression
ISO
Thimerosal results in increased expression of EPC1 mRNA
CTD
PMID:27188386
NCBI chr17:54,503,358...54,594,444
Ensembl chr17:54,503,358...54,594,425
G
Epcam
epithelial cell adhesion molecule
increases expression
ISO
Thimerosal results in increased expression of EPCAM mRNA
CTD
PMID:24675092
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Epop
elongin BC and polycomb repressive complex 2 associated protein
decreases expression
ISO
Thimerosal results in decreased expression of EPOP mRNA
CTD
PMID:27188386
NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
decreases expression
ISO
Thimerosal results in decreased expression of EPRS1 mRNA
CTD
PMID:27188386
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Erc1
ELKS/RAB6-interacting/CAST family member 1
decreases expression
ISO
Thimerosal results in decreased expression of ERC1 mRNA
CTD
PMID:27188386
NCBI chr 4:152,763,664...153,055,724
Ensembl chr 4:152,767,419...153,055,639
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
decreases expression
ISO
Thimerosal results in decreased expression of ERCC2 mRNA
CTD
PMID:27188386
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
decreases expression
ISO
Thimerosal results in decreased expression of ERGIC1 mRNA
CTD
PMID:27188386
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
G
Ergic2
ERGIC and golgi 2
increases expression
ISO
Thimerosal results in increased expression of ERGIC2 mRNA
CTD
PMID:27188386
NCBI chr 4:181,090,808...181,123,074
Ensembl chr 4:181,090,808...181,123,060
G
Esco1
establishment of sister chromatid cohesion N-acetyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of ESCO1 mRNA
CTD
PMID:27188386
NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
decreases expression
ISO
Thimerosal results in decreased expression of ESCO2 mRNA
CTD
PMID:27188386
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esf1
ESF1 nucleolar pre-rRNA processing protein homolog
increases expression
ISO
Thimerosal results in increased expression of ESF1 mRNA
CTD
PMID:27188386
NCBI chr 3:127,454,744...127,507,941
Ensembl chr 3:127,454,811...127,507,817
G
Etnk1
ethanolamine kinase 1
increases expression
ISO
Thimerosal results in increased expression of ETNK1 mRNA
CTD
PMID:27188386
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
G
Evc2
EvC ciliary complex subunit 2
decreases expression
ISO
Thimerosal results in decreased expression of EVC2 mRNA
CTD
PMID:27188386
NCBI chr14:73,366,832...73,454,539
Ensembl chr14:73,367,963...73,454,516
G
Evi5
ecotropic viral integration site 5
decreases expression
ISO
Thimerosal results in decreased expression of EVI5 mRNA
CTD
PMID:27188386
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Exoc6
exocyst complex component 6
increases expression
ISO
Thimerosal results in increased expression of EXOC6 mRNA
CTD
PMID:27188386
NCBI chr 1:235,314,612...235,457,824
Ensembl chr 1:235,300,369...235,457,015
G
F12
coagulation factor XII
decreases expression
ISO
Thimerosal results in decreased expression of F12 mRNA
CTD
PMID:27188386
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
Fabp7
fatty acid binding protein 7
increases expression
ISO
Thimerosal results in increased expression of FABP7 mRNA
CTD
PMID:24675092
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fads1
fatty acid desaturase 1
decreases expression
ISO
Thimerosal results in decreased expression of FADS1 mRNA
CTD
PMID:27188386
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fads2
fatty acid desaturase 2
decreases expression
ISO
Thimerosal results in decreased expression of FADS2 mRNA
CTD
PMID:27188386
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Faf2
Fas associated factor family member 2
decreases expression
ISO
Thimerosal results in decreased expression of FAF2 mRNA
CTD
PMID:27188386
NCBI chr17:9,947,211...9,989,474
Ensembl chr17:9,947,220...9,989,485
G
Fah
fumarylacetoacetate hydrolase
decreases expression
ISO
Thimerosal results in decreased expression of FAH mRNA
CTD
PMID:27188386
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fam124b
family with sequence similarity 124 member B
decreases expression
ISO
Thimerosal results in decreased expression of FAM124B mRNA
CTD
PMID:27188386
NCBI chr 9:81,513,018...81,533,621
Ensembl chr 9:81,515,399...81,533,341
G
Fam135a
family with sequence similarity 135, member A
affects expression
ISO
Thimerosal affects the expression of FAM135A mRNA
CTD
PMID:27188386
NCBI chr 9:26,420,116...26,500,803
Ensembl chr 9:26,420,528...26,500,717
G
Fam149a
family with sequence similarity 149, member A
decreases expression
ISO
Thimerosal results in decreased expression of FAM149A mRNA
CTD
PMID:27188386
NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066
G
Fam162a
family with sequence similarity 162, member A
decreases expression
ISO
Thimerosal results in decreased expression of FAM162A mRNA
CTD
PMID:27188386
NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239
G
Fam168b
family with sequence similarity 168, member B
decreases expression
ISO
Thimerosal results in decreased expression of FAM168B mRNA
CTD
PMID:27188386
NCBI chr 9:37,005,569...37,038,631
Ensembl chr 9:37,006,689...37,033,723
G
Fam234b
family with sequence similarity 234, member B
decreases expression
ISO
Thimerosal results in decreased expression of FAM234B mRNA
CTD
PMID:27188386
NCBI chr 4:168,048,313...168,124,017
Ensembl chr 4:168,048,396...168,097,338
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
ISO
Thimerosal results in increased expression of FAM3C mRNA
CTD
PMID:27188386
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
G
Fam76b
family with sequence similarity 76, member B
increases expression
ISO
Thimerosal results in increased expression of FAM76B mRNA
CTD
PMID:24675092
NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861
G
Fam81b
family with sequence similarity 81, member B
increases expression
ISO
Thimerosal results in increased expression of FAM81B mRNA
CTD
PMID:27188386
NCBI chr 2:5,750,678...5,870,580
Ensembl chr 2:5,771,240...5,879,440
G
Fancf
FA complementation group F
decreases expression
ISO
Thimerosal results in decreased expression of FANCF mRNA
CTD
PMID:16870260
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
G
Fas
Fas cell surface death receptor
increases expression
ISO
Thimerosal results in increased expression of FAS mRNA
CTD
PMID:27188386
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
decreases expression
ISO
Thimerosal results in decreased expression of FASN mRNA
CTD
PMID:27188386
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fastkd2
FAST kinase domains 2
increases expression
ISO
Thimerosal results in increased expression of FASTKD2 mRNA
CTD
PMID:27188386
NCBI chr 9:65,166,148...65,188,184
Ensembl chr 9:65,168,228...65,188,174
G
Fbln2
fibulin 2
decreases expression
ISO
Thimerosal results in decreased expression of FBLN2 mRNA
CTD
PMID:27188386
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
G
Fbn1
fibrillin 1
decreases expression
ISO
Thimerosal results in decreased expression of FBN1 mRNA
CTD
PMID:27188386
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
G
Fbxo3
F-box protein 3
increases expression
ISO
Thimerosal results in increased expression of FBXO3 mRNA
CTD
PMID:27188386
NCBI chr 3:90,417,262...90,449,557
Ensembl chr 3:90,417,297...90,449,557
G
Fbxo7
F-box protein 7
decreases expression
ISO
Thimerosal results in decreased expression of FBXO7 mRNA
CTD
PMID:27188386
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
G
Fbxo9
f-box protein 9
increases expression
ISO
Thimerosal results in increased expression of FBXO9 mRNA
CTD
PMID:27188386
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fer
FER tyrosine kinase
increases expression
ISO
Thimerosal results in increased expression of FER mRNA
CTD
PMID:27188386
NCBI chr 9:103,520,452...103,827,364
Ensembl chr 9:103,520,493...103,821,451
G
Fer1l4
fer-1-like family member 4
decreases expression
ISO
Thimerosal results in decreased expression of FER1L4 mRNA
CTD
PMID:27188386
NCBI chr 3:144,536,099...144,571,634
Ensembl chr 3:144,536,099...144,571,634
G
Fgd6
FYVE, RhoGEF and PH domain containing 6
increases expression
ISO
Thimerosal results in increased expression of FGD6 mRNA
CTD
PMID:27188386
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
G
Fgf11
fibroblast growth factor 11
decreases expression
ISO
Thimerosal results in decreased expression of FGF11 mRNA
CTD
PMID:27188386
NCBI chr10:54,516,508...54,522,067
Ensembl chr10:54,517,077...54,522,062
G
Fgfbp3
fibroblast growth factor binding protein 3
decreases expression
ISO
Thimerosal results in decreased expression of FGFBP3 mRNA
CTD
PMID:27188386
NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:234,644,019...234,646,547
G
Fgfr1op2
FGFR1 oncogene partner 2
increases expression
ISO
Thimerosal results in increased expression of FGFR1OP2 mRNA
CTD
PMID:27188386
NCBI chr 4:179,491,602...179,512,630
Ensembl chr 4:179,491,599...179,512,630
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
Thimerosal results in decreased expression of FGFR2 mRNA
CTD
PMID:27188386
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fkbp10
FKBP prolyl isomerase 10
decreases expression
ISO
Thimerosal results in decreased expression of FKBP10 mRNA
CTD
PMID:27188386
NCBI chr10:85,345,434...85,357,998
Ensembl chr10:85,346,126...85,427,330
G
Flcn
folliculin
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA
CTD
PMID:27188386
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
G
Fmnl2
formin-like 2
decreases expression
ISO
Thimerosal results in decreased expression of FMNL2 mRNA
CTD
PMID:27188386
NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754
G
Fn1
fibronectin 1
increases secretion
ISO
Thimerosal results in increased secretion of FN1 protein
CTD
PMID:24942245
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fnbp4
formin binding protein 4
decreases expression
ISO
Thimerosal results in decreased expression of FNBP4 mRNA
CTD
PMID:27188386
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
G
Fndc10
fibronectin type III domain containing 10
decreases expression
ISO
Thimerosal results in decreased expression of FNDC10 mRNA
CTD
PMID:27188386
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
G
Fndc11
fibronectin type III domain containing 11
decreases expression
ISO
Thimerosal results in decreased expression of FNDC11 mRNA
CTD
PMID:27188386
NCBI chr 3:168,330,607...168,333,111
Ensembl chr 3:168,330,602...168,334,617
G
Fndc4
fibronectin type III domain containing 4
decreases expression
ISO
Thimerosal results in decreased expression of FNDC4 mRNA
CTD
PMID:27188386
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Folr1
folate receptor alpha
decreases expression
ISO
Thimerosal results in decreased expression of FOLR1 mRNA
CTD
PMID:24675092
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Thimerosal results in increased expression of FOS mRNA
CTD
PMID:16870260
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Thimerosal results in increased expression of FOSB mRNA
CTD
PMID:16870260
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Foxc1
forkhead box C1
decreases expression
ISO
Thimerosal results in decreased expression of FOXC1 mRNA
CTD
PMID:27188386
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
G
Foxp2
forkhead box P2
increases expression
ISO
Thimerosal results in increased expression of FOXP2 mRNA
CTD
PMID:27188386
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
G
Fra10ac1
FRA10A associated CGG repeat 1
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA
CTD
PMID:27188386
NCBI chr 1:235,969,071...236,001,074
Ensembl chr 1:235,969,112...236,001,210
G
Frmd7
FERM domain containing 7
increases expression
ISO
Thimerosal results in increased expression of FRMD7 mRNA
CTD
PMID:24675092
NCBI chr X:130,375,925...130,423,836
Ensembl chr X:130,377,227...130,423,771
G
Frmpd3
FERM and PDZ domain containing 3
increases expression
ISO
Thimerosal results in increased expression of FRMPD3 mRNA
CTD
PMID:24675092
NCBI chr X:103,964,168...104,113,864
Ensembl chr X:104,043,194...104,111,968
G
Frs2
fibroblast growth factor receptor substrate 2
increases expression
ISO
Thimerosal results in increased expression of FRS2 mRNA
CTD
PMID:27188386
NCBI chr 7:52,711,255...52,792,738
Ensembl chr 7:52,711,257...52,792,743
G
Fshb
follicle stimulating hormone subunit beta
increases expression
ISO
Thimerosal results in increased expression of FSHB mRNA; Thimerosal results in increased expression of FSHB protein
CTD
PMID:24675092
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Fsip2
fibrous sheath-interacting protein 2
increases expression
ISO
Thimerosal results in increased expression of FSIP2 mRNA
CTD
PMID:27188386
NCBI chr 3:67,962,345...68,032,866
Ensembl chr 3:67,962,360...68,032,868
G
Fut1
fucosyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of FUT1 mRNA
CTD
PMID:27188386
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
G
Fut11
fucosyltransferase 11
decreases expression
ISO
Thimerosal results in decreased expression of FUT11 mRNA
CTD
PMID:27188386
NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356
G
Fxyd6
FXYD domain-containing ion transport regulator 6
decreases expression
ISO
Thimerosal results in decreased expression of FXYD6 mRNA
CTD
PMID:27188386
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
G
Fzd2
frizzled class receptor 2
decreases expression
ISO
Thimerosal results in decreased expression of FZD2 mRNA
CTD
PMID:27188386
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
G
Fzd7
frizzled class receptor 7
decreases expression
ISO
Thimerosal results in decreased expression of FZD7 mRNA
CTD
PMID:27188386
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
G3bp1
G3BP stress granule assembly factor 1
affects expression
ISO
Thimerosal affects the expression of G3BP1 mRNA
CTD
PMID:27188386
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression
ISO
Thimerosal results in decreased expression of G6PD mRNA
CTD
PMID:27188386
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
increases expression
ISO
Thimerosal results in increased expression of GABRA1 mRNA
CTD
PMID:27188386
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabrr1
gamma-aminobutyric acid type A receptor subunit rho 1
increases expression
ISO
Thimerosal results in increased expression of GABRR1 mRNA
CTD
PMID:27188386
NCBI chr 5:47,524,151...47,561,228
Ensembl chr 5:47,524,151...47,561,228
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
ISO
Thimerosal results in increased expression of GADD45G mRNA
CTD
PMID:16870260
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Gapvd1
GTPase activating protein and VPS9 domains 1
decreases expression
ISO
Thimerosal results in decreased expression of GAPVD1 mRNA
CTD
PMID:27188386
NCBI chr 3:17,968,345...18,041,888
Ensembl chr 3:17,969,599...18,055,218
G
Garem1
GRB2 associated regulator of MAPK1 subtype 1
decreases expression
ISO
Thimerosal results in decreased expression of GAREM1 mRNA
CTD
PMID:27188386
NCBI chr18:12,420,169...12,585,323
Ensembl chr18:12,423,882...12,585,345
G
Garem2
GRB2 associated regulator of MAPK1 subtype 2
decreases expression
ISO
Thimerosal results in decreased expression of GAREM2 mRNA
CTD
PMID:27188386
NCBI chr 6:26,228,965...26,255,576
Ensembl chr 6:26,230,048...26,241,762
G
Gas2l1
growth arrest-specific 2 like 1
decreases expression
ISO
Thimerosal results in decreased expression of GAS2L1 mRNA
CTD
PMID:27188386
NCBI chr14:79,955,350...79,961,830
Ensembl chr14:79,950,555...79,961,438
G
Gbe1
1,4-alpha-glucan branching enzyme 1
decreases expression
ISO
Thimerosal results in decreased expression of GBE1 mRNA
CTD
PMID:27188386
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
G
Gemin4
gem (nuclear organelle) associated protein 4
decreases expression
ISO
Thimerosal results in decreased expression of GEMIN4 mRNA
CTD
PMID:16870260
NCBI chr10:61,062,420...61,073,529
Ensembl chr10:61,066,425...61,073,431 Ensembl chr10:61,066,425...61,073,431
G
Gfm1
G elongation factor, mitochondrial 1
increases expression
ISO
Thimerosal results in increased expression of GFM1 mRNA
CTD
PMID:27188386
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
G
Gh1
growth hormone 1
increases expression
ISO
Thimerosal results in increased expression of GH mRNA
CTD
PMID:24675092
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Ghrhr
growth hormone releasing hormone receptor
increases expression
ISO
Thimerosal results in increased expression of GHRHR mRNA
CTD
PMID:24675092
NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
G
Gigyf1
GRB10 interacting GYF protein 1
increases expression
ISO
Thimerosal results in increased expression of GIGYF1 mRNA
CTD
PMID:27188386
NCBI chr12:19,166,070...19,181,570
Ensembl chr12:19,166,088...19,175,023
G
Gin1
gypsy retrotransposon integrase 1
increases expression
ISO
Thimerosal results in increased expression of GIN1 mRNA
CTD
PMID:27188386
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
G
Git2
GIT ArfGAP 2
decreases expression
ISO
Thimerosal results in decreased expression of GIT2 mRNA
CTD
PMID:27188386
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
G
Gja4
gap junction protein, alpha 4
decreases expression
ISO
Thimerosal results in decreased expression of GJA4 mRNA
CTD
PMID:27188386
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
G
Glmp
glycosylated lysosomal membrane protein
decreases expression
ISO
Thimerosal results in decreased expression of GLMP mRNA
CTD
PMID:27188386
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
G
Gls
glutaminase
increases expression
ISO
Thimerosal results in increased expression of GLS mRNA
CTD
PMID:27188386
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Gm2a
ganglioside GM2 activator
decreases expression
ISO
Thimerosal results in decreased expression of GM2A mRNA
CTD
PMID:27188386
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
G
Gmds
GDP-mannose 4, 6-dehydratase
decreases expression
ISO
Thimerosal results in decreased expression of GMDS mRNA
CTD
PMID:27188386
NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961
G
Gnal
G protein subunit alpha L
decreases expression
ISO
Thimerosal results in decreased expression of GNAL mRNA
CTD
PMID:27188386
NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599
G
Gnb1
G protein subunit beta 1
decreases expression
ISO
Thimerosal results in decreased expression of GNB1 mRNA
CTD
PMID:27188386
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
G
Gng4
G protein subunit gamma 4
increases expression
ISO
Thimerosal results in increased expression of GNG4 mRNA
CTD
PMID:24675092
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
G
Gng7
G protein subunit gamma 7
decreases expression
ISO
Thimerosal results in decreased expression of GNG7 mRNA
CTD
PMID:27188386
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
G
Gnrhr
gonadotropin releasing hormone receptor
increases expression
ISO
Thimerosal results in increased expression of GNRHR mRNA
CTD
PMID:24675092
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
G
Gon4l
gon-4 like
decreases expression
ISO
Thimerosal results in decreased expression of GON4L mRNA
CTD
PMID:27188386
NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
G
Gpcpd1
glycerophosphocholine phosphodiesterase 1
increases expression
ISO
Thimerosal results in increased expression of GPCPD1 mRNA
CTD
PMID:27188386
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:119,787,682...119,832,517
G
Gpi
glucose-6-phosphate isomerase
decreases expression
ISO
Thimerosal results in decreased expression of GPI mRNA
CTD
PMID:27188386
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Gpr135
G protein-coupled receptor 135
decreases expression
ISO
Thimerosal results in decreased expression of GPR135 mRNA
CTD
PMID:27188386
NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551
G
Gpr22
G protein-coupled receptor 22
increases expression
ISO
Thimerosal results in increased expression of GPR22 mRNA
CTD
PMID:27188386
NCBI chr 6:48,309,619...48,317,864
Ensembl chr 6:48,310,505...48,317,486
G
Grem2
gremlin 2, DAN family BMP antagonist
decreases expression
ISO
Thimerosal results in decreased expression of GREM2 mRNA
CTD
PMID:27188386
NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
increases expression
ISO
Thimerosal results in increased expression of GRIK2 mRNA
CTD
PMID:27188386
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
affects expression
ISO
Thimerosal affects the expression of GRIK5 protein
CTD
PMID:15184908
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
ISO
Thimerosal results in decreased expression of GRIN1 protein
CTD
PMID:15184908
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
decreases expression
ISO
Thimerosal results in decreased expression of GRIN2B protein
CTD
PMID:15184908
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Grk3
G protein-coupled receptor kinase 3
decreases expression
ISO
Thimerosal results in decreased expression of GRK3 mRNA
CTD
PMID:27188386
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
G
Gstm1
glutathione S-transferase mu 1
affects response to substance
ISO
GSTM1 affects the susceptibility to Thimerosal
CTD
PMID:11007341
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
decreases expression
ISO
Thimerosal results in decreased expression of GSTM2 mRNA
CTD
PMID:27188386
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstt1
glutathione S-transferase theta 1
affects response to substance decreases expression
ISO
GSTT1 affects the susceptibility to Thimerosal Thimerosal results in decreased expression of GSTT1 mRNA
CTD
PMID:11007341 PMID:27188386
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gtf2a1
general transcription factor 2A subunit 1
decreases expression
ISO
Thimerosal results in decreased expression of GTF2A1 mRNA
CTD
PMID:27188386
NCBI chr 6:110,488,891...110,521,502
Ensembl chr 6:110,488,931...110,521,511
G
Gtf2b
general transcription factor IIB
increases expression
ISO
Thimerosal results in increased expression of GTF2B mRNA
CTD
PMID:27188386
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
G
Gtf2f1
general transcription factor IIF subunit 1
decreases expression
ISO
Thimerosal results in decreased expression of GTF2F1 mRNA
CTD
PMID:27188386
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
G
Guca1a
guanylate cyclase activator 1A
decreases expression
ISO
Thimerosal results in decreased expression of GUCA1A mRNA
CTD
PMID:27188386
NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
increases expression
ISO
Thimerosal results in increased expression of GULP1 mRNA
CTD
PMID:27188386
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
G
Gxylt1
glucoside xylosyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of GXYLT1 mRNA
CTD
PMID:27188386
NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699
G
H1f0
H1.0 linker histone
decreases expression
ISO
Thimerosal results in decreased expression of H1-0 mRNA
CTD
PMID:27188386
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
G
H1f10
H1.10 linker histone
decreases expression
ISO
Thimerosal results in decreased expression of H1-10 mRNA
CTD
PMID:27188386
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
G
H1f4
H1.4 linker histone, cluster member
decreases expression
ISO
Thimerosal results in decreased expression of H1-4 mRNA
CTD
PMID:27188386
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
G
H4f3
H1.3 linker histone, cluster member
decreases expression
ISO
Thimerosal results in decreased expression of H1-3 mRNA
CTD
PMID:27188386
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
G
Hacd2
3-hydroxyacyl-CoA dehydratase 2
decreases expression
ISO
Thimerosal results in decreased expression of HACD2 mRNA
CTD
PMID:27188386
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
Thimerosal results in decreased expression of HADHA mRNA
CTD
PMID:27188386
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hat1
histone acetyltransferase 1
increases expression
ISO
Thimerosal results in increased expression of HAT1 mRNA
CTD
PMID:27188386
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
Thimerosal results in increased expression of HBEGF mRNA
CTD
PMID:16870260
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hbs1l
HBS1-like translational GTPase
increases expression
ISO
Thimerosal results in increased expression of HBS1L mRNA
CTD
PMID:27188386
NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074
G
Hcfc1r1
host cell factor C1 regulator 1
decreases expression
ISO
Thimerosal results in decreased expression of HCFC1R1 mRNA
CTD
PMID:27188386
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
G
Hdac4
histone deacetylase 4
multiple interactions increases expression
ISO EXP
MC1568 inhibits the reaction [Thimerosal results in increased expression of HDAC4 protein]
CTD
PMID:27660204
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hdx
highly divergent homeobox
increases expression
ISO
Thimerosal results in increased expression of HDX mRNA
CTD
PMID:27188386
NCBI chr X:76,552,539...76,697,177
Ensembl chr X:76,560,665...76,869,972
G
Heatr1
HEAT repeat containing 1
decreases expression
ISO
Thimerosal results in decreased expression of HEATR1 mRNA
CTD
PMID:27188386
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
G
Hebp1
heme binding protein 1
decreases expression
ISO
Thimerosal results in decreased expression of HEBP1 mRNA
CTD
PMID:27188386
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
decreases expression
ISO
Thimerosal results in decreased expression of HECTD1 mRNA
CTD
PMID:27188386
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
G
Hectd2
HECT domain E3 ubiquitin protein ligase 2
increases expression
ISO
Thimerosal results in increased expression of HECTD2 mRNA
CTD
PMID:27188386
NCBI chr 1:234,274,967...234,345,598
Ensembl chr 1:234,275,705...234,343,487
G
Hecw1
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
increases expression
ISO
Thimerosal results in increased expression of HECW1 mRNA
CTD
PMID:27188386
NCBI chr17:50,671,239...51,084,536
Ensembl chr17:50,670,954...51,080,720
G
Hells
helicase, lymphoid specific
increases expression
ISO
Thimerosal results in increased expression of HELLS mRNA
CTD
PMID:27188386
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Henmt1
HEN methyltransferase 1
increases expression
ISO
Thimerosal results in increased expression of HENMT1 mRNA
CTD
PMID:27188386
NCBI chr 2:196,585,732...196,603,700
Ensembl chr 2:196,586,797...196,599,738
G
Heph
hephaestin
decreases expression
ISO
Thimerosal results in decreased expression of HEPH mRNA
CTD
PMID:27188386
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Hes1
hes family bHLH transcription factor 1
decreases expression
ISO
Thimerosal results in decreased expression of HES1 mRNA
CTD
PMID:27188386
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hes3
hes family bHLH transcription factor 3
decreases expression
ISO
Thimerosal results in decreased expression of HES3 mRNA
CTD
PMID:24675092
NCBI chr 5:162,793,611...162,799,578
Ensembl chr 5:162,794,367...162,796,261
G
Hif3a
hypoxia inducible factor 3 subunit alpha
decreases expression
ISO
Thimerosal results in decreased expression of HIF3A mRNA
CTD
PMID:27188386
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
G
Hip1
huntingtin interacting protein 1
decreases expression
ISO
Thimerosal results in decreased expression of HIP1 mRNA
CTD
PMID:27188386
NCBI chr12:21,133,364...21,267,796
Ensembl chr12:21,133,406...21,267,725
G
Hipk2
homeodomain interacting protein kinase 2
decreases expression
ISO
Thimerosal results in decreased expression of HIPK2 mRNA
CTD
PMID:27188386
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
G
Hk1
hexokinase 1
decreases expression
ISO
Thimerosal results in decreased expression of HK1 mRNA
CTD
PMID:27188386
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Hk2
hexokinase 2
decreases expression
ISO
Thimerosal results in decreased expression of HK2 mRNA
CTD
PMID:27188386
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Hmga1
high mobility group AT-hook 1
decreases expression
ISO
Thimerosal results in decreased expression of HMGA1 mRNA
CTD
PMID:27188386
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmgb1
high mobility group box 1
increases expression
ISO
Thimerosal results in increased expression of HMGB1 mRNA
CTD
PMID:27188386
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgn5
high mobility group nucleosome binding domain 5
increases expression
ISO
Thimerosal results in increased expression of HMGN5 mRNA
CTD
PMID:27188386
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
G
Hmox1
heme oxygenase 1
increases expression
ISO
Thimerosal results in increased expression of HMOX1 mRNA
CTD
PMID:16870260
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa0
heterogeneous nuclear ribonucleoprotein A0
decreases expression
ISO
Thimerosal results in decreased expression of HNRNPA0 mRNA
CTD
PMID:27188386
NCBI chr17:6,507,728...6,510,385
Ensembl chr17:6,507,275...6,509,375
G
Hnrnpul2
heterogeneous nuclear ribonucleoprotein U-like 2
decreases expression
ISO
Thimerosal results in decreased expression of HNRNPUL2 mRNA
CTD
PMID:27188386
NCBI chr 1:205,713,431...205,725,553
Ensembl chr 1:205,711,886...205,725,553
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
decreases expression
ISO
Thimerosal results in decreased expression of HSD17B6 mRNA
CTD
PMID:27188386
NCBI chr 7:422,466...442,008
Ensembl chr 7:422,480...442,425
G
Hsf2
heat shock transcription factor 2
increases expression
ISO
Thimerosal results in increased expression of HSF2 mRNA
CTD
PMID:27188386
NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
decreases expression
ISO
Thimerosal results in decreased expression of HSP90AB1 mRNA
CTD
PMID:27188386
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa13
heat shock protein family A (Hsp70) member 13
increases expression
ISO
Thimerosal results in increased expression of HSPA13 mRNA
CTD
PMID:27188386
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression decreases expression
ISO
Thimerosal results in increased expression of HSPA1A mRNA Thimerosal results in decreased expression of HSPA1A mRNA
CTD
PMID:16870260 PMID:24675092
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
Thimerosal results in increased expression of HSPA1B mRNA
CTD
PMID:16870260
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
increases expression
ISO
Thimerosal results in increased expression of HSPA1L mRNA
CTD
PMID:16870260
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Hspa4l
heat shock protein family A (Hsp70) member 4 like
increases expression
ISO
Thimerosal results in increased expression of HSPA4L mRNA
CTD
PMID:27188386
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Thimerosal results in increased expression of HSPA6 mRNA
CTD
PMID:16870260
NCBI chr13:83,273,176...83,274,317
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
Thimerosal results in increased expression of HSPB1 mRNA
CTD
PMID:16870260
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Htatsf1
HIV-1 Tat specific factor 1
decreases expression
ISO
Thimerosal results in decreased expression of HTATSF1 mRNA
CTD
PMID:27188386
NCBI chr X:134,935,426...134,949,607
Ensembl chr X:134,935,426...134,949,607
G
Htr2c
5-hydroxytryptamine receptor 2C
increases expression
ISO
Thimerosal results in increased expression of HTR2C mRNA
CTD
PMID:27188386
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Hyls1
HYLS1, centriolar and ciliogenesis associated
increases expression
ISO
Thimerosal results in increased expression of HYLS1 mRNA
CTD
PMID:27188386
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
G
Ier5l
immediate early response 5-like
decreases expression
ISO
Thimerosal results in decreased expression of IER5L mRNA
CTD
PMID:24675092 PMID:27188386
NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647
G
Ifng
interferon gamma
affects response to substance multiple interactions
ISO
IFNG affects the susceptibility to Thimerosal Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]
CTD
PMID:15808517 PMID:17079650
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ift80
intraflagellar transport 80
increases expression
ISO
Thimerosal results in increased expression of IFT80 mRNA
CTD
PMID:27188386
NCBI chr 2:153,144,707...153,240,024
Ensembl chr 2:153,145,795...153,240,024
G
Igdcc3
immunoglobulin superfamily, DCC subclass, member 3
decreases expression
ISO
Thimerosal results in decreased expression of IGDCC3 mRNA
CTD
PMID:27188386
NCBI chr 8:65,661,165...65,707,961
Ensembl chr 8:65,661,196...65,707,959
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein] IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]
CTD
PMID:14745455 PMID:23145070
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
decreases expression
ISO
Thimerosal results in decreased expression of IGF2BP3 mRNA
CTD
PMID:27188386
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
Thimerosal results in decreased expression of IGFBP2 mRNA
CTD
PMID:27188386
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
ISO
Thimerosal results in decreased expression of IGFBP5 mRNA
CTD
PMID:27188386
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Iglon5
IgLON family member 5
decreases expression
ISO
Thimerosal results in decreased expression of IGLON5 mRNA
CTD
PMID:27188386
NCBI chr 1:93,880,906...93,898,929
Ensembl chr 1:93,881,991...93,898,754
G
Ikzf1
IKAROS family zinc finger 1
decreases expression
ISO
Thimerosal results in decreased expression of IKZF1 mRNA
CTD
PMID:27188386
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il13
interleukin 13
multiple interactions
ISO
[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein; Glutathione inhibits the reaction [[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein]
CTD
PMID:17079650
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra1
interleukin 13 receptor subunit alpha 1
decreases expression
ISO
Thimerosal results in decreased expression of IL13RA1 mRNA
CTD
PMID:27188386
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il17ra
interleukin 17 receptor A
decreases expression
ISO
Thimerosal results in decreased expression of IL17RA mRNA
CTD
PMID:27188386
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il27ra
interleukin 27 receptor subunit alpha
decreases expression
ISO
Thimerosal results in decreased expression of IL27RA mRNA
CTD
PMID:27188386
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Il5
interleukin 5
multiple interactions
ISO
[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL5 protein
CTD
PMID:17079650
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
affects response to substance multiple interactions
ISO
IL6 affects the susceptibility to Thimerosal Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:15808517 PMID:17079650
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ilf3
interleukin enhancer binding factor 3
decreases expression
ISO
Thimerosal results in decreased expression of ILF3 mRNA
CTD
PMID:27188386
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
G
Ilrun
inflammation and lipid regulator with UBA-like and NBR1-like domains
decreases expression
ISO
Thimerosal results in decreased expression of ILRUN mRNA
CTD
PMID:27188386
NCBI chr20:5,809,931...5,876,197
Ensembl chr20:5,809,936...5,876,012
G
Immp1l
inner mitochondrial membrane peptidase subunit 1
increases expression
ISO
Thimerosal results in increased expression of IMMP1L mRNA
CTD
PMID:27188386
NCBI chr 3:92,385,329...92,449,559
Ensembl chr 3:92,385,379...92,452,313
G
Inafm1
InaF-motif containing 1
decreases expression
ISO
Thimerosal results in decreased expression of INAFM1 mRNA
CTD
PMID:27188386
NCBI chr 1:76,976,808...76,978,292
G
Ing3
inhibitor of growth family, member 3
increases expression
ISO
Thimerosal results in increased expression of ING3 mRNA
CTD
PMID:27188386
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
G
Ino80d
INO80 complex subunit D
increases expression
ISO
Thimerosal results in increased expression of INO80D mRNA
CTD
PMID:27188386
NCBI chr 9:64,447,075...64,514,013
Ensembl chr 9:64,457,165...64,515,242
G
Insig1
insulin induced gene 1
decreases expression
ISO
Thimerosal results in decreased expression of INSIG1 mRNA
CTD
PMID:27188386
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Ints10
integrator complex subunit 10
increases expression
ISO
Thimerosal results in increased expression of INTS10 mRNA
CTD
PMID:27188386
NCBI chr16:20,915,223...20,947,146
Ensembl chr16:20,916,082...20,967,610
G
Ints14
integrator complex subunit 14
increases expression
ISO
Thimerosal results in increased expression of INTS14 mRNA
CTD
PMID:27188386
NCBI chr 8:65,475,788...65,500,807
Ensembl chr 8:65,475,910...65,500,804
G
Ints6
integrator complex subunit 6
increases expression
ISO
Thimerosal results in increased expression of INTS6 mRNA
CTD
PMID:27188386
NCBI chr15:36,908,966...37,048,043
Ensembl chr15:36,933,724...37,021,527
G
Iqgap1
IQ motif containing GTPase activating protein 1
decreases expression
ISO
Thimerosal results in decreased expression of IQGAP1 mRNA
CTD
PMID:27188386
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
G
Irag1
inositol 1,4,5-triphosphate receptor associated 1
decreases expression
ISO
Thimerosal results in decreased expression of IRAG1 mRNA
CTD
PMID:27188386
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
ISO
Thimerosal results in decreased expression of IRF2BP2 mRNA
CTD
PMID:27188386
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Isyna1
inositol-3-phosphate synthase 1
decreases expression
ISO
Thimerosal results in decreased expression of ISYNA1 mRNA
CTD
PMID:27188386
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
decreases expression
ISO
Thimerosal results in decreased expression of ITPR3 mRNA
CTD
PMID:27188386
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Itprid2
ITPR interacting domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of ITPRID2 mRNA
CTD
PMID:27188386
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
G
Itpripl1
ITPRIP like 1
decreases expression
ISO
Thimerosal results in decreased expression of ITPRIPL1 mRNA
CTD
PMID:27188386
NCBI chr 3:114,403,123...114,407,917
Ensembl chr 3:114,402,270...114,414,497
G
Itpripl2
ITPRIP like 2
decreases expression
ISO
Thimerosal results in decreased expression of ITPRIPL2 mRNA
CTD
PMID:27188386
NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:172,796,849...172,802,950
G
Itsn2
intersectin 2
decreases expression
ISO
Thimerosal results in decreased expression of ITSN2 mRNA
CTD
PMID:27188386
NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124
G
Iws1
interacts with SUPT6H, CTD assembly factor 1
decreases expression
ISO
Thimerosal results in decreased expression of IWS1 mRNA
CTD
PMID:27188386
NCBI chr18:23,695,496...23,737,363
Ensembl chr18:23,695,425...23,736,172
G
Jmjd1c
jumonji domain containing 1C
decreases expression
ISO
Thimerosal results in decreased expression of JMJD1C mRNA
CTD
PMID:27188386
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Jph3
junctophilin 3
decreases expression
ISO
Thimerosal results in decreased expression of JPH3 mRNA
CTD
PMID:27188386
NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Thimerosal results in increased expression of JUN mRNA
CTD
PMID:16870260
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Thimerosal results in decreased expression of JUND mRNA
CTD
PMID:27188386
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kansl1l
KAT8 regulatory NSL complex subunit 1-like
increases expression
ISO
Thimerosal results in increased expression of KANSL1L mRNA
CTD
PMID:16870260
NCBI chr 9:68,211,151...68,316,992
Ensembl chr 9:68,211,189...68,300,222
G
Kat2b
lysine acetyltransferase 2B
increases expression
ISO
Thimerosal results in increased expression of KAT2B mRNA
CTD
PMID:27188386
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
G
Kat6a
lysine acetyltransferase 6A
decreases expression
ISO
Thimerosal results in decreased expression of KAT6A mRNA
CTD
PMID:27188386
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
G
Kat8
lysine acetyltransferase 8
decreases expression
ISO
Thimerosal results in decreased expression of KAT8 mRNA
CTD
PMID:27188386
NCBI chr 1:182,524,355...182,536,638
Ensembl chr 1:182,515,327...182,536,633
G
Kbtbd2
kelch repeat and BTB domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of KBTBD2 mRNA
CTD
PMID:27188386
NCBI chr 4:86,027,947...86,050,266
Ensembl chr 4:86,027,947...86,050,211
G
Kbtbd8
kelch repeat and BTB domain containing 8
increases expression
ISO
Thimerosal results in increased expression of KBTBD8 mRNA
CTD
PMID:27188386
NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697
G
Kcnb2
potassium voltage-gated channel subfamily B member 2
increases expression
ISO
Thimerosal results in increased expression of KCNB2 mRNA
CTD
PMID:24675092
NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599
G
Kcnip3
potassium voltage-gated channel interacting protein 3
multiple interactions
ISO
[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]]
CTD
PMID:30503815
NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556
G
Kcnrg
potassium channel regulator
increases expression
ISO
Thimerosal results in increased expression of KCNRG mRNA
CTD
PMID:27188386
NCBI chr15:35,774,456...35,779,409
Ensembl chr15:35,774,326...35,779,415
G
Kdelr1
KDEL endoplasmic reticulum protein retention receptor 1
decreases expression
ISO
Thimerosal results in decreased expression of KDELR1 mRNA
CTD
PMID:27188386
NCBI chr 1:96,347,258...96,358,145
Ensembl chr 1:96,347,150...96,358,157
G
Kdm4b
lysine demethylase 4B
decreases expression
ISO
Thimerosal results in decreased expression of KDM4B mRNA
CTD
PMID:27188386
NCBI chr 9:1,158,737...1,237,233
Ensembl chr 9:1,158,752...1,236,543
G
Kdm6a
lysine demethylase 6A
decreases expression
ISO
Thimerosal results in decreased expression of KDM6A mRNA
CTD
PMID:27188386
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
G
Khk
ketohexokinase
decreases expression
ISO
Thimerosal results in decreased expression of KHK mRNA
CTD
PMID:27188386
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
G
Kif1a
kinesin family member 1A
decreases expression
ISO
Thimerosal results in decreased expression of KIF1A mRNA
CTD
PMID:27188386
NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480
G
Kif21b
kinesin family member 21B
decreases expression
ISO
Thimerosal results in decreased expression of KIF21B mRNA
CTD
PMID:24675092
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
G
Kif22
kinesin family member 22
decreases expression
ISO
Thimerosal results in decreased expression of KIF22 mRNA
CTD
PMID:24675092
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
G
Kiss1r
KISS1 receptor
decreases expression
ISO
Thimerosal results in decreased expression of KISS1R mRNA
CTD
PMID:27188386
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Klf12
KLF transcription factor 12
increases expression
ISO
Thimerosal results in increased expression of KLF12 mRNA
CTD
PMID:27188386
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
G
Klf13
KLF transcription factor 13
decreases expression
ISO
Thimerosal results in decreased expression of KLF13 mRNA
CTD
PMID:27188386
NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227
G
Klf15
KLF transcription factor 15
increases expression
ISO
Thimerosal results in increased expression of KLF15 mRNA
CTD
PMID:27188386
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Klf4
KLF transcription factor 4
increases expression
ISO
Thimerosal results in increased expression of KLF4 mRNA
CTD
PMID:16870260
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klhdc10
kelch domain containing 10
decreases expression
ISO
Thimerosal results in decreased expression of KLHDC10 mRNA
CTD
PMID:27188386
NCBI chr 4:59,021,300...59,079,118
Ensembl chr 4:59,021,310...59,074,941
G
Klhl24
kelch-like family member 24
decreases expression
ISO
Thimerosal results in decreased expression of KLHL24 mRNA
CTD
PMID:27188386
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
G
Klhl3
kelch-like family member 3
decreases expression
ISO
Thimerosal results in decreased expression of KLHL3 mRNA
CTD
PMID:27188386
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
G
Klhl41
kelch-like family member 41
increases expression
ISO
Thimerosal results in increased expression of KLHL41 mRNA
CTD
PMID:27188386
NCBI chr 3:54,434,291...54,447,415
Ensembl chr 3:54,434,234...54,449,222
G
Kmt2a
lysine methyltransferase 2A
decreases expression
ISO
Thimerosal results in decreased expression of KMT2A mRNA
CTD
PMID:27188386
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Knl1
kinetochore scaffold 1
decreases expression
ISO
Thimerosal results in decreased expression of KNL1 mRNA
CTD
PMID:27188386
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
G
Kras
KRAS proto-oncogene, GTPase
decreases expression
ISO
Thimerosal results in decreased expression of KRAS mRNA
CTD
PMID:27188386
NCBI chr 4:178,185,418...178,218,484
G
Krcc1
lysine-rich coiled-coil 1
increases expression
ISO
Thimerosal results in increased expression of KRCC1 mRNA
CTD
PMID:27188386
NCBI chr 4:103,261,642...103,274,672
Ensembl chr 4:103,261,536...103,277,156
G
Krr1
KRR1, small subunit processome component homolog
increases expression
ISO
Thimerosal results in increased expression of KRR1 mRNA
CTD
PMID:27188386
NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985
G
Larp1b
La ribonucleoprotein 1B
increases expression
ISO
Thimerosal results in increased expression of LARP1B mRNA
CTD
PMID:27188386
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Larp4
La ribonucleoprotein 4
decreases expression
ISO
Thimerosal results in decreased expression of LARP4 mRNA
CTD
PMID:27188386
NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811
G
Larp7
La ribonucleoprotein 7, transcriptional regulator
increases expression
ISO
Thimerosal results in increased expression of LARP7 mRNA
CTD
PMID:27188386
NCBI chr 2:215,997,641...216,012,833
Ensembl chr 2:215,997,649...216,012,865
G
Lars1
leucyl-tRNA synthetase 1
decreases expression
ISO
Thimerosal results in decreased expression of LARS1 mRNA
CTD
PMID:27188386
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
G
Lcorl
ligand dependent nuclear receptor corepressor-like
increases expression
ISO
Thimerosal results in increased expression of LCORL mRNA
CTD
PMID:27188386
NCBI chr14:65,271,339...65,407,732
Ensembl chr14:65,271,135...65,404,174
G
Ldha
lactate dehydrogenase A
decreases expression
ISO
Thimerosal results in decreased expression of LDHA mRNA
CTD
PMID:27188386
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Lgals3bp
galectin 3 binding protein
decreases expression
ISO
Thimerosal results in decreased expression of LGALS3BP mRNA
CTD
PMID:27188386
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lgalsl
galectin-like
decreases expression
ISO
Thimerosal results in decreased expression of LGALSL mRNA
CTD
PMID:27188386
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
increases expression
ISO
Thimerosal results in increased expression of LGR5 mRNA
CTD
PMID:24675092
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
G
Lgr6
leucine-rich repeat-containing G protein-coupled receptor 6
increases expression
ISO
Thimerosal results in increased expression of LGR6 mRNA
CTD
PMID:24675092
NCBI chr13:46,424,382...46,544,074
Ensembl chr13:46,424,383...46,543,945
G
Lhb
luteinizing hormone subunit beta
increases expression
ISO
Thimerosal results in increased expression of LHB mRNA; Thimerosal results in increased expression of LHB protein
CTD
PMID:24675092
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhx9
LIM homeobox 9
decreases expression
ISO
Thimerosal results in decreased expression of LHX9 mRNA
CTD
PMID:27188386
NCBI chr13:50,389,052...50,409,947
Ensembl chr13:50,389,738...50,410,806
G
Lima1
LIM domain and actin binding 1
decreases expression
ISO
Thimerosal results in decreased expression of LIMA1 mRNA
CTD
PMID:27188386
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
Thimerosal results in increased expression of LIMS1 mRNA
CTD
PMID:27188386
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lin7c
lin-7 homolog C, crumbs cell polarity complex component
increases expression
ISO
Thimerosal results in increased expression of LIN7C mRNA
CTD
PMID:27188386
NCBI chr 3:96,406,800...96,417,779
Ensembl chr 3:96,406,813...96,417,728
G
Lin9
lin-9 DREAM MuvB core complex component
increases expression
ISO
Thimerosal results in increased expression of LIN9 mRNA
CTD
PMID:27188386
NCBI chr13:92,374,612...92,419,664
Ensembl chr13:92,374,593...92,419,654
G
Litaf
lipopolysaccharide-induced TNF factor
decreases expression
ISO
Thimerosal results in decreased expression of LITAF mRNA
CTD
PMID:27188386
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lix1l
limb and CNS expressed 1 like
decreases expression
ISO
Thimerosal results in decreased expression of LIX1L mRNA
CTD
PMID:27188386
NCBI chr 2:184,136,018...184,161,918
Ensembl chr 2:184,136,038...184,161,916
G
Lmbrd2
LMBR1 domain containing 2
increases expression
ISO
Thimerosal results in increased expression of LMBRD2 mRNA
CTD
PMID:27188386
NCBI chr 2:58,189,558...58,251,565
Ensembl chr 2:58,189,558...58,247,076
G
Lmf1
lipase maturation factor 1
decreases expression
ISO
Thimerosal results in decreased expression of LMF1 mRNA
CTD
PMID:27188386
NCBI chr10:14,597,726...14,684,071
Ensembl chr10:14,597,594...14,684,119
G
Lnpep
leucyl and cystinyl aminopeptidase
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA
CTD
PMID:27188386
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
G
Lpcat1
lysophosphatidylcholine acyltransferase 1
increases expression
ISO
Thimerosal results in increased expression of LPCAT1 mRNA
CTD
PMID:24675092
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
G
Lpgat1
lysophosphatidylglycerol acyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of LPGAT1 mRNA
CTD
PMID:27188386
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
G
Lrp6
LDL receptor related protein 6
decreases expression
ISO
Thimerosal results in decreased expression of LRP6 mRNA
CTD
PMID:27188386
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
G
Lrpprc
leucine-rich pentatricopeptide repeat containing
increases expression
ISO
Thimerosal results in increased expression of LRPPRC mRNA
CTD
PMID:27188386
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
G
Lrrc26
leucine rich repeat containing 26
decreases expression
ISO
Thimerosal results in decreased expression of LRRC26 mRNA
CTD
PMID:24675092
NCBI chr 3:8,102,361...8,103,687
Ensembl chr 3:8,102,361...8,103,687
G
Lrrc7
leucine rich repeat containing 7
increases expression
ISO
Thimerosal results in increased expression of LRRC7 mRNA
CTD
PMID:27188386
NCBI chr 2:247,146,616...247,634,945
Ensembl chr 2:247,147,752...247,634,547
G
Lrrc75b
leucine rich repeat containing 75B
decreases expression
ISO
Thimerosal results in decreased expression of LRRC75B mRNA
CTD
PMID:27188386
NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503
G
Lsm12
LSM12 homolog
decreases expression
ISO
Thimerosal results in decreased expression of LSM12 mRNA
CTD
PMID:27188386
NCBI chr10:87,118,334...87,140,395
Ensembl chr10:87,118,416...87,140,396
G
Lsm14b
LSM family member 14B
decreases expression
ISO
Thimerosal results in decreased expression of LSM14B mRNA
CTD
PMID:27188386
NCBI chr 3:167,125,633...167,136,417
Ensembl chr 3:167,125,628...167,136,432
G
Lsm5
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated
increases expression
ISO
Thimerosal results in increased expression of LSM5 mRNA
CTD
PMID:27188386
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
G
Lss
lanosterol synthase
decreases expression
ISO
Thimerosal results in decreased expression of LSS mRNA
CTD
PMID:27188386
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Lta4h
leukotriene A4 hydrolase
decreases expression
ISO
Thimerosal results in decreased expression of LTA4H mRNA
CTD
PMID:27188386
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
G
Ltbp2
latent transforming growth factor beta binding protein 2
decreases expression
ISO
Thimerosal results in decreased expression of LTBP2 mRNA
CTD
PMID:24675092
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Ltn1
listerin E3 ubiquitin protein ligase 1
decreases expression
ISO
Thimerosal results in decreased expression of LTN1 mRNA
CTD
PMID:27188386
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
G
Luzp1
leucine zipper protein 1
decreases expression
ISO
Thimerosal results in decreased expression of LUZP1 mRNA
CTD
PMID:24675092
NCBI chr 5:148,706,094...148,781,616
Ensembl chr 5:148,706,138...148,781,609
G
Lysmd4
LysM domain containing 4
decreases expression
ISO
Thimerosal results in decreased expression of LYSMD4 mRNA
CTD
PMID:24675092
NCBI chr 1:120,839,180...120,845,148
Ensembl chr 1:120,839,282...120,845,135
G
Mafb
MAF bZIP transcription factor B
increases expression
ISO
Thimerosal results in increased expression of MAFB mRNA
CTD
PMID:16870260
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Maff
MAF bZIP transcription factor F
decreases expression
ISO
Thimerosal results in decreased expression of MAFF mRNA
CTD
PMID:27188386
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Magel2
MAGE family member L2
decreases expression
ISO
Thimerosal results in decreased expression of MAGEL2 mRNA
CTD
PMID:27188386
NCBI chr 1:115,880,142...115,884,684
Ensembl chr 1:115,880,474...115,884,250
G
Magi2
membrane associated guanylate kinase, WW and PDZ domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of MAGI2 mRNA
CTD
PMID:27188386
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
G
Mansc1
MANSC domain containing 1
decreases expression
ISO
Thimerosal results in decreased expression of MANSC1 mRNA
CTD
PMID:27188386
NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606
G
Maoa
monoamine oxidase A
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA
CTD
PMID:27188386
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Map2k2
mitogen activated protein kinase kinase 2
decreases expression
ISO
Thimerosal results in decreased expression of MAP2K2 mRNA
CTD
PMID:27188386
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Map3k11
mitogen-activated protein kinase kinase kinase 11
decreases expression
ISO
Thimerosal results in decreased expression of MAP3K11 mRNA
CTD
PMID:27188386
NCBI chr 1:202,975,353...202,988,655
Ensembl chr 1:202,975,353...202,988,652
G
Map3k3
mitogen activated protein kinase kinase kinase 3
decreases expression
ISO
Thimerosal results in decreased expression of MAP3K3 mRNA
CTD
PMID:27188386
NCBI chr10:91,020,174...91,088,852
Ensembl chr10:91,020,174...91,088,848
G
Map3k6
mitogen-activated protein kinase kinase kinase 6
decreases expression
ISO
Thimerosal results in decreased expression of MAP3K6 mRNA
CTD
PMID:27188386
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
G
Map4
microtubule-associated protein 4
decreases expression
ISO
Thimerosal results in decreased expression of MAP4 mRNA
CTD
PMID:27188386
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
G
Map4k1
mitogen activated protein kinase kinase kinase kinase 1
decreases expression
ISO
Thimerosal results in decreased expression of MAP4K1 mRNA
CTD
PMID:27188386
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
G
Map4k5
mitogen-activated protein kinase kinase kinase kinase 5
decreases expression
ISO
Thimerosal results in decreased expression of MAP4K5 mRNA
CTD
PMID:27188386
NCBI chr 6:88,284,087...88,377,118
Ensembl chr 6:88,284,094...88,376,799
G
Map9
microtubule-associated protein 9
increases expression
ISO
Thimerosal results in increased expression of MAP9 mRNA
CTD
PMID:27188386
NCBI chr 2:167,708,661...167,743,927
Ensembl chr 2:167,708,765...167,740,736
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation
ISO
Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:18495191
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
increases phosphorylation decreases expression
ISO
Thimerosal results in increased phosphorylation of MAPK14 protein Thimerosal results in decreased expression of MAPK14 mRNA
CTD
PMID:15737199 PMID:27188386
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation increases phosphorylation multiple interactions
ISO
Thimerosal results in decreased phosphorylation of MAPK3 protein Thimerosal results in increased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:17698513 PMID:18495191
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation increases expression
ISO
Thimerosal results in increased phosphorylation of MAPK8 protein Thimerosal results in increased expression of MAPK8 mRNA
CTD
PMID:18495191 PMID:27188386
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
ISO
Thimerosal results in increased phosphorylation of MAPK9 protein
CTD
PMID:17698513
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapkapk2
MAPK activated protein kinase 2
decreases expression
ISO
Thimerosal results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:27188386
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Marchf1
membrane associated ring-CH-type finger 1
increases expression
ISO
Thimerosal results in increased expression of MARCHF1 mRNA
CTD
PMID:27188386
NCBI chr16:23,255,551...24,114,290
Ensembl chr16:23,258,799...24,114,277
G
Mark4
microtubule affinity regulating kinase 4
decreases expression
ISO
Thimerosal results in decreased expression of MARK4 mRNA
CTD
PMID:27188386
NCBI chr 1:79,075,353...79,108,882
Ensembl chr 1:79,068,904...79,108,556
G
Mbd2
methyl-CpG binding domain protein 2
decreases expression
ISO
Thimerosal results in decreased expression of MBD2 mRNA
CTD
PMID:27188386
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbnl2
muscleblind-like splicing regulator 2
decreases expression
ISO
Thimerosal results in decreased expression of MBNL2 mRNA
CTD
PMID:27188386
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mboat7
membrane bound O-acyltransferase domain containing 7
decreases expression
ISO
Thimerosal results in decreased expression of MBOAT7 mRNA
CTD
PMID:27188386
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
G
Mcph1
microcephalin 1
increases expression
ISO
Thimerosal results in increased expression of MCPH1 mRNA
CTD
PMID:27188386
NCBI chr16:71,021,855...71,224,067
Ensembl chr16:71,024,588...71,224,122
G
Mdh2
malate dehydrogenase 2
decreases expression
ISO
Thimerosal results in decreased expression of MDH2 mRNA
CTD
PMID:27188386
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Meak7
MTOR associated protein, eak-7 homolog
decreases expression
ISO
Thimerosal results in decreased expression of MEAK7 mRNA
CTD
PMID:27188386
NCBI chr19:47,813,899...47,836,830
Ensembl chr19:47,811,416...47,841,278
G
Mecom
MDS1 and EVI1 complex locus
increases expression
ISO
Thimerosal results in increased expression of MECOM mRNA
CTD
PMID:27188386
NCBI chr 2:112,909,353...113,464,583
Ensembl chr 2:112,909,321...113,464,590
G
Med13
mediator complex subunit 13
decreases expression
ISO
Thimerosal results in decreased expression of MED13 mRNA
CTD
PMID:27188386
NCBI chr10:71,086,978...71,176,535
Ensembl chr10:71,090,516...71,177,242
G
Med13l
mediator complex subunit 13L
increases expression
ISO
Thimerosal results in increased expression of MED13L mRNA
CTD
PMID:27188386
NCBI chr12:37,807,596...38,004,886
Ensembl chr12:37,808,285...38,004,473
G
Med16
mediator complex subunit 16
decreases expression
ISO
Thimerosal results in decreased expression of MED16 mRNA
CTD
PMID:27188386
NCBI chr 7:9,798,641...9,811,172
Ensembl chr 7:9,798,668...9,811,172
G
Med17
mediator complex subunit 17
increases expression
ISO
Thimerosal results in increased expression of MED17 mRNA
CTD
PMID:27188386
NCBI chr 8:12,101,594...12,120,592
Ensembl chr 8:12,101,594...12,120,592
G
Med18
mediator complex subunit 18
decreases expression
ISO
Thimerosal results in decreased expression of MED18 mRNA
CTD
PMID:16870260
NCBI chr 5:144,663,316...144,668,652
Ensembl chr 5:144,663,252...144,668,635
G
Med21
mediator complex subunit 21
increases expression
ISO
Thimerosal results in increased expression of MED21 mRNA
CTD
PMID:27188386
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
G
Med25
mediator complex subunit 25
decreases expression
ISO
Thimerosal results in decreased expression of MED25 mRNA
CTD
PMID:27188386
NCBI chr 1:95,359,961...95,375,827
Ensembl chr 1:95,360,284...95,375,877
G
Medag
mesenteric estrogen-dependent adipogenesis
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA
CTD
PMID:27188386
NCBI chr12:5,613,191...5,634,583
Ensembl chr12:5,613,208...5,634,767
G
Megf6
multiple EGF-like-domains 6
decreases expression
ISO
Thimerosal results in decreased expression of MEGF6 mRNA
CTD
PMID:24675092
NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139
G
Mettl18
methyltransferase 18, RPL3 N3(tau)-histidine
increases expression
ISO
Thimerosal results in increased expression of METTL18 mRNA
CTD
PMID:27188386
NCBI chr13:76,345,888...76,348,798
Ensembl chr13:76,345,957...76,348,836
G
Mgmt
O-6-methylguanine-DNA methyltransferase
decreases expression
ISO
Thimerosal results in decreased expression of MGMT mRNA
CTD
PMID:27188386
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mia3
MIA SH3 domain ER export factor 3
increases expression
ISO
Thimerosal results in increased expression of MIA3 mRNA
CTD
PMID:27188386
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
G
Mid1
midline 1
decreases expression
ISO
Thimerosal results in decreased expression of MID1 mRNA
CTD
PMID:24675092
NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353
G
Mier3
MIER family member 3
increases expression
ISO
Thimerosal results in increased expression of MIER3 mRNA
CTD
PMID:27188386
NCBI chr 2:43,287,546...43,316,422
Ensembl chr 2:43,287,916...43,316,136
G
Mill1
MHC I like leukocyte 1
decreases expression
ISO
Thimerosal results in decreased expression of MICA mRNA
CTD
PMID:27188386
NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930
G
Mis18bp1
MIS18 binding protein 1
decreases expression
ISO
Thimerosal results in decreased expression of MIS18BP1 mRNA
CTD
PMID:27188386
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
G
Mkln1
muskelin 1
increases expression
ISO
Thimerosal results in increased expression of MKLN1 mRNA
CTD
PMID:27188386
NCBI chr 4:59,815,912...60,124,047
Ensembl chr 4:60,002,464...60,123,993
G
Mkrn3
makorin, ring finger protein, 3
decreases expression
ISO
Thimerosal results in decreased expression of MKRN3 mRNA
CTD
PMID:27188386
NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283
G
Mlf2
myeloid leukemia factor 2
decreases expression
ISO
Thimerosal results in decreased expression of MLF2 mRNA
CTD
PMID:27188386
NCBI chr 4:157,739,651...157,744,325
Ensembl chr 4:157,728,756...157,744,317
G
Mmp16
matrix metallopeptidase 16
affects expression
ISO
Thimerosal affects the expression of MMP16 mRNA
CTD
PMID:27188386
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
G
Mob1a
MOB kinase activator 1A
decreases expression
ISO
Thimerosal results in decreased expression of MOB1A mRNA
CTD
PMID:27188386
NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561
G
Mpi
mannose phosphate isomerase
decreases expression
ISO
Thimerosal results in decreased expression of MPI mRNA
CTD
PMID:27188386
NCBI chr 8:57,947,883...57,956,205
Ensembl chr 8:57,947,893...57,956,150
G
Mrap2
melanocortin 2 receptor accessory protein 2
decreases expression
ISO
Thimerosal results in decreased expression of MRAP2 mRNA
CTD
PMID:27188386
NCBI chr 8:88,088,293...88,144,636
Ensembl chr 8:88,088,272...88,143,886
G
Mroh1
maestro heat-like repeat family member 1
decreases expression
ISO
Thimerosal results in decreased expression of MROH1 mRNA
CTD
PMID:27188386
NCBI chr 7:108,098,708...108,172,146
Ensembl chr 7:108,102,734...108,172,146
G
Mrpl1
mitochondrial ribosomal protein L1
increases expression
ISO
Thimerosal results in increased expression of MRPL1 mRNA
CTD
PMID:27188386
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
G
Mrpl10
mitochondrial ribosomal protein L10
decreases expression
ISO
Thimerosal results in decreased expression of MRPL10 mRNA
CTD
PMID:27188386
NCBI chr10:82,026,031...82,034,451
Ensembl chr10:82,026,031...82,034,443
G
Mrpl50
mitochondrial ribosomal protein L50
increases expression
ISO
Thimerosal results in increased expression of MRPL50 mRNA
CTD
PMID:27188386
NCBI chr 5:63,867,437...63,872,591
G
Mrps2
mitochondrial ribosomal protein S2
decreases expression
ISO
Thimerosal results in decreased expression of MRPS2 mRNA
CTD
PMID:27188386
NCBI chr 3:11,803,044...11,806,341
Ensembl chr 3:11,801,310...11,806,313
G
Ms4a15
membrane spanning 4-domains A15
increases expression
ISO
Thimerosal results in increased expression of MS4A15 mRNA
CTD
PMID:24675092
NCBI chr 1:207,628,305...207,641,799
Ensembl chr 1:207,628,305...207,641,799
G
Msn
moesin
decreases expression
ISO
Thimerosal results in decreased expression of MSN mRNA
CTD
PMID:27188386
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mt1
metallothionein 1
affects expression increases expression
ISO
Thimerosal affects the expression of MT1 mRNA Thimerosal results in increased expression of MT1 mRNA; Thimerosal results in increased expression of MT1 protein
CTD
PMID:19357975 PMID:19386279
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
increases expression
ISO
Thimerosal results in increased expression of MT2 mRNA; Thimerosal results in increased expression of MT2 protein
CTD
PMID:19357975
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
increases expression
ISO
Thimerosal results in increased expression of MT3 mRNA
CTD
PMID:19357975
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Mta1
metastasis associated 1
decreases expression
ISO
Thimerosal results in decreased expression of MTA1 mRNA
CTD
PMID:27188386
NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641
G
Mta2
metastasis associated 1 family, member 2
decreases expression
ISO
Thimerosal results in decreased expression of MTA2 mRNA
CTD
PMID:27188386
NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946
G
Mtarc2
mitochondrial amidoxime reducing component 2
decreases expression
ISO
Thimerosal results in decreased expression of MTARC2 mRNA
CTD
PMID:27188386
NCBI chr13:96,362,810...96,397,284
G
Mtcl2
microtubule crosslinking factor 2
increases expression
ISO
Thimerosal results in increased expression of MTCL2 mRNA
CTD
PMID:27188386
NCBI chr 3:145,669,102...145,741,578
Ensembl chr 3:145,675,443...145,740,871
G
Mtcl3
MTCL family member 3
decreases expression
ISO
Thimerosal results in decreased expression of MTCL3 mRNA
CTD
PMID:27188386
NCBI chr 1:28,629,036...28,701,416
Ensembl chr 1:28,620,293...28,701,796
G
Mtfp1
mitochondrial fission process 1
decreases expression
ISO
Thimerosal results in decreased expression of MTFP1 mRNA
CTD
PMID:27188386
NCBI chr14:78,968,434...78,972,274
Ensembl chr14:78,968,442...78,972,274
G
Mthfd2l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like
increases expression
ISO
Thimerosal results in increased expression of MTHFD2L mRNA
CTD
PMID:27188386
NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112
G
Mtpap
mitochondrial poly(A) polymerase
increases expression
ISO
Thimerosal results in increased expression of MTPAP mRNA
CTD
PMID:27188386
NCBI chr17:53,320,739...53,341,500
Ensembl chr17:53,320,741...53,341,538
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
multiple interactions decreases expression
ISO
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form] Thimerosal results in decreased expression of MTR mRNA
CTD
PMID:14745455 PMID:26989453 PMID:27188386
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Mvb12a
multivesicular body subunit 12A
decreases expression
ISO
Thimerosal results in decreased expression of MVB12A mRNA
CTD
PMID:27188386
NCBI chr16:18,252,227...18,257,111
Ensembl chr16:18,252,222...18,257,539
G
Mxd1
max dimerization protein 1
increases expression
ISO
Thimerosal results in increased expression of MXD1 mRNA
CTD
PMID:16870260
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Mxra8
matrix remodeling associated 8
decreases expression
ISO
Thimerosal results in decreased expression of MXRA8 mRNA
CTD
PMID:27188386
NCBI chr 5:166,448,919...166,453,645
Ensembl chr 5:166,449,154...166,453,636
G
Mynn
myoneurin
increases expression
ISO
Thimerosal results in increased expression of MYNN mRNA
CTD
PMID:27188386
NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397
G
Myo1e
myosin IE
decreases expression
ISO
Thimerosal results in decreased expression of MYO1E mRNA
CTD
PMID:27188386
NCBI chr 8:70,887,934...71,080,180
Ensembl chr 8:70,887,870...71,080,169
G
Myo5a
myosin VA
decreases expression
ISO
Thimerosal results in decreased expression of MYO5A mRNA
CTD
PMID:27188386
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
G
Myo6
myosin VI
decreases expression
ISO
Thimerosal results in decreased expression of MYO6 mRNA
CTD
PMID:27188386
NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292
G
Myo9a
myosin IXA
increases expression
ISO
Thimerosal results in increased expression of MYO9A mRNA
CTD
PMID:27188386
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
G
Mzf1
myeloid zinc finger 1
decreases expression
ISO
Thimerosal results in decreased expression of MZF1 mRNA
CTD
PMID:24675092
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
G
N4bp2l2
NEDD4 binding protein 2-like 2
increases expression
ISO
Thimerosal results in increased expression of N4BP2L2 mRNA
CTD
PMID:27188386
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
N4bp3
Nedd4 binding protein 3
decreases expression
ISO
Thimerosal results in decreased expression of N4BP3 mRNA
CTD
PMID:27188386
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
G
Naa16
N(alpha)-acetyltransferase 16, NatA auxiliary subunit
decreases expression
ISO
Thimerosal results in decreased expression of NAA16 mRNA
CTD
PMID:27188386
NCBI chr15:54,711,620...54,770,915
Ensembl chr15:54,711,621...54,770,896
G
Naaa
N-acylethanolamine acid amidase
increases expression
ISO
Thimerosal results in increased expression of NAAA mRNA
CTD
PMID:27188386
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
G
Naprt
nicotinate phosphoribosyltransferase
decreases expression
ISO
Thimerosal results in decreased expression of NAPRT mRNA
CTD
PMID:27188386
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
Thimerosal results in decreased expression of NASP mRNA
CTD
PMID:27188386
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
G
Natd1
N-acetyltransferase domain containing 1
decreases expression
ISO
Thimerosal results in decreased expression of NATD1 mRNA
CTD
PMID:27188386
NCBI chr10:45,580,154...45,590,333
G
Nav3
neuron navigator 3
increases expression
ISO
Thimerosal results in increased expression of NAV3 mRNA
CTD
PMID:27188386
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
G
Nbas
NBAS subunit of NRZ tethering complex
decreases expression
ISO
Thimerosal results in decreased expression of NBAS mRNA
CTD
PMID:27188386
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
G
Ncam1
neural cell adhesion molecule 1
decreases expression
ISO
Thimerosal results in decreased expression of NCAM1 mRNA
CTD
PMID:27188386
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Ndrg1
N-myc downstream regulated 1
decreases expression
ISO
Thimerosal results in decreased expression of NDRG1 mRNA
CTD
PMID:27188386
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndufa5
NADH:ubiquinone oxidoreductase subunit A5
increases expression
ISO
Thimerosal results in increased expression of NDUFA5 mRNA
CTD
PMID:27188386
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598
G
Ndufa9
NADH:ubiquinone oxidoreductase subunit A9
increases expression
ISO
Thimerosal results in increased expression of NDUFA9 mRNA
CTD
PMID:27188386
NCBI chr 4:159,659,242...159,688,034
Ensembl chr 4:159,659,242...159,688,018
G
Ndufaf4
NADH:ubiquinone oxidoreductase complex assembly factor 4
increases expression
ISO
Thimerosal results in increased expression of NDUFAF4 mRNA
CTD
PMID:27188386
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
G
Ndufb7
NADH:ubiquinone oxidoreductase subunit B7
decreases expression
ISO
Thimerosal results in decreased expression of NDUFB7 mRNA
CTD
PMID:27188386
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
G
Nefh
neurofilament heavy chain
decreases expression
ISO
Thimerosal results in decreased expression of NEFH mRNA
CTD
PMID:27188386
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Negr1
neuronal growth regulator 1
decreases expression
ISO
Thimerosal results in decreased expression of NEGR1 mRNA
CTD
PMID:27188386
NCBI chr 2:245,624,460...246,359,605
Ensembl chr 2:245,624,435...246,356,730
G
Nes
nestin
decreases expression
ISO
Thimerosal results in decreased expression of NES mRNA
CTD
PMID:27188386
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nf1
neurofibromin 1
affects expression
ISO
Thimerosal affects the expression of NF1 mRNA
CTD
PMID:27188386
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
G
Nfat5
nuclear factor of activated T-cells 5
decreases expression
ISO
Thimerosal results in decreased expression of NFAT5 mRNA
CTD
PMID:27188386
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nfatc2ip
nuclear factor of activated T-cells 2 interacting protein
decreases expression
ISO
Thimerosal results in decreased expression of NFATC2IP mRNA
CTD
PMID:27188386
NCBI chr 1:180,954,834...180,971,847
Ensembl chr 1:180,955,043...180,971,747
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression multiple interactions
ISO
Thimerosal results in increased expression of NFE2L2 protein Aluminum Hydroxide promotes the reaction [Thimerosal results in increased expression of NFE2L2 protein]
CTD
PMID:36411272
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfyb
nuclear transcription factor Y subunit beta
increases expression
ISO
Thimerosal results in increased expression of NFYB mRNA
CTD
PMID:27188386
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
G
Ngf
nerve growth factor
multiple interactions decreases response to substance
ISO
[Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein NGF protein results in decreased susceptibility to Thimerosal
CTD
PMID:15843506
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nipal3
NIPA-like domain containing 3
decreases expression
ISO
Thimerosal results in decreased expression of NIPAL3 mRNA
CTD
PMID:27188386
NCBI chr 5:147,687,310...147,725,838
Ensembl chr 5:147,685,288...147,726,351
G
Nipbl
NIPBL, cohesin loading factor
decreases expression
ISO
Thimerosal results in decreased expression of NIPBL mRNA
CTD
PMID:27188386
NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899
G
Nipsnap1
nipsnap homolog 1
decreases expression
ISO
Thimerosal results in decreased expression of NIPSNAP1 mRNA
CTD
PMID:27188386
NCBI chr14:79,734,234...79,758,101
Ensembl chr14:79,734,209...79,758,098
G
Nkain2
sodium/potassium transporting ATPase interacting 2
decreases expression
ISO
Thimerosal results in decreased expression of NKAIN2 mRNA
CTD
PMID:24675092
NCBI chr 1:24,668,627...25,877,051
Ensembl chr 1:24,669,462...25,877,064
G
Nlrx1
NLR family member X1
decreases expression
ISO
Thimerosal results in decreased expression of NLRX1 mRNA
CTD
PMID:24675092
NCBI chr 8:44,588,476...44,606,678
Ensembl chr 8:44,590,048...44,606,484
G
Nme4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
ISO
Thimerosal results in decreased expression of NME4 mRNA
CTD
PMID:27188386
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
G
Nog
noggin
multiple interactions decreases expression
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP1LC3C mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLCO4A1-AS1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA Thimerosal results in decreased expression of NOG mRNA
CTD
PMID:27188386
NCBI chr10:74,128,712...74,130,339
Ensembl chr10:74,128,712...74,130,339
G
Nol3
nucleolar protein 3
decreases expression
ISO
Thimerosal results in decreased expression of NOL3 mRNA
CTD
PMID:27188386
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
G
Nop53
NOP53 ribosome biogenesis factor
decreases expression
ISO
Thimerosal results in decreased expression of NOP53 mRNA
CTD
PMID:27188386
NCBI chr 1:76,629,084...76,636,902
Ensembl chr 1:76,629,069...76,636,902
G
Npas3
neuronal PAS domain protein 3
increases expression
ISO
Thimerosal results in increased expression of NPAS3 mRNA
CTD
PMID:24675092
NCBI chr 6:70,702,773...71,527,928
Ensembl chr 6:70,703,170...71,524,884
G
Npat
nuclear protein, co-activator of histone transcription
increases expression
ISO
Thimerosal results in increased expression of NPAT mRNA
CTD
PMID:16870260
NCBI chr 8:53,932,993...53,970,875
Ensembl chr 8:53,932,993...53,970,875
G
Nphp1
nephrocystin 1
increases expression
ISO
Thimerosal results in increased expression of NPHP1 mRNA
CTD
PMID:27188386
NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:114,960,650...115,016,234
G
Nprl3
NPR3-like, GATOR1 complex subunit
decreases expression
ISO
Thimerosal results in decreased expression of NPRL3 mRNA
CTD
PMID:27188386
NCBI chr10:15,355,361...15,395,812
Ensembl chr10:15,355,355...15,395,810
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Thimerosal results in increased expression of NQO1 mRNA
CTD
PMID:27188386
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr2c2
nuclear receptor subfamily 2, group C, member 2
decreases expression
ISO
Thimerosal results in decreased expression of NR2C2 mRNA
CTD
PMID:27188386
NCBI chr 4:124,610,216...124,666,813
Ensembl chr 4:124,608,960...124,661,902
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
Thimerosal results in increased expression of NR4A1 mRNA
CTD
PMID:16870260
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Thimerosal results in increased expression of NR4A2 mRNA
CTD
PMID:16870260
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nrdc
nardilysin convertase
increases expression
ISO
Thimerosal results in increased expression of NRDC mRNA
CTD
PMID:27188386
NCBI chr 5:123,755,807...123,818,910
Ensembl chr 5:123,755,806...123,818,595
G
Nrm
nurim
decreases expression
ISO
Thimerosal results in decreased expression of NRM mRNA
CTD
PMID:27188386
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
G
Nt5dc2
5'-nucleotidase domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of NT5DC2 mRNA
CTD
PMID:27188386
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
multiple interactions
ISO
[Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein
CTD
PMID:15843506
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
decreases expression
ISO
Thimerosal results in decreased expression of NTRK3 mRNA
CTD
PMID:24675092
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
G
Nub1
negative regulator of ubiquitin-like proteins 1
decreases expression
ISO
Thimerosal results in decreased expression of NUB1 mRNA
CTD
PMID:27188386
NCBI chr 4:10,442,917...10,473,689
Ensembl chr 4:10,442,917...10,473,694
G
Nynrin
NYN domain and retroviral integrase containing
decreases expression
ISO
Thimerosal results in decreased expression of NYNRIN mRNA
CTD
PMID:27188386
NCBI chr15:29,332,873...29,355,215
Ensembl chr15:29,332,869...29,355,215
G
Obi1
ORC ubiquitin ligase 1
increases expression
ISO
Thimerosal results in increased expression of OBI1 mRNA
CTD
PMID:27188386
NCBI chr15:81,269,413...81,308,734
Ensembl chr15:81,269,416...81,308,734
G
Obsl1
obscurin like cytoskeletal adaptor 1
decreases expression
ISO
Thimerosal results in decreased expression of OBSL1 mRNA
CTD
PMID:27188386
NCBI chr 9:76,967,802...76,993,771
Ensembl chr 9:76,974,253...76,993,560
G
Ociad1
OCIA domain containing 1
decreases expression
ISO
Thimerosal results in decreased expression of OCIAD1 mRNA
CTD
PMID:27188386
NCBI chr14:34,897,851...34,915,291
Ensembl chr14:34,897,847...34,915,286
G
Omp
olfactory marker protein
increases expression
ISO
Thimerosal results in increased expression of OMP mRNA
CTD
PMID:24675092
NCBI chr 1:152,440,278...152,440,828
Ensembl chr 1:152,433,652...152,441,922
G
Osbpl8
oxysterol binding protein-like 8
decreases expression
ISO
Thimerosal results in decreased expression of OSBPL8 mRNA
CTD
PMID:27188386
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Otub2
OTU deubiquitinase, ubiquitin aldehyde binding 2
decreases expression
ISO
Thimerosal results in decreased expression of OTUB2 mRNA
CTD
PMID:27188386
NCBI chr 6:122,545,067...122,563,657
Ensembl chr 6:122,545,061...122,563,644
G
Otud4
OTU deubiquitinase 4
decreases expression
ISO
Thimerosal results in decreased expression of OTUD4 mRNA
CTD
PMID:27188386
NCBI chr19:28,236,713...28,279,815
Ensembl chr19:28,236,713...28,279,815
G
Otud6b
OTU deubiquitinase 6B
increases expression
ISO
Thimerosal results in increased expression of OTUD6B mRNA
CTD
PMID:27188386
NCBI chr 5:28,181,992...28,214,486
Ensembl chr 5:28,023,594...28,214,334
G
Otulinl
OTU deubiquitinase with linear linkage specificity like
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA
CTD
PMID:27188386
NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
Thimerosal results in decreased expression of P4HA1 mRNA
CTD
PMID:27188386
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Pacsin1
protein kinase C and casein kinase substrate in neurons 1
decreases expression
ISO
Thimerosal results in decreased expression of PACSIN1 mRNA
CTD
PMID:27188386
NCBI chr20:5,718,134...5,768,064
Ensembl chr20:5,719,857...5,765,313
G
Paip2b
poly(A) binding protein interacting protein 2B
decreases expression
ISO
Thimerosal results in decreased expression of PAIP2B mRNA
CTD
PMID:27188386
NCBI chr 4:116,292,001...116,323,387
Ensembl chr 4:116,292,020...116,323,379
G
Pald1
phosphatase domain containing, paladin 1
decreases expression
ISO
Thimerosal results in decreased expression of PALD1 mRNA
CTD
PMID:27188386
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
G
Pank2
pantothenate kinase 2
increases expression
ISO
Thimerosal results in increased expression of PANK2 mRNA
CTD
PMID:27188386
NCBI chr 3:118,483,382...118,519,551
Ensembl chr 3:118,483,444...118,518,320
G
Pard3b
par-3 family cell polarity regulator beta
increases expression
ISO
Thimerosal results in increased expression of PARD3B mRNA
CTD
PMID:24675092
NCBI chr 9:63,038,435...64,067,178
Ensembl chr 9:63,038,436...64,068,053
G
Parpbp
PARP1 binding protein
increases expression
ISO
Thimerosal results in increased expression of PARPBP mRNA
CTD
PMID:27188386
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
G
Pc
pyruvate carboxylase
decreases expression
ISO
Thimerosal results in decreased expression of PC mRNA
CTD
PMID:27188386
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcbp2
poly(rC) binding protein 2
decreases expression
ISO
Thimerosal results in decreased expression of PCBP2 mRNA
CTD
PMID:27188386
NCBI chr 7:133,605,375...133,631,312
Ensembl chr 7:133,605,573...133,629,863
G
Pcdha9
protocadherin alpha 9
increases expression
ISO
Thimerosal results in increased expression of PCDHA9 mRNA
CTD
PMID:27188386
Ensembl chr18:28,581,225...28,846,211
G
Pclo
piccolo (presynaptic cytomatrix protein)
increases expression
ISO
Thimerosal results in increased expression of PCLO mRNA
CTD
PMID:27188386
NCBI chr 4:19,691,439...20,050,015
Ensembl chr 4:19,695,315...20,049,885
G
Pcm1
pericentriolar material 1
decreases expression
ISO
Thimerosal results in decreased expression of PCM1 mRNA
CTD
PMID:27188386
NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091
G
Pcnp
PEST proteolytic signal containing nuclear protein
decreases expression
ISO
Thimerosal results in decreased expression of PCNP mRNA
CTD
PMID:27188386
NCBI chr11:44,592,766...44,607,372
Ensembl chr11:44,592,742...44,607,348
G
Pcnx1
pecanex 1
increases expression
ISO
Thimerosal results in increased expression of PCNX1 mRNA
CTD
PMID:27188386
NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271
G
Pcp4
Purkinje cell protein 4
increases expression
ISO
Thimerosal results in increased expression of PCP4 mRNA
CTD
PMID:27188386
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
increases expression
ISO
Thimerosal results in increased expression of PCSK2 mRNA
CTD
PMID:27188386
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
G
Pdia3
protein disulfide isomerase family A, member 3
decreases expression
ISO
Thimerosal results in decreased expression of PDIA3 mRNA
CTD
PMID:27188386
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
Pdk1
pyruvate dehydrogenase kinase 1
decreases expression
ISO
Thimerosal results in decreased expression of PDK1 mRNA
CTD
PMID:27188386
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pdlim4
PDZ and LIM domain 4
decreases expression
ISO
Thimerosal results in decreased expression of PDLIM4 mRNA
CTD
PMID:27188386
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
G
Pdss2
decaprenyl diphosphate synthase subunit 2
decreases expression
ISO
Thimerosal results in decreased expression of PDSS2 mRNA
CTD
PMID:27188386
NCBI chr20:46,709,631...46,938,704
Ensembl chr20:46,709,649...46,938,708
G
Pdyn
prodynorphin
multiple interactions
ISO
[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA]
CTD
PMID:30503815
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Peds1
plasmanylethanolamine desaturase 1
decreases expression
ISO
Thimerosal results in decreased expression of PEDS1 mRNA
CTD
PMID:27188386
NCBI chr 3:156,350,135...156,369,309
Ensembl chr 3:156,349,526...156,369,314
G
Pelp1
proline, glutamate and leucine rich protein 1
decreases expression
ISO
Thimerosal results in decreased expression of PELP1 mRNA
CTD
PMID:27188386
NCBI chr10:55,094,798...55,111,833
Ensembl chr10:55,094,796...55,111,994
G
Pex6
peroxisomal biogenesis factor 6
decreases expression
ISO
Thimerosal results in decreased expression of PEX6 mRNA
CTD
PMID:27188386
NCBI chr 9:14,258,145...14,270,335
Ensembl chr 9:14,258,145...14,270,303
G
Pfdn4
prefoldin subunit 4
increases expression
ISO
Thimerosal results in increased expression of PFDN4 mRNA
CTD
PMID:27188386
NCBI chr 3:159,303,173...159,311,221
Ensembl chr 3:159,303,071...159,311,219
G
Pfkfb2
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
decreases expression
ISO
Thimerosal results in decreased expression of PFKFB2 mRNA
CTD
PMID:27188386
NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
decreases expression
ISO
Thimerosal results in decreased expression of PFKFB4 mRNA
CTD
PMID:27188386
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pfkp
phosphofructokinase, platelet
decreases expression
ISO
Thimerosal results in decreased expression of PFKP mRNA
CTD
PMID:27188386
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pfn1
profilin 1
decreases expression
ISO
Thimerosal results in decreased expression of PFN1 mRNA
CTD
PMID:27188386
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pgam1
phosphoglycerate mutase 1
decreases expression
ISO
Thimerosal results in decreased expression of PGAM1 mRNA
CTD
PMID:27188386
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgap1
post-GPI attachment to proteins inositol deacylase 1
increases expression
ISO
Thimerosal results in increased expression of PGAP1 mRNA
CTD
PMID:27188386
NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464
G
Pgap2
post-GPI attachment to proteins 2
decreases expression
ISO
Thimerosal results in decreased expression of PGAP2 mRNA
CTD
PMID:27188386
NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114
G
Pgap4
post-GPI attachment to proteins GalNAc transferase 4
decreases expression
ISO
Thimerosal results in decreased expression of PGAP4 mRNA
CTD
PMID:27188386
NCBI chr 5:63,931,916...63,947,004
Ensembl chr 5:63,930,682...63,951,716
G
Pgap6
post-GPI attachment to proteins 6
decreases expression
ISO
Thimerosal results in decreased expression of PGAP6 mRNA
CTD
PMID:27188386
NCBI chr10:15,138,918...15,148,431
Ensembl chr10:15,138,959...15,148,431
G
Pgf
placental growth factor
increases expression
ISO
Thimerosal results in increased expression of PGF mRNA
CTD
PMID:16870260
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pgk1
phosphoglycerate kinase 1
decreases expression
ISO
Thimerosal results in decreased expression of PGK1 mRNA
CTD
PMID:27188386
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgls
6-phosphogluconolactonase
decreases expression
ISO
Thimerosal results in decreased expression of PGLS mRNA
CTD
PMID:27188386
NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,300,317...18,305,803
G
Pgm1
phosphoglucomutase 1
decreases expression
ISO
Thimerosal results in decreased expression of PGM1 mRNA
CTD
PMID:27188386
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pgpep1
pyroglutamyl-peptidase I
decreases expression
ISO
Thimerosal results in decreased expression of PGPEP1 mRNA
CTD
PMID:27188386
NCBI chr16:18,770,563...18,782,968
Ensembl chr16:18,771,021...18,783,478
G
Phax
phosphorylated adaptor for RNA export
increases expression
ISO
Thimerosal results in increased expression of PHAX mRNA
CTD
PMID:27188386
NCBI chr18:50,053,133...50,069,823
Ensembl chr18:50,053,023...50,069,823
G
Phf20
PHD finger protein 20
increases expression
ISO
Thimerosal results in increased expression of PHF20 mRNA
CTD
PMID:27188386
NCBI chr 3:144,710,253...144,816,696
Ensembl chr 3:144,710,353...144,814,439
G
Phf20l1
PHD finger protein 20-like 1
decreases expression
ISO
Thimerosal results in decreased expression of PHF20L1 mRNA
CTD
PMID:16870260
NCBI chr 7:98,330,580...98,396,526
Ensembl chr 7:98,330,580...98,396,526
G
Phf21a
PHD finger protein 21A
decreases expression
ISO
Thimerosal results in decreased expression of PHF21A mRNA
CTD
PMID:27188386
NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
Thimerosal results in decreased expression of PHKB mRNA
CTD
PMID:27188386
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Phldb2
pleckstrin homology-like domain, family B, member 2
decreases expression
ISO
Thimerosal results in decreased expression of PHLDB2 mRNA
CTD
PMID:27188386
NCBI chr11:54,859,173...55,078,212
Ensembl chr11:54,859,135...55,078,467
G
Phldb3
pleckstrin homology-like domain, family B, member 3
decreases expression
ISO
Thimerosal results in decreased expression of PHLDB3 mRNA
CTD
PMID:27188386
NCBI chr 1:80,201,083...80,219,541
Ensembl chr 1:80,201,578...80,219,534
G
Phtf2
putative homeodomain transcription factor 2
increases expression
ISO
Thimerosal results in increased expression of PHTF2 mRNA
CTD
PMID:27188386
NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513
G
Pi4k2a
phosphatidylinositol 4-kinase type 2 alpha
decreases expression
ISO
Thimerosal results in decreased expression of PI4K2A mRNA
CTD
PMID:27188386
NCBI chr 1:240,902,804...240,929,234
Ensembl chr 1:240,902,855...240,929,337
G
Pias2
protein inhibitor of activated STAT, 2
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA
CTD
PMID:27188386
NCBI chr18:70,608,034...70,714,295
Ensembl chr18:70,607,665...70,710,033
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
increases expression
ISO
Thimerosal results in increased expression of PIK3C2A mRNA
CTD
PMID:27188386
NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
increases expression
ISO
Thimerosal results in increased expression of PIK3CA mRNA
CTD
PMID:27188386
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
G
Pin4
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
decreases expression
ISO
Thimerosal results in decreased expression of PIN4 mRNA
CTD
PMID:27188386
NCBI chr X:67,232,066...67,238,709
Ensembl chr X:67,232,081...67,238,702
G
Pir
pirin
increases expression
ISO
Thimerosal results in increased expression of PIR mRNA
CTD
PMID:27188386
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pitpnm2
phosphatidylinositol transfer protein, membrane-associated 2
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA
CTD
PMID:27188386
NCBI chr12:32,347,455...32,479,103
Ensembl chr12:32,380,805...32,479,102
G
Pkn3
protein kinase N3
decreases expression
ISO
Thimerosal results in decreased expression of PKN3 mRNA
CTD
PMID:27188386
NCBI chr 3:13,350,082...13,363,572
Ensembl chr 3:13,335,041...13,363,567
G
Plaat1
phospholipase A and acyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of PLAAT1 mRNA
CTD
PMID:27188386
NCBI chr11:71,517,492...71,537,142
Ensembl chr11:71,517,493...71,527,020
G
Plcb4
phospholipase C, beta 4
decreases expression
ISO
Thimerosal results in decreased expression of PLCB4 mRNA
CTD
PMID:27188386
NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392
G
Plcg1
phospholipase C, gamma 1
increases cleavage
ISO
Thimerosal results in increased cleavage of PLCG1 protein
CTD
PMID:16649253
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
G
Plekha2
pleckstrin homology domain containing A2
decreases expression
ISO
Thimerosal results in decreased expression of PLEKHA2 mRNA
CTD
PMID:27188386
NCBI chr16:66,938,684...67,000,661
Ensembl chr16:66,939,109...66,999,395
G
Plekha5
pleckstrin homology domain containing A5
decreases expression
ISO
Thimerosal results in decreased expression of PLEKHA5 mRNA
CTD
PMID:27188386
NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546
G
Plekha6
pleckstrin homology domain containing A6
decreases expression
ISO
Thimerosal results in decreased expression of PLEKHA6 mRNA
CTD
PMID:24675092
NCBI chr13:44,614,740...44,754,951
Ensembl chr13:44,615,011...44,754,673
G
Plekhb1
pleckstrin homology domain containing B1
decreases expression
ISO
Thimerosal results in decreased expression of PLEKHB1 mRNA
CTD
PMID:27188386
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
G
Plekhf2
pleckstrin homology and FYVE domain containing 2
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA
CTD
PMID:27188386
NCBI chr 5:24,091,077...24,106,758
Ensembl chr 5:24,090,688...24,106,601
G
Plekhg4
pleckstrin homology and RhoGEF domain containing G4
decreases expression
ISO
Thimerosal results in decreased expression of PLEKHG4 mRNA
CTD
PMID:27188386
NCBI chr19:33,251,788...33,266,490
Ensembl chr19:33,249,706...33,266,357
G
Plk2
polo-like kinase 2
increases expression
ISO
Thimerosal results in increased expression of PLK2 mRNA
CTD
PMID:16870260
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Plod1
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
decreases expression
ISO
Thimerosal results in decreased expression of PLOD1 mRNA
CTD
PMID:27188386
NCBI chr 5:158,340,674...158,367,581
Ensembl chr 5:158,340,490...158,367,620
G
Plppr3
phospholipid phosphatase related 3
decreases expression
ISO
Thimerosal results in decreased expression of PLPPR3 mRNA
CTD
PMID:27188386
NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296
G
Plxnc1
plexin C1
decreases expression
ISO
Thimerosal results in decreased expression of PLXNC1 mRNA
CTD
PMID:27188386
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779
G
Pmch
pro-melanin-concentrating hormone
increases expression
ISO
Thimerosal results in increased expression of PMCH mRNA
CTD
PMID:27188386
NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250
G
Pml
PML nuclear body scaffold
decreases expression
ISO
Thimerosal results in decreased expression of PML mRNA
CTD
PMID:27188386
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pnpla3
patatin-like phospholipase domain containing 3
decreases expression
ISO
Thimerosal results in decreased expression of PNPLA3 mRNA
CTD
PMID:27188386
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
G
Pole4
DNA polymerase epsilon 4, accessory subunit
increases expression
ISO
Thimerosal results in increased expression of POLE4 mRNA
CTD
PMID:27188386
NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097
G
Polrmt
RNA polymerase mitochondrial
decreases expression
ISO
Thimerosal results in decreased expression of POLRMT mRNA
CTD
PMID:27188386
NCBI chr 7:9,959,532...9,969,791
Ensembl chr 7:9,959,576...9,969,791
G
Pomc
proopiomelanocortin
increases expression
ISO
Thimerosal results in increased expression of POMC mRNA; Thimerosal results in increased expression of POMC protein
CTD
PMID:24675092
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pomgnt2
protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)
decreases expression
ISO
Thimerosal results in decreased expression of POMGNT2 mRNA
CTD
PMID:27188386
NCBI chr 8:121,645,106...121,660,761
Ensembl chr 8:121,644,970...121,660,757
G
Pop1
POP1 homolog, ribonuclease P/MRP subunit
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA
CTD
PMID:27188386
NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141
G
Pou1f1
POU class 1 homeobox 1
increases expression
ISO
Thimerosal results in increased expression of POU1F1 mRNA
CTD
PMID:24675092
NCBI chr11:3,316,818...3,334,804
Ensembl chr11:3,317,058...3,334,801
G
Ppfia4
PTPRF interacting protein alpha 4
decreases expression
ISO
Thimerosal results in decreased expression of PPFIA4 mRNA
CTD
PMID:27188386
NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261
G
Ppfibp1
PPFIA binding protein 1
decreases expression
ISO
Thimerosal results in decreased expression of PPFIBP1 mRNA
CTD
PMID:27188386
NCBI chr 4:179,807,579...179,951,428
Ensembl chr 4:179,808,794...179,951,428
G
Ppia
peptidylprolyl isomerase A
decreases expression
ISO
Thimerosal results in decreased expression of PPIA mRNA
CTD
PMID:27188386
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Ppil2
peptidylprolyl isomerase like 2
decreases expression
ISO
Thimerosal results in decreased expression of PPIL2 mRNA
CTD
PMID:27188386
NCBI chr11:83,897,719...83,920,970
Ensembl chr11:83,897,764...83,922,144
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
decreases expression
ISO
Thimerosal results in decreased expression of PPP1R14A mRNA
CTD
PMID:27188386
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
G
Ppp1r3b
protein phosphatase 1, regulatory subunit 3B
decreases expression
ISO
Thimerosal results in decreased expression of PPP1R3B mRNA
CTD
PMID:27188386
NCBI chr16:56,830,011...56,842,395
Ensembl chr16:56,829,660...56,842,406
G
Ppp1r3e
protein phosphatase 1, regulatory subunit 3E
decreases expression
ISO
Thimerosal results in decreased expression of PPP1R3E mRNA
CTD
PMID:27188386
NCBI chr15:28,348,443...28,349,603
Ensembl chr15:28,347,854...28,349,603
G
Prdm2
PR/SET domain 2
decreases expression
ISO
Thimerosal results in decreased expression of PRDM2 mRNA
CTD
PMID:27188386
NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825
G
Prelid2
PRELI domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of PRELID2 mRNA
CTD
PMID:27188386
NCBI chr18:33,869,934...33,961,320
Ensembl chr18:33,873,599...33,961,225
G
Prepl
prolyl endopeptidase-like
increases expression
ISO
Thimerosal results in increased expression of PREPL mRNA
CTD
PMID:27188386
NCBI chr 6:9,580,367...9,609,957
Ensembl chr 6:9,580,217...9,607,772
G
Prex2
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
increases expression
ISO
Thimerosal results in increased expression of PREX2 mRNA
CTD
PMID:27188386
NCBI chr 5:7,937,692...8,253,112
Ensembl chr 5:7,942,573...8,253,068
G
Prim2
DNA primase subunit 2
increases expression
ISO
Thimerosal results in increased expression of PRIM2 mRNA
CTD
PMID:27188386
NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030
G
Prima1
proline rich membrane anchor 1
decreases expression
ISO
Thimerosal results in decreased expression of PRIMA1 mRNA
CTD
PMID:27188386
NCBI chr 6:122,338,365...122,390,955
Ensembl chr 6:122,338,370...122,389,921
G
Prkab2
protein kinase AMP-activated non-catalytic subunit beta 2
decreases expression
ISO
Thimerosal results in decreased expression of PRKAB2 mRNA
CTD
PMID:27188386
NCBI chr 2:185,257,218...185,272,846
Ensembl chr 2:185,257,213...185,269,872
G
Prkd2
protein kinase D2
decreases expression
ISO
Thimerosal results in decreased expression of PRKD2 mRNA
CTD
PMID:27188386
NCBI chr 1:77,513,625...77,542,386
Ensembl chr 1:77,513,986...77,542,376
G
Prkd3
protein kinase D3
increases expression
ISO
Thimerosal results in increased expression of PRKD3 mRNA
CTD
PMID:27188386
NCBI chr 6:16,032,507...16,108,444
Ensembl chr 6:16,032,585...16,108,443
G
Prkrip1
PRKR interacting protein 1
decreases expression
ISO
Thimerosal results in decreased expression of PRKRIP1 mRNA
CTD
PMID:27188386
NCBI chr12:20,470,802...20,491,789
Ensembl chr12:20,470,820...20,489,115
G
Prl
prolactin
increases expression
ISO
Thimerosal results in increased expression of PRL mRNA; Thimerosal results in increased expression of PRL protein
CTD
PMID:24675092
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prlr
prolactin receptor
increases expression
ISO
Thimerosal results in increased expression of PRLR mRNA
CTD
PMID:27188386
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prpf6
pre-mRNA processing factor 6
decreases expression
ISO
Thimerosal results in decreased expression of PRPF6 mRNA
CTD
PMID:27188386
NCBI chr 3:168,706,952...168,771,191
Ensembl chr 3:168,704,299...168,774,991
G
Prr14l
proline rich 14-like
decreases expression
ISO
Thimerosal results in decreased expression of PRR14L mRNA
CTD
PMID:27188386
NCBI chr14:77,869,848...77,937,141
Ensembl chr14:77,869,799...77,936,521
G
Prr5l
proline rich 5 like
decreases expression
ISO
Thimerosal results in decreased expression of PRR5L mRNA
CTD
PMID:27188386
NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:88,003,617...88,082,763
G
Prrc2c
proline-rich coiled-coil 2C
decreases expression
ISO
Thimerosal results in decreased expression of PRRC2C mRNA
CTD
PMID:27188386
NCBI chr13:75,003,995...75,073,701
Ensembl chr13:75,004,010...75,073,643
G
Prrt1
proline-rich transmembrane protein 1
decreases expression
ISO
Thimerosal results in decreased expression of PRRT1 mRNA
CTD
PMID:27188386
NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600
G
Psme4
proteasome activator subunit 4
decreases expression
ISO
Thimerosal results in decreased expression of PSME4 mRNA
CTD
PMID:27188386
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Psmf1
proteasome inhibitor subunit 1
decreases expression
ISO
Thimerosal results in decreased expression of PSMF1 mRNA
CTD
PMID:27188386
NCBI chr 3:140,235,371...140,260,546
Ensembl chr 3:140,235,373...140,260,546
G
Ptbp2
polypyrimidine tract binding protein 2
increases expression
ISO
Thimerosal results in increased expression of PTBP2 mRNA
CTD
PMID:27188386
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
G
Ptchd4
patched domain containing 4
increases expression
ISO
Thimerosal results in increased expression of PTCHD4 mRNA
CTD
PMID:27188386
NCBI chr 9:18,462,934...18,666,272
Ensembl chr 9:18,463,737...18,665,705
G
Ptk2
protein tyrosine kinase 2
multiple interactions increases response to substance
ISO
[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein] PTK2 protein results in increased susceptibility to Thimerosal
CTD
PMID:17888894
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptms
parathymosin
decreases expression
ISO
Thimerosal results in decreased expression of PTMS mRNA
CTD
PMID:27188386
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Ptov1
PTOV1, extended AT-hook containing adaptor protein
decreases expression
ISO
Thimerosal results in decreased expression of PTOV1 mRNA
CTD
PMID:27188386
NCBI chr 1:95,347,065...95,354,514
Ensembl chr 1:95,347,068...95,353,613
G
Ptp4a3
protein tyrosine phosphatase 4A3
decreases expression
ISO
Thimerosal results in decreased expression of PTP4A3 mRNA
CTD
PMID:27188386
NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919
G
Ptpn12
protein tyrosine phosphatase, non-receptor type 12
decreases expression
ISO
Thimerosal results in decreased expression of PTPN12 mRNA
CTD
PMID:27188386
NCBI chr 4:14,020,997...14,092,931
Ensembl chr 4:14,021,052...14,092,927
G
Ptpn4
protein tyrosine phosphatase, non-receptor type 4
increases expression
ISO
Thimerosal results in increased expression of PTPN4 mRNA
CTD
PMID:27188386
NCBI chr13:30,772,012...30,952,340
Ensembl chr13:30,776,682...30,952,170
G
Ptpra
protein tyrosine phosphatase, receptor type, A
decreases expression
ISO
Thimerosal results in decreased expression of PTPRA mRNA
CTD
PMID:27188386
NCBI chr 3:117,650,146...117,759,744
Ensembl chr 3:117,650,183...117,759,728
G
Ptprk
protein tyrosine phosphatase, receptor type, K
increases expression
ISO
Thimerosal results in increased expression of PTPRK mRNA
CTD
PMID:27188386
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
G
Purb
purine rich element binding protein B
decreases expression
ISO
Thimerosal results in decreased expression of PURB mRNA
CTD
PMID:27188386
NCBI chr14:81,342,374...81,344,857
Ensembl chr14:81,336,448...81,351,432
G
Pxmp4
peroxisomal membrane protein 4
decreases expression
ISO
Thimerosal results in decreased expression of PXMP4 mRNA
CTD
PMID:27188386
NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651
G
Pygl
glycogen phosphorylase L
decreases expression
ISO
Thimerosal results in decreased expression of PYGL mRNA
CTD
PMID:27188386
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Pyroxd1
pyridine nucleotide-disulphide oxidoreductase domain 1
increases expression
ISO
Thimerosal results in increased expression of PYROXD1 mRNA
CTD
PMID:27188386
NCBI chr 4:175,292,124...175,311,143
Ensembl chr 4:175,292,177...175,308,689
G
Qprt
quinolinate phosphoribosyltransferase
decreases expression
ISO
Thimerosal results in decreased expression of QPRT mRNA
CTD
PMID:27188386
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
G
Rab29
RAB29, member RAS oncogene family
decreases expression
ISO
Thimerosal results in decreased expression of RAB29 mRNA
CTD
PMID:27188386
NCBI chr13:43,307,757...43,313,420
Ensembl chr13:43,307,775...43,313,417
G
Rab30
RAB30, member RAS oncogene family
increases expression
ISO
Thimerosal results in increased expression of RAB30 mRNA
CTD
PMID:24675092
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
G
Rab3b
RAB3B, member RAS oncogene family
affects expression
ISO
Thimerosal affects the expression of RAB3B mRNA
CTD
PMID:27188386
NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:123,644,423...123,697,401
G
Rab3gap1
RAB3 GTPase activating protein catalytic subunit 1
increases expression
ISO
Thimerosal results in increased expression of RAB3GAP1 mRNA
CTD
PMID:24675092
NCBI chr13:39,355,698...39,429,154
Ensembl chr13:39,352,247...39,429,169
G
Rabl3
RAB, member of RAS oncogene family-like 3
increases expression
ISO
Thimerosal results in increased expression of RABL3 mRNA
CTD
PMID:27188386
NCBI chr11:63,153,281...63,182,240
Ensembl chr11:63,152,792...63,182,671
G
Rad18
RAD18 E3 ubiquitin protein ligase
increases expression
ISO
Thimerosal results in increased expression of RAD18 mRNA
CTD
PMID:27188386
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
Thimerosal results in decreased expression of RAD23A mRNA
CTD
PMID:27188386
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Ralgapa2
Ral GTPase activating protein catalytic subunit alpha 2
increases expression
ISO
Thimerosal results in increased expression of RALGAPA2 mRNA
CTD
PMID:27188386
NCBI chr 3:133,658,725...133,938,821
Ensembl chr 3:133,659,761...133,938,916
G
Rapgef2
Rap guanine nucleotide exchange factor 2
increases expression
ISO
Thimerosal results in increased expression of RAPGEF2 mRNA
CTD
PMID:27188386
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
G
Rapgef5
Rap guanine nucleotide exchange factor 5
decreases expression
ISO
Thimerosal results in decreased expression of RAPGEF5 mRNA
CTD
PMID:27188386
NCBI chr 6:138,445,184...138,679,943
Ensembl chr 6:138,437,991...138,679,936
G
Rapgefl1
Rap guanine nucleotide exchange factor like 1
decreases expression
ISO
Thimerosal results in decreased expression of RAPGEFL1 mRNA
CTD
PMID:27188386
NCBI chr10:83,793,711...83,810,373
Ensembl chr10:83,793,694...83,810,371
G
Rarres1
retinoic acid receptor responder 1
increases expression
ISO
Thimerosal results in increased expression of RARRES1 mRNA
CTD
PMID:27188386
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
G
Rasa2
RAS p21 protein activator 2
increases expression
ISO
Thimerosal results in increased expression of RASA2 mRNA
CTD
PMID:27188386
NCBI chr 8:97,119,983...97,236,687
Ensembl chr 8:97,118,802...97,236,671
G
Rasgef1a
RasGEF domain family, member 1A
increases expression decreases expression
ISO
Thimerosal results in increased expression of RASGEF1A mRNA Thimerosal results in decreased expression of RASGEF1A mRNA
CTD
PMID:24675092 PMID:27188386
NCBI chr 4:151,187,533...151,267,982
Ensembl chr 4:151,225,856...151,267,995
G
Rassf4
Ras association domain family member 4
decreases expression
ISO
Thimerosal results in decreased expression of RASSF4 mRNA
CTD
PMID:27188386
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
G
Rassf8
Ras association domain family member 8
decreases expression
ISO
Thimerosal results in decreased expression of RASSF8 mRNA
CTD
PMID:27188386
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rbak
RB-associated KRAB zinc finger
decreases expression
ISO
Thimerosal results in decreased expression of RBAK mRNA
CTD
PMID:27188386
NCBI chr12:11,375,314...11,388,937
Ensembl chr12:11,375,318...11,388,934
G
Rbfox3
RNA binding fox-1 homolog 3
decreases expression
ISO
Thimerosal results in decreased expression of RBFOX3 mRNA
CTD
PMID:27188386
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
G
Rbm22
RNA binding motif protein 22
decreases expression
ISO
Thimerosal results in decreased expression of RBM22 mRNA
CTD
PMID:27188386
NCBI chr18:54,013,374...54,024,182
Ensembl chr18:54,013,351...54,024,569
G
Rbm26
RNA binding motif protein 26
decreases expression
ISO
Thimerosal results in decreased expression of RBM26 mRNA
CTD
PMID:27188386
NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118
G
Rbm7
RNA binding motif protein 7
decreases expression
ISO
Thimerosal results in decreased expression of RBM7 mRNA
CTD
PMID:24675092
NCBI chr 8:48,831,894...48,838,399
Ensembl chr 8:48,831,894...48,838,411
G
Rbm8a
RNA binding motif protein 8A
decreases expression
ISO
Thimerosal results in decreased expression of RBM8A mRNA
CTD
PMID:27188386
NCBI chr 2:184,165,189...184,167,959
Ensembl chr 2:184,165,193...184,167,959
G
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
decreases expression
ISO
Thimerosal results in decreased expression of RBPJ mRNA
CTD
PMID:24675092
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
G
Rbpms2
RNA binding protein, mRNA processing factor 2
decreases expression
ISO
Thimerosal results in decreased expression of RBPMS2 mRNA
CTD
PMID:27188386
NCBI chr 8:66,153,169...66,184,278
Ensembl chr 8:66,153,593...66,184,268
G
Rcan3
RCAN family member 3
decreases expression
ISO
Thimerosal results in decreased expression of RCAN3 mRNA
CTD
PMID:27188386
NCBI chr 5:147,650,935...147,671,881
Ensembl chr 5:147,655,085...147,671,937
G
Rcor2
REST corepressor 2
decreases expression
ISO
Thimerosal results in decreased expression of RCOR2 mRNA
CTD
PMID:27188386
NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:204,454,360...204,460,838
G
Reep6
receptor accessory protein 6
decreases expression
ISO
Thimerosal results in decreased expression of REEP6 mRNA
CTD
PMID:27188386
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rell1
RELT-like 1
decreases expression
ISO
Thimerosal results in decreased expression of RELL1 mRNA
CTD
PMID:24675092
NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500
G
Reps1
RALBP1 associated Eps domain containing 1
increases expression
ISO
Thimerosal results in increased expression of REPS1 mRNA
CTD
PMID:27188386
NCBI chr 1:12,697,742...12,775,562
Ensembl chr 1:12,697,747...12,775,561
G
Rfc1
replication factor C subunit 1
increases expression
ISO
Thimerosal results in increased expression of RFC1 mRNA
CTD
PMID:24675092
NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370
G
Rfx7
regulatory factor X, 7
decreases expression
ISO
Thimerosal results in decreased expression of RFX7 mRNA
CTD
PMID:27188386
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
G
Rhobtb2
Rho-related BTB domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of RHOBTB2 mRNA
CTD
PMID:27188386
NCBI chr15:44,868,251...44,888,436
Ensembl chr15:44,870,376...44,888,651
G
Rhobtb3
Rho-related BTB domain containing 3
decreases expression
ISO
Thimerosal results in decreased expression of RHOBTB3 mRNA
CTD
PMID:27188386
NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041
G
Rhou
ras homolog family member U
decreases expression
ISO
Thimerosal results in decreased expression of RHOU mRNA
CTD
PMID:27188386
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
G
Rimkla
ribosomal modification protein rimK-like family member A
decreases expression
ISO
Thimerosal results in decreased expression of RIMKLA mRNA
CTD
PMID:27188386
NCBI chr 5:133,072,179...133,098,840
Ensembl chr 5:133,073,960...133,098,792
G
Rims1
regulating synaptic membrane exocytosis 1
increases expression
ISO
Thimerosal results in increased expression of RIMS1 mRNA
CTD
PMID:27188386
NCBI chr 9:24,696,959...25,196,404
Ensembl chr 9:24,698,854...25,196,631
G
Rlig1
RNA 5'-phosphate and 3'-OH ligase 1
increases expression
ISO
Thimerosal results in increased expression of RLIG1 mRNA
CTD
PMID:27188386
NCBI chr 7:35,396,876...35,408,633
Ensembl chr 7:35,397,995...35,409,600
G
Rnase4
ribonuclease A family member 4
decreases expression
ISO
Thimerosal results in decreased expression of RNASE4 mRNA
CTD
PMID:27188386
NCBI chr15:24,312,765...24,330,112
Ensembl chr15:24,312,464...24,330,117
G
Rnaset2
ribonuclease T2
decreases expression
ISO
Thimerosal results in decreased expression of RNASET2 mRNA
CTD
PMID:27188386
NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147
G
Rnf130
ring finger protein 130
decreases expression
ISO
Thimerosal results in decreased expression of RNF130 mRNA
CTD
PMID:27188386
NCBI chr10:34,342,835...34,456,048
Ensembl chr10:34,342,830...34,456,062
G
Rnf43
ring finger protein 43
decreases expression
ISO
Thimerosal results in decreased expression of RNF43 mRNA
CTD
PMID:27188386
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
G
Rnmt
RNA (guanine-7-) methyltransferase
increases expression
ISO
Thimerosal results in increased expression of RNMT mRNA
CTD
PMID:27188386
NCBI chr18:61,886,230...61,909,775
Ensembl chr18:61,886,292...61,909,775
G
Rora
RAR-related orphan receptor A
decreases expression
ISO
Thimerosal results in decreased expression of RORA mRNA
CTD
PMID:27188386
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpl7
ribosomal protein L7
increases expression
ISO
Thimerosal results in increased expression of RPL7 mRNA
CTD
PMID:27188386
NCBI chr 5:3,217,184...3,220,192
G
Rps23
ribosomal protein S23
decreases expression
ISO
Thimerosal results in decreased expression of RPS23 mRNA
CTD
PMID:27188386
NCBI chr 2:22,079,339...22,080,909
Ensembl chr 2:22,079,302...22,080,918
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
Thimerosal results in increased expression of RPS27L mRNA
CTD
PMID:27188386
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
Thimerosal results in increased expression of RRAD mRNA
CTD
PMID:16870260
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rsph9
radial spoke head component 9
decreases expression
ISO
Thimerosal results in decreased expression of RSPH9 mRNA
CTD
PMID:27188386
NCBI chr 9:14,840,115...14,852,950
Ensembl chr 9:14,840,115...14,860,062
G
RT1-A2
RT1 class Ia, locus A2
decreases expression
ISO
Thimerosal results in decreased expression of HLA-E mRNA
CTD
PMID:27188386
NCBI chr20:4,870,939...4,910,183
G
RT1-CE16
RT1 class I, locus CE16
decreases expression
ISO
Thimerosal results in decreased expression of HLA-A mRNA
CTD
PMID:27188386
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
decreases expression
ISO
Thimerosal results in decreased expression of HLA-DPB1 mRNA
CTD
PMID:27188386
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Rtl8a
retrotransposon Gag like 8A
decreases expression
ISO
Thimerosal results in decreased expression of RTL8A mRNA
CTD
PMID:27188386
NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240
G
Rtn4r
reticulon 4 receptor
decreases expression
ISO
Thimerosal results in decreased expression of RTN4R mRNA
CTD
PMID:27188386
NCBI chr11:82,844,309...82,869,251
Ensembl chr11:82,844,309...82,869,466
G
Rufy2
RUN and FYVE domain containing 2
increases expression
ISO
Thimerosal results in increased expression of RUFY2 mRNA
CTD
PMID:27188386
NCBI chr20:25,626,958...25,658,157
Ensembl chr20:25,621,999...25,658,186
G
Rusc2
RUN and SH3 domain containing 2
decreases expression
ISO
Thimerosal results in decreased expression of RUSC2 mRNA
CTD
PMID:24675092
NCBI chr 5:57,628,397...57,675,524
Ensembl chr 5:57,629,904...57,675,524
G
Ryr3
ryanodine receptor 3
increases expression
ISO
Thimerosal results in increased expression of RYR3 mRNA
CTD
PMID:27188386
NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:99,432,505...99,704,961
G
Sall4
spalt-like transcription factor 4
decreases expression
ISO
Thimerosal results in decreased expression of SALL4 mRNA
CTD
PMID:27188386
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
G
Samhd1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
decreases expression
ISO
Thimerosal results in decreased expression of SAMHD1 mRNA
CTD
PMID:27188386
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
G
Sapcd2
suppressor APC domain containing 2
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA
CTD
PMID:27188386
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
Thimerosal results in increased expression of SAR1B mRNA
CTD
PMID:27188386
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
G
Sav1
salvador family WW domain containing protein 1
decreases expression
ISO
Thimerosal results in decreased expression of SAV1 mRNA
CTD
PMID:27188386
NCBI chr 6:88,478,536...88,500,121
Ensembl chr 6:88,478,539...88,499,968
G
Saxo2
stabilizer of axonemal microtubules 2
increases expression
ISO
Thimerosal results in increased expression of SAXO2 mRNA
CTD
PMID:27188386
NCBI chr 1:136,596,445...136,638,444
Ensembl chr 1:136,623,493...136,638,454
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
Thimerosal results in decreased expression of SCD mRNA
CTD
PMID:27188386
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scoc
short coiled-coil protein
increases expression
ISO
Thimerosal results in increased expression of SCOC mRNA
CTD
PMID:27188386
NCBI chr19:24,659,651...24,689,237
Ensembl chr19:24,659,651...24,693,217
G
Scrn3
secernin 3
decreases expression
ISO
Thimerosal results in decreased expression of SCRN3 mRNA
CTD
PMID:27188386
NCBI chr 3:58,188,820...58,213,623
Ensembl chr 3:58,188,889...58,213,623
G
Scrt1
scratch family transcriptional repressor 1
increases expression
ISO
Thimerosal results in increased expression of SCRT1 mRNA
CTD
PMID:27188386
NCBI chr 7:108,240,986...108,244,636
Ensembl chr 7:108,240,986...108,244,636
G
Scyl2
SCY1 like pseudokinase 2
decreases expression
ISO
Thimerosal results in decreased expression of SCYL2 mRNA
CTD
PMID:27188386
NCBI chr 7:24,064,404...24,117,338
Ensembl chr 7:24,064,404...24,117,305
G
Sdc1
syndecan 1
decreases expression
ISO
Thimerosal results in decreased expression of SDC1 mRNA
CTD
PMID:27188386
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Secisbp2l
SECIS binding protein 2-like
decreases expression
ISO
Thimerosal results in decreased expression of SECISBP2L mRNA
CTD
PMID:27188386
NCBI chr 3:112,989,613...113,036,060
Ensembl chr 3:112,991,908...113,035,884
G
Sel1l
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
decreases expression
ISO
Thimerosal results in decreased expression of SEL1L mRNA
CTD
PMID:27188386
NCBI chr 6:110,735,450...110,779,695
Ensembl chr 6:110,735,450...110,779,648
G
Sema3f
semaphorin 3F
decreases expression
ISO
Thimerosal results in decreased expression of SEMA3F mRNA
CTD
PMID:27188386
NCBI chr 8:108,357,629...108,386,569
Ensembl chr 8:108,357,629...108,387,083
G
Sema4f
ssemaphorin 4F
decreases expression
ISO
Thimerosal results in decreased expression of SEMA4F mRNA
CTD
PMID:27188386
NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721
G
Sema6a
semaphorin 6A
decreases expression
ISO
Thimerosal results in decreased expression of SEMA6A mRNA
CTD
PMID:27188386
NCBI chr18:40,050,623...40,171,954
Ensembl chr18:40,050,624...40,171,954
G
Senp7
SUMO specific peptidase 7
increases expression
ISO
Thimerosal results in increased expression of SENP7 mRNA
CTD
PMID:27188386
NCBI chr11:44,423,733...44,584,129
Ensembl chr11:44,423,735...44,564,711
G
Sepsecs
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
increases expression multiple interactions
ISO
Thimerosal results in increased expression of SEPSECS mRNA [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA
CTD
PMID:27188386
NCBI chr14:58,311,484...58,341,745
Ensembl chr14:58,311,499...58,341,740
G
Septin9
septin 9
decreases expression
ISO
Thimerosal results in decreased expression of SEPTIN9 mRNA
CTD
PMID:27188386
NCBI chr10:102,409,798...102,579,056
Ensembl chr10:102,409,711...102,579,055
G
Serinc2
serine incorporator 2
decreases expression
ISO
Thimerosal results in decreased expression of SERINC2 mRNA
CTD
PMID:27188386
NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364
G
Serpine1
serpin family E member 1
increases expression
ISO
Thimerosal results in increased expression of SERPINE1 mRNA
CTD
PMID:16870260
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinh1
serpin family H member 1
increases expression
ISO
Thimerosal results in increased expression of SERPINH1 mRNA
CTD
PMID:16870260
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Setd2
SET domain containing 2, histone lysine methyltransferase
decreases expression
ISO
Thimerosal results in decreased expression of SETD2 mRNA
CTD
PMID:27188386
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Setd9-ps1
SET domain containing, pseudogene 1
increases expression
ISO
Thimerosal results in increased expression of SETD9 mRNA
CTD
PMID:27188386
NCBI chr 2:43,319,359...43,322,764
G
Setx
senataxin
decreases expression
ISO
Thimerosal results in decreased expression of SETX mRNA
CTD
PMID:27188386
NCBI chr 3:12,428,091...12,480,801
Ensembl chr 3:12,427,635...12,480,803
G
Sez6l2
seizure related 6 homolog like 2
decreases expression
ISO
Thimerosal results in decreased expression of SEZ6L2 mRNA
CTD
PMID:27188386
NCBI chr 1:181,557,109...181,577,456
Ensembl chr 1:181,557,109...181,577,456
G
Sf3a2
splicing factor 3A subunit 2
decreases expression
ISO
Thimerosal results in decreased expression of SF3A2 mRNA
CTD
PMID:27188386
NCBI chr 7:8,909,507...8,916,104
Ensembl chr 7:8,909,507...8,915,530
G
Sf3b1
splicing factor 3b, subunit 1
decreases expression
ISO
Thimerosal results in decreased expression of SF3B1 mRNA
CTD
PMID:27188386
NCBI chr 9:56,492,403...56,532,300
Ensembl chr 9:56,492,403...56,532,300
G
Sf3b4
splicing factor 3B subunit 4
decreases expression
ISO
Thimerosal results in decreased expression of SF3B4 mRNA
CTD
PMID:27188386
NCBI chr 2:183,732,791...183,737,545
Ensembl chr 2:183,732,754...183,737,959
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
ISO
Thimerosal results in decreased expression of SFPQ mRNA
CTD
PMID:27188386
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sfr1
SWI5-dependent homologous recombination repair protein 1
increases expression
ISO
Thimerosal results in increased expression of SFR1 mRNA
CTD
PMID:27188386
NCBI chr 1:246,619,235...246,623,250
Ensembl chr 1:246,597,044...246,623,250
G
Sfrp1
secreted frizzled-related protein 1
decreases expression
ISO
Thimerosal results in decreased expression of SFRP1 mRNA
CTD
PMID:27188386
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
G
Sgpl1
sphingosine-1-phosphate lyase 1
increases expression
ISO
Thimerosal results in increased expression of SGPL1 mRNA
CTD
PMID:24675092
NCBI chr20:29,047,793...29,094,209
Ensembl chr20:29,047,796...29,094,084
G
Sh3bgrl3
SH3 domain binding glutamate-rich protein like 3
decreases expression
ISO
Thimerosal results in decreased expression of SH3BGRL3 mRNA
CTD
PMID:27188386
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
G
Shfl
shiftless antiviral inhibitor of ribosomal frameshifting
decreases expression
ISO
Thimerosal results in decreased expression of SHFL mRNA
CTD
PMID:27188386
NCBI chr 8:19,408,298...19,414,084
Ensembl chr 8:19,408,333...19,413,971
G
Shisa5
shisa family member 5
decreases expression
ISO
Thimerosal results in decreased expression of SHISA5 mRNA
CTD
PMID:27188386
NCBI chr 8:109,691,504...109,706,411
Ensembl chr 8:109,691,522...109,706,408
G
Shoc2
SHOC2 leucine-rich repeat scaffold protein
increases expression
ISO
Thimerosal results in increased expression of SHOC2 mRNA
CTD
PMID:27188386
NCBI chr 1:252,958,939...253,048,820
Ensembl chr 1:252,959,723...253,047,337
G
Siah1
siah E3 ubiquitin protein ligase 1
increases expression
ISO
Thimerosal results in increased expression of SIAH1 mRNA
CTD
PMID:27188386
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Sike1
suppressor of IKBKE 1
decreases expression
ISO
Thimerosal results in decreased expression of SIKE1 mRNA
CTD
PMID:27188386
NCBI chr 2:190,518,002...190,525,833
Ensembl chr 2:190,518,002...190,525,832
G
Sipa1
signal-induced proliferation-associated 1
decreases expression
ISO
Thimerosal results in decreased expression of SIPA1 mRNA
CTD
PMID:27188386
NCBI chr 1:202,938,532...202,950,672
Ensembl chr 1:202,938,580...202,950,591
G
Sirpa
signal-regulatory protein alpha
decreases expression
ISO
Thimerosal results in decreased expression of SIRPA mRNA
CTD
PMID:27188386
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
G
Sirt1
sirtuin 1
multiple interactions
ISO
SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]]
CTD
PMID:30503815
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Six5
SIX homeobox 5
decreases expression
ISO
Thimerosal results in decreased expression of SIX5 mRNA
CTD
PMID:27188386
NCBI chr 1:78,740,812...78,745,890
Ensembl chr 1:78,741,367...78,745,890
G
Six6
SIX homeobox 6
increases expression
ISO
Thimerosal results in increased expression of SIX6 mRNA
CTD
PMID:24675092
NCBI chr 6:91,634,568...91,639,548
Ensembl chr 6:91,634,568...91,639,548
G
Ska2
spindle and kinetochore associated complex subunit 2
increases expression
ISO
Thimerosal results in increased expression of SKA2 mRNA
CTD
PMID:27188386
NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458
G
Skic3
SKI3 subunit of superkiller complex
decreases expression
ISO
Thimerosal results in decreased expression of SKIC3 mRNA
CTD
PMID:27188386
NCBI chr 2:5,631,544...5,783,643
Ensembl chr 2:5,631,635...5,751,626
G
Slc10a7
solute carrier family 10, member 7
increases expression
ISO
Thimerosal results in increased expression of SLC10A7 mRNA
CTD
PMID:27188386
NCBI chr19:29,183,143...29,407,470
Ensembl chr19:29,183,155...29,407,464
G
Slc12a2
solute carrier family 12 member 2
increases expression
ISO
Thimerosal results in increased expression of SLC12A2 mRNA
CTD
PMID:27188386
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Slc16a1
solute carrier family 16 member 1
decreases expression
ISO
Thimerosal results in decreased expression of SLC16A1 mRNA
CTD
PMID:27188386
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a14
solute carrier family 16, member 14
increases expression
ISO
Thimerosal results in increased expression of SLC16A14 mRNA
CTD
PMID:27188386
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
G
Slc16a6
solute carrier family 16, member 6
increases expression
ISO
Thimerosal results in increased expression of SLC16A6 mRNA
CTD
PMID:27188386
NCBI chr10:94,424,377...94,447,482
Ensembl chr10:94,426,244...94,448,779
G
Slc16a9
solute carrier family 16, member 9
increases expression
ISO
Thimerosal results in increased expression of SLC16A9 mRNA
CTD
PMID:27188386
NCBI chr20:18,335,862...18,377,125
Ensembl chr20:18,335,862...18,377,022
G
Slc18b1
solute carrier family 18 member B1
decreases expression
ISO
Thimerosal results in decreased expression of SLC18B1 mRNA
CTD
PMID:27188386
NCBI chr 1:21,628,235...21,670,807
Ensembl chr 1:21,628,237...21,670,684
G
Slc1a1
solute carrier family 1 member 1
increases expression
ISO
Thimerosal results in increased expression of SLC1A1 protein
CTD
PMID:15184908
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc22a4
solute carrier family 22 member 4
decreases activity
ISO
Thimerosal results in decreased activity of SLC22A4 protein
CTD
PMID:25490951
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc25a1
solute carrier family 25 member 1
decreases expression
ISO
Thimerosal results in decreased expression of SLC25A1 mRNA
CTD
PMID:27188386
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a21
solute carrier family 25 member 21
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA
CTD
PMID:27188386
NCBI chr 6:74,203,439...74,702,902
Ensembl chr 6:74,203,440...74,702,680
G
Slc25a23
solute carrier family 25 member 23
decreases expression
ISO
Thimerosal results in decreased expression of SLC25A23 mRNA
CTD
PMID:27188386
NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561
G
Slc25a44
solute carrier family 25, member 44
increases expression
ISO
Thimerosal results in increased expression of SLC25A44 mRNA
CTD
PMID:27188386
NCBI chr 2:173,868,317...173,883,137
Ensembl chr 2:173,868,320...173,883,020
G
Slc29a2
solute carrier family 29 member 2
decreases expression
ISO
Thimerosal results in decreased expression of SLC29A2 mRNA
CTD
PMID:27188386
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Slc2a1
solute carrier family 2 member 1
decreases expression
ISO
Thimerosal results in decreased expression of SLC2A1 mRNA
CTD
PMID:27188386
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a12
solute carrier family 2 member 12
decreases expression
ISO
Thimerosal results in decreased expression of SLC2A12 mRNA
CTD
PMID:27188386
NCBI chr 1:22,803,068...22,862,204
Ensembl chr 1:22,804,418...22,860,971
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Thimerosal results in decreased expression of SLC2A3 mRNA
CTD
PMID:27188386
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc30a5
solute carrier family 30 member 5
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA
CTD
PMID:27188386
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
G
Slc38a1
solute carrier family 38, member 1
decreases expression
ISO
Thimerosal results in decreased expression of SLC38A1 mRNA
CTD
PMID:27188386
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
G
Slc5a3
solute carrier family 5 member 3
increases expression
ISO
Thimerosal results in increased expression of SLC5A3 mRNA
CTD
PMID:27188386
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
G
Slc5a7
solute carrier family 5 member 7
decreases expression
ISO
Thimerosal results in decreased expression of SLC5A7 mRNA
CTD
PMID:27188386
NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258
G
Slc6a3
solute carrier family 6 member 3
increases expression multiple interactions
ISO
Thimerosal results in increased expression of SLC6A3 protein [Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of SLC6A3 protein
CTD
PMID:36411272
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc7a1
solute carrier family 7 member 1
decreases expression
ISO
Thimerosal results in decreased expression of SLC7A1 mRNA
CTD
PMID:27188386
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a3
solute carrier family 7 member 3
decreases expression
ISO
Thimerosal results in decreased expression of SLC7A3 mRNA
CTD
PMID:27188386
NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708
G
Slc8a1
solute carrier family 8 member A1
increases expression
ISO
Thimerosal results in increased expression of SLC8A1 mRNA
CTD
PMID:27188386
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Smarcc2
SWI/SNF related BAF chromatin remodeling complex subunit C2
affects expression
ISO
Thimerosal affects the expression of SMARCC2 mRNA
CTD
PMID:27188386
NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978
G
Smc1a
structural maintenance of chromosomes 1A
decreases expression
ISO
Thimerosal results in decreased expression of SMC1A mRNA
CTD
PMID:27188386
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
G
Smchd1
structural maintenance of chromosomes flexible hinge domain containing 1
decreases expression
ISO
Thimerosal results in decreased expression of SMCHD1 mRNA
CTD
PMID:27188386
NCBI chr 9:111,243,445...111,387,272
Ensembl chr 9:111,247,702...111,349,665
G
Smim3
small integral membrane protein 3
decreases expression
ISO
Thimerosal results in decreased expression of SMIM3 mRNA
CTD
PMID:27188386
NCBI chr18:53,930,019...53,982,339
Ensembl chr18:53,930,020...53,957,416
G
Smox
spermine oxidase
decreases expression
ISO
Thimerosal results in decreased expression of SMOX mRNA
CTD
PMID:27188386
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Snap25
synaptosome associated protein 25
decreases expression
EXP
Thimerosal results in decreased expression of SNAP25 protein
CTD
PMID:27693314
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
G
Sncaip
synuclein, alpha interacting protein
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA
CTD
PMID:27188386
NCBI chr18:46,205,846...46,343,932
Ensembl chr18:46,207,152...46,343,929
G
Snrpa
small nuclear ribonucleoprotein polypeptide A
decreases expression
ISO
Thimerosal results in decreased expression of SNRPA mRNA
CTD
PMID:27188386
NCBI chr 1:82,481,770...82,490,540
Ensembl chr 1:82,481,770...82,490,538
G
Snx2
sorting nexin 2
increases expression
ISO
Thimerosal results in increased expression of SNX2 mRNA
CTD
PMID:27188386
NCBI chr18:46,602,223...46,643,870
Ensembl chr18:46,602,284...46,643,865
G
Snx21
sorting nexin family member 21
decreases expression
ISO
Thimerosal results in decreased expression of SNX21 mRNA
CTD
PMID:27188386
NCBI chr 3:153,522,474...153,532,235
Ensembl chr 3:153,522,486...153,532,221
G
Snx4
sorting nexin 4
increases expression
ISO
Thimerosal results in increased expression of SNX4 mRNA
CTD
PMID:27188386
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Snx9
sorting nexin 9
decreases expression
ISO
Thimerosal results in decreased expression of SNX9 mRNA
CTD
PMID:27188386
NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036
G
Sod1
superoxide dismutase 1
multiple interactions increases response to substance
ISO
[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]]
CTD
PMID:30503815
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Son
SON DNA and RNA binding protein
decreases expression
ISO
Thimerosal results in decreased expression of SON mRNA
CTD
PMID:27188386
NCBI chr11:30,850,890...30,923,167
Ensembl chr11:30,892,005...30,923,167
G
Sorbs2
sorbin and SH3 domain containing 2
increases expression
ISO
Thimerosal results in increased expression of SORBS2 mRNA
CTD
PMID:27188386
NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514
G
Sorbs3
sorbin and SH3 domain containing 3
decreases expression
ISO
Thimerosal results in decreased expression of SORBS3 mRNA
CTD
PMID:27188386
NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758
G
Sorl1
sortilin related receptor 1
decreases expression
ISO
Thimerosal results in decreased expression of SORL1 mRNA
CTD
PMID:27188386
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Sox18
SRY-box transcription factor 18
decreases expression
ISO
Thimerosal results in decreased expression of SOX18 mRNA
CTD
PMID:24675092
NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290
G
Sox7
SRY-box transcription factor 7
decreases expression
ISO
Thimerosal results in decreased expression of SOX7 mRNA
CTD
PMID:27188386
NCBI chr15:38,180,503...38,187,264
Ensembl chr15:38,180,503...38,187,264
G
Sox8
SRY-box transcription factor 8
decreases expression
ISO
Thimerosal results in decreased expression of SOX8 mRNA
CTD
PMID:27188386
NCBI chr10:14,584,829...14,589,818
Ensembl chr10:14,584,829...14,589,818
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
Thimerosal results in increased expression of SOX9 mRNA
CTD
PMID:24675092
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp4
Sp4 transcription factor
decreases expression
ISO
Thimerosal results in decreased expression of SP4 mRNA
CTD
PMID:27188386
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Sp5
Sp5 transcription factor
decreases expression
ISO
Thimerosal results in decreased expression of SP5 mRNA
CTD
PMID:27188386
NCBI chr 3:55,274,931...55,277,733
Ensembl chr 3:55,274,931...55,277,733
G
Sp8
Sp8 transcription factor
increases expression
ISO
Thimerosal results in increased expression of SP8 mRNA
CTD
PMID:24675092
NCBI chr 6:139,816,258...139,818,865
Ensembl chr 6:139,814,819...139,823,168 Ensembl chr 6:139,814,819...139,823,168
G
Spag4
sperm associated antigen 4
decreases expression
ISO
Thimerosal results in decreased expression of SPAG4 mRNA
CTD
PMID:27188386
NCBI chr 3:144,581,006...144,587,879
Ensembl chr 3:144,581,095...144,585,435
G
Spag9
sperm associated antigen 9
increases expression
ISO
Thimerosal results in increased expression of SPAG9 mRNA
CTD
PMID:27188386
NCBI chr10:78,943,439...79,077,797
Ensembl chr10:78,943,479...79,077,797
G
Spata18
spermatogenesis associated 18
increases expression
ISO
Thimerosal results in increased expression of SPATA18 mRNA
CTD
PMID:27188386
NCBI chr14:34,531,931...34,558,671
Ensembl chr14:34,531,061...34,558,687
G
Spata2
spermatogenesis associated 2
decreases expression
ISO
Thimerosal results in decreased expression of SPATA2 mRNA
CTD
PMID:27188386
NCBI chr 3:156,202,962...156,213,283
Ensembl chr 3:156,202,967...156,211,705
G
Spatc1l
spermatogenesis and centriole associated 1-like
decreases expression
ISO
Thimerosal results in decreased expression of SPATC1L mRNA
CTD
PMID:27188386
NCBI chr20:12,074,040...12,083,873
Ensembl chr20:12,074,047...12,083,301
G
Specc1
sperm antigen with calponin homology and coiled-coil domains 1
increases expression
ISO
Thimerosal results in increased expression of SPECC1 mRNA
CTD
PMID:27188386
NCBI chr10:46,638,947...46,912,989
Ensembl chr10:46,638,809...46,912,802
G
Spen
spen family transcriptional repressor
decreases expression
ISO
Thimerosal results in decreased expression of SPEN mRNA
CTD
PMID:27188386
NCBI chr 5:153,775,287...153,848,677
Ensembl chr 5:153,776,234...153,848,811
G
Spmip4
sperm microtubule inner protein 4
decreases expression
ISO
Thimerosal results in decreased expression of SPMIP4 mRNA
CTD
PMID:27188386
NCBI chr 4:79,663,375...79,688,291
Ensembl chr 4:79,663,376...79,689,072
G
Sppl2b
signal peptide peptidase-like 2B
decreases expression
ISO
Thimerosal results in decreased expression of SPPL2B mRNA
CTD
PMID:27188386
NCBI chr 7:8,843,918...8,856,642
Ensembl chr 7:8,843,918...8,856,608
G
Sptbn1
spectrin, beta, non-erythrocytic 1
decreases expression
ISO
Thimerosal results in decreased expression of SPTBN1 mRNA
CTD
PMID:27188386
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
G
Sqle
squalene epoxidase
decreases expression
ISO
Thimerosal results in decreased expression of SQLE mRNA
CTD
PMID:27188386
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srd5a3
steroid 5 alpha-reductase 3
decreases expression
ISO
Thimerosal results in decreased expression of SRD5A3 mRNA
CTD
PMID:27188386
NCBI chr14:32,046,408...32,060,796
Ensembl chr14:32,046,408...32,060,747
G
Srl
sarcalumenin
decreases expression
ISO
Thimerosal results in decreased expression of SRL mRNA
CTD
PMID:24675092
NCBI chr10:11,033,976...11,078,103
Ensembl chr10:11,034,035...11,078,101
G
Srpra
SRP receptor subunit alpha
decreases expression
ISO
Thimerosal results in decreased expression of SRPRA mRNA
CTD
PMID:27188386
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srrm1
serine and arginine repetitive matrix 1
decreases expression
ISO
Thimerosal results in decreased expression of SRRM1 mRNA
CTD
PMID:27188386
NCBI chr 5:147,559,515...147,591,895
Ensembl chr 5:147,559,514...147,591,849
G
Srrm2
serine/arginine repetitive matrix 2
decreases expression
ISO
Thimerosal results in decreased expression of SRRM2 mRNA
CTD
PMID:27188386
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
G
Srsf4
serine and arginine rich splicing factor 4
increases expression
ISO
Thimerosal results in increased expression of SRSF4 mRNA
CTD
PMID:27188386
NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229
G
Ssrp1
structure specific recognition protein 1
decreases expression
ISO
Thimerosal results in decreased expression of SSRP1 mRNA
CTD
PMID:27188386
NCBI chr 3:70,124,371...70,134,481
Ensembl chr 3:70,118,655...70,134,482
G
Stag1
STAG1 cohesin complex component
increases expression
ISO
Thimerosal results in increased expression of STAG1 mRNA
CTD
PMID:27188386
NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677
G
Stag2
STAG2 cohesin complex component
increases expression
ISO
Thimerosal results in increased expression of STAG2 mRNA
CTD
PMID:27188386
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases phosphorylation
ISO
[Thimerosal co-treated with Temozolomide] results in decreased phosphorylation of STAT3 protein Thimerosal results in decreased phosphorylation of STAT3 protein
CTD
PMID:38325586
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stc1
stanniocalcin 1
decreases expression
ISO
Thimerosal results in decreased expression of STC1 mRNA
CTD
PMID:27188386
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
decreases expression
ISO
Thimerosal results in decreased expression of STC2 mRNA
CTD
PMID:27188386
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stim2
stromal interaction molecule 2
increases expression
ISO
Thimerosal results in increased expression of STIM2 mRNA
CTD
PMID:27188386
NCBI chr14:56,878,428...57,004,405
Ensembl chr14:56,878,645...57,004,179
G
Stk35
serine/threonine kinase 35
increases expression
ISO
Thimerosal results in increased expression of STK35 mRNA
CTD
PMID:27188386
NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066
G
Ston2
stonin 2
decreases expression
ISO
Thimerosal results in decreased expression of STON2 mRNA
CTD
PMID:27188386
NCBI chr 6:110,567,485...110,676,376
Ensembl chr 6:110,567,485...110,676,376
G
Stpg1
sperm-tail PG-rich repeat containing 1
decreases expression
ISO
Thimerosal results in decreased expression of STPG1 mRNA
CTD
PMID:27188386
NCBI chr 5:147,717,084...147,769,792
Ensembl chr 5:147,726,646...147,769,788
G
Stx2
syntaxin 2
decreases expression
ISO
Thimerosal results in decreased expression of STX2 mRNA
CTD
PMID:27188386
NCBI chr12:27,678,744...27,714,751
Ensembl chr12:27,689,819...27,714,751
G
Stx4
syntaxin 4
increases expression
ISO
Thimerosal results in increased expression of STX4 mRNA
CTD
PMID:27188386
NCBI chr 1:182,451,108...182,459,701
Ensembl chr 1:182,451,117...182,459,979
G
Styx
serine/threonine/tyrosine interacting protein
decreases expression
ISO
Thimerosal results in decreased expression of STYX mRNA
CTD
PMID:27188386
NCBI chr15:18,565,214...18,595,797
Ensembl chr15:18,564,633...18,593,524
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
ISO
Thimerosal results in increased expression of SUN2 mRNA
CTD
PMID:24675092
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Supt16h
SPT16 homolog, facilitates chromatin remodeling subunit
decreases expression
ISO
Thimerosal results in decreased expression of SUPT16H mRNA
CTD
PMID:27188386
NCBI chr15:24,867,697...24,904,818
Ensembl chr15:24,866,489...24,904,846
G
Sycp2
synaptonemal complex protein 2
increases expression
ISO
Thimerosal results in increased expression of SYCP2 mRNA
CTD
PMID:27188386
NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:165,436,331...165,498,789
G
Sycp3
synaptonemal complex protein 3
increases expression
ISO
Thimerosal results in increased expression of SYCP3 mRNA
CTD
PMID:24675092
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Thimerosal results in decreased expression of SYNCRIP mRNA
CTD
PMID:27188386
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
Thimerosal results in decreased expression of SYNE2 mRNA
CTD
PMID:27188386
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Syngr3
synaptogyrin 3
decreases expression
ISO
Thimerosal results in decreased expression of SYNGR3 mRNA
CTD
PMID:27188386
NCBI chr10:13,710,553...13,715,309
Ensembl chr10:13,704,998...13,715,669
G
Synj2bp
synaptojanin 2 binding protein
decreases expression
ISO
Thimerosal results in decreased expression of SYNJ2BP mRNA
CTD
PMID:27188386
NCBI chr 6:101,189,714...101,227,400
Ensembl chr 6:101,189,714...101,227,406
G
Syt6
synaptotagmin 6
decreases expression
ISO
Thimerosal results in decreased expression of SYT6 mRNA
CTD
PMID:27188386
NCBI chr 2:191,093,009...191,152,283
Ensembl chr 2:191,093,007...191,149,956
G
Sytl4
synaptotagmin-like 4
decreases expression
ISO
Thimerosal results in decreased expression of SYTL4 mRNA
CTD
PMID:27188386
NCBI chr X:97,135,496...97,185,867
Ensembl chr X:97,135,500...97,185,854
G
Taf9
TATA-box binding protein associated factor 9
increases expression
ISO
Thimerosal results in increased expression of TAF9 mRNA
CTD
PMID:27188386
NCBI chr 2:31,794,316...31,798,324
Ensembl chr 2:31,794,142...31,798,769
G
Taf9b
TATA-box binding protein associated factor 9b
affects expression
ISO
Thimerosal affects the expression of TAF9B mRNA
CTD
PMID:27188386
NCBI chr X:71,289,290...71,300,142
Ensembl chr X:71,289,290...71,300,604
G
Tanc2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
decreases expression
ISO
Thimerosal results in decreased expression of TANC2 mRNA
CTD
PMID:27188386
NCBI chr10:90,553,124...90,873,477
Ensembl chr10:90,553,002...90,868,756
G
Taok1
TAO kinase 1
decreases expression
ISO
Thimerosal results in decreased expression of TAOK1 mRNA
CTD
PMID:27188386
NCBI chr10:62,373,072...62,465,295
Ensembl chr10:62,381,404...62,465,766
G
Tap2
transporter 2, ATP binding cassette subfamily B member
decreases expression
ISO
Thimerosal results in decreased expression of TAP2 mRNA
CTD
PMID:27188386
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tasor2
transcription activation suppressor family member 2
increases expression
ISO
Thimerosal results in increased expression of TASOR2 mRNA
CTD
PMID:27188386
NCBI chr17:66,583,554...66,650,127
Ensembl chr17:66,594,908...66,649,135
G
Tax1bp1
Tax1 binding protein 1
increases expression
ISO
Thimerosal results in increased expression of TAX1BP1 mRNA
CTD
PMID:27188386
NCBI chr 4:81,821,991...81,877,906
Ensembl chr 4:81,821,989...81,879,100
G
Tbc1d16
TBC1 domain family, member 16
decreases expression
ISO
Thimerosal results in decreased expression of TBC1D16 mRNA
CTD
PMID:27188386
NCBI chr10:104,400,963...104,486,698
Ensembl chr10:104,402,398...104,486,670
G
Tbc1d8b
TBC1 domain family member 8B
decreases expression
ISO
Thimerosal results in decreased expression of TBC1D8B mRNA
CTD
PMID:27188386
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbl1x
transducin (beta)-like 1 X-linked
decreases expression
ISO
Thimerosal results in decreased expression of TBL1X mRNA
CTD
PMID:27188386
NCBI chr X:41,574,558...41,731,117
Ensembl chr X:41,576,047...41,731,101
G
Tbl1xr1
TBL1X/Y related 1
increases expression
ISO
Thimerosal results in increased expression of TBL1XR1 mRNA
CTD
PMID:27188386
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tbrg4
transforming growth factor beta regulator 4
decreases expression
ISO
Thimerosal results in decreased expression of TBRG4 mRNA
CTD
PMID:24675092
NCBI chr14:81,481,977...81,490,781
Ensembl chr14:81,481,981...81,490,756
G
Tcf7l1
transcription factor 7 like 1
decreases expression
ISO
Thimerosal results in decreased expression of TCF7L1 mRNA
CTD
PMID:27188386
NCBI chr 4:104,680,734...104,846,086
Ensembl chr 4:104,680,739...104,845,287
G
Tdrd6
tudor domain containing 6
increases expression
ISO
Thimerosal results in increased expression of TDRD6 mRNA
CTD
PMID:27188386
NCBI chr 9:17,344,033...17,359,348
Ensembl chr 9:17,344,026...17,359,344
G
Tdrd7
tudor domain containing 7
decreases expression
ISO
Thimerosal results in decreased expression of TDRD7 mRNA
CTD
PMID:27188386
NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544
G
Tdrkh
tudor and KH domain containing
decreases expression
ISO
Thimerosal results in decreased expression of TDRKH mRNA
CTD
PMID:27188386
NCBI chr 2:182,049,175...182,071,516
Ensembl chr 2:182,049,215...182,070,755
G
Tead1
TEA domain transcription factor 1
decreases expression
ISO
Thimerosal results in decreased expression of TEAD1 mRNA
CTD
PMID:27188386
NCBI chr 1:166,791,900...167,010,591
Ensembl chr 1:166,792,628...167,003,369
G
Tecr
trans-2,3-enoyl-CoA reductase
decreases expression
ISO
Thimerosal results in decreased expression of TECR mRNA
CTD
PMID:27188386
NCBI chr19:24,526,700...24,568,168
Ensembl chr19:24,541,615...24,568,168
G
Tet1
tet methylcytosine dioxygenase 1
decreases expression
ISO
Thimerosal results in decreased expression of TET1 mRNA
CTD
PMID:27188386
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
G
Tet2
tet methylcytosine dioxygenase 2
decreases expression
ISO
Thimerosal results in decreased expression of TET2 mRNA
CTD
PMID:27188386
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
G
Tet3
tet methylcytosine dioxygenase 3
decreases expression
ISO
Thimerosal results in decreased expression of TET3 mRNA
CTD
PMID:24675092
NCBI chr 4:115,867,412...115,964,433
Ensembl chr 4:115,871,265...115,964,193
G
Tex10
testis expressed 10
decreases expression
ISO
Thimerosal results in decreased expression of TEX10 mRNA
CTD
PMID:27188386
NCBI chr 5:62,762,230...62,808,373
Ensembl chr 5:62,762,230...62,808,373
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Thimerosal results in increased expression of TGFB1
CTD
PMID:24942245
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Them4
thioesterase superfamily member 4
increases expression
ISO
Thimerosal results in increased expression of THEM4 mRNA
CTD
PMID:27188386
NCBI chr 2:181,953,550...181,974,708
Ensembl chr 2:181,953,550...181,974,708
G
Themis2
thymocyte selection associated family member 2
decreases expression
ISO
Thimerosal results in decreased expression of THEMIS2 mRNA
CTD
PMID:27188386
NCBI chr 5:144,991,110...145,006,362
Ensembl chr 5:144,991,112...145,006,400
G
Thpo
thrombopoietin
decreases expression
ISO
Thimerosal results in decreased expression of THPO mRNA
CTD
PMID:24675092
Ensembl chr11:80,182,820...80,188,167
G
Thrap3
thyroid hormone receptor associated protein 3
decreases expression
ISO
Thimerosal results in decreased expression of THRAP3 mRNA
CTD
PMID:27188386
NCBI chr 5:138,445,284...138,487,544
Ensembl chr 5:138,445,295...138,487,477
G
Thy1
Thy-1 cell surface antigen
decreases expression
ISO
Thimerosal results in decreased expression of THY1 mRNA
CTD
PMID:27188386
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
G
Tkt
transketolase
decreases expression
ISO
Thimerosal results in decreased expression of TKT mRNA
CTD
PMID:27188386
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tle4
TLE family member 4, transcriptional corepressor
decreases expression
ISO
Thimerosal results in decreased expression of TLE4 mRNA
CTD
PMID:27188386
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tmc5
transmembrane channel-like 5
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA
CTD
PMID:27188386
NCBI chr 1:172,914,915...172,999,478
Ensembl chr 1:172,914,457...172,999,474
G
Tmc6
transmembrane channel like 6
decreases expression
ISO
Thimerosal results in decreased expression of TMC6 mRNA
CTD
PMID:27188386
NCBI chr10:102,982,059...102,999,509
Ensembl chr10:102,971,229...102,998,960
G
Tmeff2
transmembrane protein with EGF-like and two follistatin-like domains 2
increases expression
ISO
Thimerosal results in increased expression of TMEFF2 mRNA
CTD
PMID:27188386
NCBI chr 9:50,445,947...50,733,473
Ensembl chr 9:50,436,079...50,733,475
G
Tmem240
transmembrane protein 240
decreases expression
ISO
Thimerosal results in decreased expression of TMEM240 mRNA
CTD
PMID:24675092
NCBI chr 5:166,344,000...166,350,210
Ensembl chr 5:166,344,386...166,350,636
G
Tmem33
transmembrane protein 33
decreases expression
ISO
Thimerosal results in decreased expression of TMEM33 mRNA
CTD
PMID:27188386
NCBI chr14:40,888,485...40,910,715
Ensembl chr14:40,885,712...40,910,715
G
Tmem74b
transmembrane protein 74B
decreases expression
ISO
Thimerosal results in decreased expression of TMEM74B mRNA
CTD
PMID:27188386
NCBI chr 3:140,219,592...140,224,208
Ensembl chr 3:140,219,412...140,235,872
G
Tmem97
transmembrane protein 97
decreases expression
ISO
Thimerosal results in decreased expression of TMEM97 mRNA
CTD
PMID:27188386
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tmod2
tropomodulin 2
increases expression
ISO
Thimerosal results in increased expression of TMOD2 mRNA
CTD
PMID:16870260
NCBI chr 8:76,316,736...76,366,003
Ensembl chr 8:76,325,667...76,365,720
G
Tmtc3
transmembrane O-mannosyltransferase targeting cadherins 3
decreases expression
ISO
Thimerosal results in decreased expression of TMTC3 mRNA
CTD
PMID:27188386
NCBI chr 7:35,264,886...35,310,010
Ensembl chr 7:35,264,892...35,310,385
G
Tnf
tumor necrosis factor
increases secretion multiple interactions
ISO
Thimerosal results in increased secretion of TNF protein Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:17079650 PMID:18495191 PMID:20417223
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf13b
TNF superfamily member 13b
increases expression
ISO
Thimerosal results in increased expression of TNFSF13B mRNA
CTD
PMID:27188386
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
G
Tnip1
TNFAIP3 interacting protein 1
decreases expression
ISO
Thimerosal results in decreased expression of TNIP1 mRNA
CTD
PMID:27188386
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
G
Tnni3
troponin I3, cardiac type
decreases expression
ISO
Thimerosal results in decreased expression of TNNI3 mRNA
CTD
PMID:27188386
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Tob2
transducer of ERBB2, 2
decreases expression
ISO
Thimerosal results in decreased expression of TOB2 mRNA
CTD
PMID:27188386
NCBI chr 7:113,362,703...113,371,423
Ensembl chr 7:113,361,148...113,372,688
G
Top2a
DNA topoisomerase II alpha
decreases activity
ISO
Thimerosal results in decreased activity of TOP2A protein
CTD
PMID:18197631
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tox2
TOX high mobility group box family member 2
decreases expression
ISO
Thimerosal results in decreased expression of TOX2 mRNA
CTD
PMID:27188386
NCBI chr 3:151,853,294...151,980,086
Ensembl chr 3:151,853,294...151,980,749
G
Tp53
tumor protein p53
affects activity
ISO
Thimerosal affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
decreases expression
ISO
Thimerosal results in decreased expression of TP53BP1 mRNA
CTD
PMID:27188386
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Tpcn1
two pore segment channel 1
decreases expression
ISO
Thimerosal results in decreased expression of TPCN1 mRNA
CTD
PMID:24675092
NCBI chr12:35,972,813...36,029,632
Ensembl chr12:35,972,846...36,029,626
G
Tpd52
tumor protein D52
decreases expression
ISO
Thimerosal results in decreased expression of TPD52 mRNA
CTD
PMID:27188386
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
G
Tpi1
triosephosphate isomerase 1
decreases expression
ISO
Thimerosal results in decreased expression of TPI1 mRNA
CTD
PMID:27188386
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Tpm4
tropomyosin 4
decreases expression
ISO
Thimerosal results in decreased expression of TPM4 mRNA
CTD
PMID:27188386
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tpp1
tripeptidyl peptidase 1
decreases expression
ISO
Thimerosal results in decreased expression of TPP1 mRNA
CTD
PMID:27188386
NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129
G
Tpp2
tripeptidyl peptidase 2
decreases expression
ISO
Thimerosal results in decreased expression of TPP2 mRNA
CTD
PMID:27188386
NCBI chr 9:46,046,712...46,128,157
Ensembl chr 9:46,046,632...46,128,157
G
Tpr
translocated promoter region, nuclear basket protein
decreases expression
ISO
Thimerosal results in decreased expression of TPR mRNA
CTD
PMID:27188386
NCBI chr13:62,424,312...62,487,502
Ensembl chr13:62,424,312...62,487,496
G
Tprkb
Tp53rk binding protein
increases expression
ISO
Thimerosal results in increased expression of TPRKB mRNA
CTD
PMID:27188386
NCBI chr 4:118,342,910...118,357,908
Ensembl chr 4:118,342,945...118,357,901
G
Traf5
TNF receptor-associated factor 5
decreases expression
ISO
Thimerosal results in decreased expression of TRAF5 mRNA
CTD
PMID:27188386
NCBI chr13:103,569,944...103,618,747
Ensembl chr13:103,572,314...103,618,709
G
Tram1
translocation associated membrane protein 1
increases expression
ISO
Thimerosal results in increased expression of TRAM1 mRNA
CTD
PMID:27188386
NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971
G
Trappc13
trafficking protein particle complex subunit 13
increases expression
ISO
Thimerosal results in increased expression of TRAPPC13 mRNA
CTD
PMID:27188386
NCBI chr 2:35,270,495...35,302,049
Ensembl chr 2:35,269,183...35,302,048
G
Trdmt1
tRNA aspartic acid methyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of TRDMT1 mRNA
CTD
PMID:27188386
NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439
G
Trerf1
transcriptional regulating factor 1
decreases expression
ISO
Thimerosal results in decreased expression of TRERF1 mRNA
CTD
PMID:27188386
NCBI chr 9:13,631,619...13,858,326
Ensembl chr 9:13,634,126...13,857,029
G
Trib3
tribbles pseudokinase 3
decreases expression
ISO
Thimerosal results in decreased expression of TRIB3 mRNA
CTD
PMID:27188386
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim13
tripartite motif-containing 13
increases expression
ISO
Thimerosal results in increased expression of TRIM13 mRNA
CTD
PMID:27188386
NCBI chr15:35,733,548...35,772,676
Ensembl chr15:35,734,107...35,772,677
G
Trim14
tripartite motif-containing 14
decreases expression
ISO
Thimerosal results in decreased expression of TRIM14 mRNA
CTD
PMID:27188386
NCBI chr 5:60,800,568...60,824,858
Ensembl chr 5:60,800,032...60,824,858
G
Trim23
tripartite motif-containing 23
increases expression
ISO
Thimerosal results in increased expression of TRIM23 mRNA
CTD
PMID:27188386
NCBI chr 2:35,302,405...35,335,746
Ensembl chr 2:35,302,409...35,335,743
G
Trim28
tripartite motif-containing 28
decreases expression
ISO
Thimerosal results in decreased expression of TRIM28 mRNA
CTD
PMID:27188386
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
G
Trim59
tripartite motif-containing 59
decreases expression
ISO
Thimerosal results in decreased expression of TRIM59 mRNA
CTD
PMID:27188386
NCBI chr 2:153,269,210...153,281,185
Ensembl chr 2:153,268,584...153,281,031
G
Trim9
tripartite motif-containing 9
decreases expression
ISO
Thimerosal results in decreased expression of TRIM9 mRNA
CTD
PMID:27188386
NCBI chr 6:88,756,824...88,856,588
Ensembl chr 6:88,757,303...88,856,542
G
Trmt10a
tRNA methyltransferase 10A
increases expression
ISO
Thimerosal results in increased expression of TRMT10A mRNA
CTD
PMID:27188386
NCBI chr 2:226,669,445...226,684,166
Ensembl chr 2:226,669,832...226,684,151
G
Trpm3
transient receptor potential cation channel, subfamily M, member 3
increases expression
ISO
Thimerosal results in increased expression of TRPM3 mRNA
CTD
PMID:27188386
NCBI chr 1:219,673,200...220,557,610
Ensembl chr 1:219,672,892...220,560,717
G
Tshb
thyroid stimulating hormone subunit beta
increases expression
ISO
Thimerosal results in increased expression of TSHB mRNA; Thimerosal results in increased expression of TSHB protein
CTD
PMID:24675092
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Tspan33
tetraspanin 33
decreases expression
ISO
Thimerosal results in decreased expression of TSPAN33 mRNA
CTD
PMID:27188386
NCBI chr 4:58,305,378...58,330,013
Ensembl chr 4:58,305,437...58,328,940
G
Ttc39c
tetratricopeptide repeat domain 39C
multiple interactions
ISO
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA
CTD
PMID:27188386
NCBI chr18:3,768,802...3,887,932
Ensembl chr18:3,805,183...3,887,930
G
Ttyh2
tweety family member 2
decreases expression
ISO
Thimerosal results in decreased expression of TTYH2 mRNA
CTD
PMID:27188386
NCBI chr10:99,709,063...99,753,449
Ensembl chr10:99,709,007...99,753,444
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
ISO
Thimerosal results in decreased expression of TUBB2A mRNA
CTD
PMID:27188386
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
ISO
Thimerosal results in decreased expression of TUBB4B mRNA
CTD
PMID:27188386
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubgcp3
tubulin gamma complex component 3
increases expression
ISO
Thimerosal results in increased expression of TUBGCP3 mRNA
CTD
PMID:27188386
NCBI chr16:76,851,859...76,912,499
Ensembl chr16:76,851,810...76,912,499
G
Txn1
thioredoxin 1
multiple interactions decreases activity
ISO
[Thimerosal co-treated with Temozolomide] results in decreased activity of TXN protein Thimerosal results in decreased activity of TXN protein
CTD
PMID:38325586
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txndc9
thioredoxin domain containing 9
increases expression
ISO
Thimerosal results in increased expression of TXNDC9 mRNA
CTD
PMID:27188386
NCBI chr 9:40,211,818...40,221,953
Ensembl chr 9:40,211,412...40,384,279 Ensembl chr 9:40,211,412...40,384,279
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
Thimerosal results in decreased expression of TXNIP mRNA
CTD
PMID:27188386
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
multiple interactions decreases activity
ISO
[Thimerosal co-treated with Temozolomide] results in decreased activity of TXNRD1 protein Thimerosal results in decreased activity of TXNRD1 protein
CTD
PMID:38325586
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ube2l3
ubiquitin-conjugating enzyme E2L 3
decreases expression
ISO
Thimerosal results in decreased expression of UBE2L3 mRNA
CTD
PMID:27188386
NCBI chr11:83,797,722...83,838,862
Ensembl chr11:83,797,722...83,838,862
G
Ubn1
ubinuclein 1
decreases expression
ISO
Thimerosal results in decreased expression of UBN1 mRNA
CTD
PMID:27188386
NCBI chr10:10,496,576...10,532,010
Ensembl chr10:10,496,576...10,532,010
G
Ubn2
ubinuclein 2
decreases expression
ISO
Thimerosal results in decreased expression of UBN2 mRNA
CTD
PMID:27188386
NCBI chr 4:67,165,278...67,251,562
Ensembl chr 4:67,166,346...67,230,491
G
Ubr1
ubiquitin protein ligase E3 component n-recognin 1
increases expression
ISO
Thimerosal results in increased expression of UBR1 mRNA
CTD
PMID:27188386
NCBI chr 3:107,813,721...107,921,701
Ensembl chr 3:107,811,392...107,922,204
G
Ucp2
uncoupling protein 2
decreases expression
ISO
Thimerosal results in decreased expression of UCP2 mRNA
CTD
PMID:27188386
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ugcg
UDP-glucose ceramide glucosyltransferase
decreases expression
ISO
Thimerosal results in decreased expression of UGCG mRNA
CTD
PMID:27188386
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Uggt1
UDP-glucose glycoprotein glucosyltransferase 1
decreases expression
ISO
Thimerosal results in decreased expression of UGGT1 mRNA
CTD
PMID:27188386
NCBI chr 9:38,355,229...38,468,473
Ensembl chr 9:38,359,089...38,468,467
G
Ugt8
UDP glycosyltransferase 8
decreases expression
ISO
Thimerosal results in decreased expression of UGT8 mRNA
CTD
PMID:27188386
NCBI chr 2:214,264,483...214,332,769
Ensembl chr 2:214,264,483...214,332,660
G
Uhmk1
U2AF homology motif kinase 1
decreases expression
ISO
Thimerosal results in decreased expression of UHMK1 mRNA
CTD
PMID:27188386
NCBI chr13:82,396,646...82,416,292
Ensembl chr13:82,401,187...82,416,292
G
Upf1
UPF1, RNA helicase and ATPase
decreases expression
ISO
Thimerosal results in decreased expression of UPF1 mRNA
CTD
PMID:27188386
NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568
G
Upp1
uridine phosphorylase 1
increases expression
ISO
Thimerosal results in increased expression of UPP1 mRNA
CTD
PMID:16870260
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Usp1
ubiquitin specific peptidase 1
decreases expression
ISO
Thimerosal results in decreased expression of USP1 mRNA
CTD
PMID:27188386
NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932
G
Usp10
ubiquitin specific peptidase 10
decreases expression
ISO
Thimerosal results in decreased expression of USP10 mRNA
CTD
PMID:27188386
NCBI chr19:47,972,858...48,014,900
Ensembl chr19:47,972,611...48,014,897
G
Usp16
ubiquitin specific peptidase 16
increases expression
ISO
Thimerosal results in increased expression of USP16 mRNA
CTD
PMID:27188386
NCBI chr11:26,681,359...26,711,313
Ensembl chr11:26,681,414...26,710,539
G
Usp25
ubiquitin specific peptidase 25
affects expression
ISO
Thimerosal affects the expression of USP25 mRNA
CTD
PMID:27188386
NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348
G
Usp29
ubiquitin specific peptidase 29
decreases expression
ISO
Thimerosal results in decreased expression of USP29 mRNA
CTD
PMID:24675092
NCBI chr 1:66,874,216...67,097,731
Ensembl chr 1:66,874,017...67,097,686
G
Usp34
ubiquitin specific peptidase 34
affects expression
ISO
Thimerosal affects the expression of USP34 mRNA
CTD
PMID:27188386
NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376
G
Usp49
ubiquitin specific peptidase 49
decreases expression
ISO
Thimerosal results in decreased expression of USP49 mRNA
CTD
PMID:27188386
NCBI chr 9:13,305,640...13,366,132
Ensembl chr 9:13,308,178...13,366,132
G
Usp51
ubiquitin specific peptidase 51
decreases expression
ISO
Thimerosal results in decreased expression of USP51 mRNA
CTD
PMID:27188386
NCBI chr X:18,374,940...18,381,472
Ensembl chr X:18,376,930...18,379,888
G
Vangl1
VANGL planar cell polarity protein 1
decreases expression
ISO
Thimerosal results in decreased expression of VANGL1 mRNA
CTD
PMID:27188386
NCBI chr 2:189,586,681...189,637,609
Ensembl chr 2:189,589,229...189,637,619
G
Vapb
VAMP associated protein B and C
decreases expression
ISO
Thimerosal results in decreased expression of VAPB mRNA
CTD
PMID:27188386
NCBI chr 3:162,535,974...162,578,747
Ensembl chr 3:162,535,905...162,573,763
G
Vasp
vasodilator-stimulated phosphoprotein
decreases expression
ISO
Thimerosal results in decreased expression of VASP mRNA
CTD
PMID:27188386
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vat1
vesicle amine transport 1
decreases expression
ISO
Thimerosal results in decreased expression of VAT1 mRNA
CTD
PMID:27188386
NCBI chr10:86,389,549...86,397,167
Ensembl chr10:86,389,545...86,397,224
G
Vcp
valosin-containing protein
decreases expression
ISO
Thimerosal results in decreased expression of VCP mRNA
CTD
PMID:27188386
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
G
Vegfa
vascular endothelial growth factor A
decreases expression multiple interactions
ISO
Thimerosal results in decreased expression of VEGFA mRNA [Thimerosal co-treated with Temozolomide] results in decreased expression of VEGFA protein
CTD
PMID:27188386 PMID:38325586
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
decreases expression
ISO
Thimerosal results in decreased expression of VEGFB mRNA
CTD
PMID:27188386
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
G
Vps37b
VPS37B subunit of ESCRT-I
decreases expression
ISO
Thimerosal results in decreased expression of VPS37B mRNA
CTD
PMID:27188386
NCBI chr12:32,560,047...32,589,015
Ensembl chr12:32,560,047...32,589,014
G
Vps53
VPS53 subunit of GARP complex
decreases expression
ISO
Thimerosal results in decreased expression of VPS53 mRNA
CTD
PMID:27188386
NCBI chr10:60,919,820...61,038,674
Ensembl chr10:60,919,820...61,038,676
G
Vsig10l
V-set and immunoglobulin domain containing 10 like
decreases expression
ISO
Thimerosal results in decreased expression of VSIG10L mRNA
CTD
PMID:27188386
NCBI chr 1:93,871,487...93,880,157
Ensembl chr 1:93,851,774...93,879,566
G
Wapl
WAPL cohesin release factor
decreases expression
ISO
Thimerosal results in decreased expression of WAPL mRNA
CTD
PMID:27188386
NCBI chr16:10,005,520...10,075,270
Ensembl chr16:10,004,941...10,073,510
G
Wasf2
WASP family member 2
decreases expression
ISO
Thimerosal results in decreased expression of WASF2 mRNA
CTD
PMID:27188386
NCBI chr 5:145,336,817...145,402,041
Ensembl chr 5:145,336,842...145,399,242
G
Wasl
WASP like actin nucleation promoting factor
decreases expression
ISO
Thimerosal results in decreased expression of WASL mRNA
CTD
PMID:27188386
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
G
Wdfy3
WD repeat and FYVE domain containing 3
increases expression
ISO
Thimerosal results in increased expression of WDFY3 mRNA
CTD
PMID:27188386
NCBI chr14:7,578,245...7,810,491
Ensembl chr14:7,606,628...7,810,482
G
Wdr49
WD repeat domain 49
increases expression
ISO
Thimerosal results in increased expression of WDR49 mRNA
CTD
PMID:27188386
NCBI chr 2:160,049,478...160,264,581
Ensembl chr 2:160,051,458...160,264,511
G
Wdr54
WD repeat domain 54
decreases expression
ISO
Thimerosal results in decreased expression of WDR54 mRNA
CTD
PMID:27188386
NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:115,654,968...115,661,562
G
Wdr59
WD repeat domain 59
decreases expression
ISO
Thimerosal results in decreased expression of WDR59 mRNA
CTD
PMID:27188386
NCBI chr19:39,416,432...39,483,773
Ensembl chr19:39,416,429...39,483,698
G
Wdr86
WD repeat domain 86
decreases expression
ISO
Thimerosal results in decreased expression of WDR86 mRNA
CTD
PMID:24675092
NCBI chr 4:10,423,496...10,443,473
Ensembl chr 4:10,424,008...10,441,465
G
Wipf3
WAS/WASL interacting protein family, member 3
decreases expression
ISO
Thimerosal results in decreased expression of WIPF3 mRNA
CTD
PMID:27188386
NCBI chr 4:83,550,075...83,629,929
Ensembl chr 4:83,550,468...83,629,386
G
Wnk1
WNK lysine deficient protein kinase 1
decreases expression
ISO
Thimerosal results in decreased expression of WNK1 mRNA
CTD
PMID:27188386
NCBI chr 4:153,128,334...153,253,905
Ensembl chr 4:153,128,334...153,253,905
G
Wnt3
Wnt family member 3
decreases expression
ISO
Thimerosal results in decreased expression of WNT3 mRNA
CTD
PMID:27188386
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Xiap
X-linked inhibitor of apoptosis
affects expression decreases expression multiple interactions
ISO
Thimerosal affects the expression of XIAP protein Thimerosal results in decreased expression of XIAP protein Glutathione inhibits the reaction [Thimerosal results in decreased expression of XIAP protein]
CTD
PMID:12140745 PMID:16649253
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Zc3h12c
zinc finger CCCH type containing 12C
increases expression
ISO
Thimerosal results in increased expression of ZC3H12C mRNA
CTD
PMID:24675092
NCBI chr 8:52,443,791...52,508,643
Ensembl chr 8:52,448,320...52,504,315
G
Zfp382
zinc finger protein 382
decreases expression
ISO
Thimerosal results in decreased expression of ZFP382 mRNA
CTD
PMID:24675092
NCBI chr 1:85,377,614...85,400,832
Ensembl chr 1:85,377,484...85,399,667
G
Zfp655
zinc finger protein 655
increases expression
ISO
Thimerosal results in increased expression of ZFP655 mRNA
CTD
PMID:24675092
NCBI chr12:9,349,985...9,375,449
Ensembl chr12:9,357,639...9,374,569
G
Zfp958
zinc finger protein 958
decreases expression
ISO
Thimerosal results in decreased expression of ZFP958 mRNA
CTD
PMID:24675092
NCBI chr12:3,953,442...3,975,328
Ensembl chr12:3,953,455...3,975,514 Ensembl chr12:3,953,455...3,975,514
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19898
chemical entity
19896
molecular entity
19896
ion
17094
anion
16653
organic anion
6854
carboxylic acid anion
2499
monocarboxylic acid anion
1606
benzoates
1281
2',4',5',7'-tetrabromo-2,3,4,5-tetrachlorofluorescein(2-) +
0
2',4',5',7'-tetrabromofluorescein(2-) +
1
2,7-dibromo-4-hydroxymercurifluorescein(2-) +
2
2-(beta-D-glucopyranosyloxy)benzoate
0
2-formylbenzoate
0
2-halobenzoate +
0
3,6-dichloro-2-methoxybenzoate +
0
3,6-dichlorosalicylate
0
3-O-methylgallate
0
3-diazo-4-hydroxybenzoate
0
4-(beta-D-glucosyloxy)benzoate
0
4-(hydroxyamino)benzoate
0
4-bromobenzoate +
0
4-carboxybenzyl alcohol
0
4-formylbenzoate
0
4-hydroxy-3-polyprenylbenzoate +
0
4-iodobenzoate +
0
4-isothiocyanatobenzoate
0
4-nitrobenzoate
0
N-alkylphthalic monoamide(1-)
0
N-benzoylanthranilate
0
acetylsalicylate
0
amidobenzoate +
0
aminobenzoate +
0
benzoate +
27
carboxylato-PTIO +
0
chlorobenzoate +
0
cumate +
0
cyclic dehypoxanthinylfutalosinate(1-)
0
dimethylbenzoate +
0
erythrosin(2-) +
21
ethoxybenzoate +
0
ethylmercurithiosalicylate +
1151
fluorobenzoate +
0
hydroxybenzoate +
6
iodobenzoate +
0
lasalocid sodium
0
lasalocid(1-) +
0
mercuribenzoate +
0
methoxybenzoate +
0
methyl red(1-)
0
mono(2-ethylhexyl) phthalate(1-)
0
nitrobenzoate +
0
sulfamoylbenzoate +
0
sulfobenzoate +
0
sulfonatobenzoate +
0
thiosalicylate(1-)
0
toluate +
0
trimethylbenzoate +
0
Path 2
CHEBI ontology
19898
subatomic particle
19896
composite particle
19896
hadron
19896
baryon
19896
nucleon
19896
atomic nucleus
19896
atom
19896
main group element atom
19835
p-block element atom
19835
carbon group element atom
19774
carbon atom
19771
organic molecular entity
19771
organic ion
11451
organic anion
6854
carboxylic acid anion
2499
monocarboxylic acid anion
1606
benzoates
1281
2',4',5',7'-tetrabromo-2,3,4,5-tetrachlorofluorescein(2-) +
0
2',4',5',7'-tetrabromofluorescein(2-) +
1
2,7-dibromo-4-hydroxymercurifluorescein(2-) +
2
2-(beta-D-glucopyranosyloxy)benzoate
0
2-formylbenzoate
0
2-halobenzoate +
0
3,6-dichloro-2-methoxybenzoate +
0
3,6-dichlorosalicylate
0
3-O-methylgallate
0
3-diazo-4-hydroxybenzoate
0
4-(beta-D-glucosyloxy)benzoate
0
4-(hydroxyamino)benzoate
0
4-bromobenzoate +
0
4-carboxybenzyl alcohol
0
4-formylbenzoate
0
4-hydroxy-3-polyprenylbenzoate +
0
4-iodobenzoate +
0
4-isothiocyanatobenzoate
0
4-nitrobenzoate
0
N-alkylphthalic monoamide(1-)
0
N-benzoylanthranilate
0
acetylsalicylate
0
amidobenzoate +
0
aminobenzoate +
0
benzoate +
27
carboxylato-PTIO +
0
chlorobenzoate +
0
cumate +
0
cyclic dehypoxanthinylfutalosinate(1-)
0
dimethylbenzoate +
0
erythrosin(2-) +
21
ethoxybenzoate +
0
ethylmercurithiosalicylate +
1151
fluorobenzoate +
0
hydroxybenzoate +
6
iodobenzoate +
0
lasalocid sodium
0
lasalocid(1-) +
0
mercuribenzoate +
0
methoxybenzoate +
0
methyl red(1-)
0
mono(2-ethylhexyl) phthalate(1-)
0
nitrobenzoate +
0
sulfamoylbenzoate +
0
sulfobenzoate +
0
sulfonatobenzoate +
0
thiosalicylate(1-)
0
toluate +
0
trimethylbenzoate +
0